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ABSTRACT OF THE DISSERTATION 
 
Radiochemistry in microdroplets: technologies and 
applications 
 
by 
 
Jia Wang 
Doctor of Philosophy in Bioengineering 
University of California, Los Angeles, 2019 
Professor Robert Michael van Dam, Chair 
 
Despite the increasing importance of positron emission tomography (PET) imaging in research 
and clinical management of disease, access to myriad new radioactive tracers is severely limited 
due to their short half-lives (which requires daily production) and the high cost and complexity of 
tracer production. Digital microfluidic radiosynthesizer technology can reduce the cost of 
equipment and facilities for tracer production, and could increase access to diverse tracers by 
reducing the cost of each batch (by reducing reagent consumption, reduced synthesis time, higher 
yield, etc.) and by enabling decentralized production closer to the point of use. 
Previously, our group has demonstrated that electrowetting on-dielectric (EWOD) microfluidic 
platform can be used to efficiently synthesize several tracers with minimal reagent usage and with 
high “specific activity”. However, widespread adoption of this new approach has not yet occurred 
in the field of radiochemistry, due in part to the operating complexity, suboptimal robustness 
(Teflon delamination, electrical breakdown of dielectric layer) and high cost of prototype chips.  
To address the robustness issue, one project I worked on was to optimize several aspects of 
the fabrication of EWOD chips (Teflon adhesion to dielectric layer, deposition of dielectric layer) 
 iii 
to improve their reliability and then demonstrated the successful production of several tracers with 
the improved chips. 
 However, even after optimization, the fabrication cost remained too high for use as a 
disposable components. To lower the cost, I developed a new, simpler microfluidic chip leveraging 
an alternative passive method of droplet manipulation method for tracer production. Cost was 
reduced through elimination of fabrication steps and reliability was increased due to elimination 
of electrodes and dielectric layers. After successful synthesis of several tracers, the chip was 
integrated with a fully-automated standalone [18F]fluoride concentrator to produce higher 
(clinically-relevant) amounts of clinical-grade tracer (i.e., that passes all quality control (QC) tests).  
Then, I developed an even further simplified microfluidic chip for microdroplet radiosynthesis 
and an ultra-compact system for operating the chips. A further advantage of this platform was that 
the reaction site was identical to that of the “model chips” we use for initial optimization when 
implementing syntheses in microdroplet format; this avoided the need for re-optimization when 
transitioning from optimization experiments to automated syntheses.  
To further reduce the time needed for reaction optimization, I also worked on developing some 
new methods and technologies (high-throughput radio-TLC analysis, high-throughput multi-
reaction microfluidic chip) to enable radiochemistry to be performed in a high-throughput fashion. 
These techniques relieve operators from tedious and repetitive work and facilitate extensive 
synthesis optimization for new tracers in a short time-frame. 
Finally, I applied these new technologies (high-throughput optimization platform and the 
compact microdroplet reactor) for optimization and then automation of the synthesis of 
[18F]FDOPA. 
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1. Chapter 1: Introduction 
1.1. Positron-emission tomography 
Due to the ability to monitor specific in vivo biochemical processes with positron emission 
tomography (PET), this imaging technology is widely used as a research tool in fundamental 
studies of disease and the development of new drugs and therapies. It is also an indispensable 
clinical tool for diagnosis and staging of disease, monitoring a patient’s response to therapy, and 
streamlining clinical trials through patient stratification [1–4]. 
Though the majority of scans are performed with the glucose analog 2-[18F]fluoro-2-deoxy-D-
glucose ([18F]FDG) to detect abnormal glucose metabolism (e.g., in oncology and neurology), 
there is increasing interest in monitoring other biochemical process using other PET tracers that 
can provide more disease-specific information in many cases. In fact, many other tracers are 
being used in preclinical research and some in clinical trials [5,6]. However, the cost of these 
tracers compared to [18F]FDG is very high, and prohibitive for many investigators, because there 
is insufficient demand and coordination of schedules for centralized production and distribution of 
these compounds, which are the keys to the low cost of [18F]FDG [7]. To increase accessibility to 
diverse PET tracers, and to facilitate the production of novel tracers for early studies, advances 
are needed in radiosynthesis technology that make it possible to produce smaller batches on 
demand at an affordable cost. 
1.2. Microfluidic radiosynthesis of PET tracers 
In recent years, there has been significant development of microfluidic devices to perform 
radiochemical synthesis of short-lived PET tracers [8,9]. The quantity of PET tracer needed for 
imaging is typically in the nmol to pmol range, and thus useful quantities can be produced even 
in the tiny volume scale of microscale devices. Among the various approaches that have been 
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explored, batch-mode systems have perhaps the most potential for cost reductions [10,11]. By 
performing reactions at the microliter scale (as opposed to the milliliter scale of conventional 
radiosynthesizer technologies and microfluidic flow-chemistry approaches), amounts of 
expensive reagents, such as precursor, peptides and proteins, can be reduced by 2-3 orders of 
magnitude. In addition, miniaturization of the overall synthesizer can significantly reduce the cost 
of equipment and specialized radiation-shielded facilities (e.g. hotcells or minicells). Furthermore, 
the small volume scale reduces contamination, and 18F-labeled tracers can be produced in much 
higher molar activity (related to the ratio of the quantity of radioactive molecules to the total 
quantity of radioactive and non-radioactive molecules [12]) due to the reduction of fluorine-19 
contamination from reagents and other sources [13]. Importantly, this high molar activity can be 
achieved, even when producing only small batches of a PET tracer; in contrast, conventional 
systems require the production of large amounts of tracer to achieve satisfactory molar activity. 
High molar radioactivity is especially important in early tracer development and preclinical 
research due to the small amounts needed, and to enable injection of sufficient activity (to achieve 
high signal-to-noise ratio image) without inducing pharmacologic effects. (Small animals are 
generally injected with much higher concentrations of the tracer per mass of the animal compared 
to humans to achieve sufficient signal in the small voxel size of small animal scanners [14,15].) 
Another advantage of microvolume radiosynthesis is that the purification of crude product can be 
simply carried out using analytical-scale (as opposed to semi-preparative scale) radio-high-
performance liquid chromatography (radio-HPLC), because of greatly reduced quantities of 
reagents and small volume (10s of microliter) of crude product. Analytical-scale chromatography 
generally enables much quicker purification (shorter retention times), and the pure product is 
collected in a much smaller volume, simplifying the downstream process of formulating the tracer 
into an injectable solution.   
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1.3. Development of batch-mode microfluidic radiosynthesizers 
The first batch-based microfluidic system used for multistep radiochemistry was reported by 
Lee et al. in 2005 (Figure 1-1)[16], who demonstrated the successful production of a small 
quantity (10s of μCi) of [18F]FDG in a chip with 40 nL reactor volume. The integrated microfluidic 
chip was made from poly(dimethylsiloxane) (PDMS) using well-established “soft lithography” 
fabrication procedures [17,18]. The chip contained numerous pneumatically-actuated micro-
mechanical valves to isolate distinct regions on the chip, to accelerate the diffusion-dominated 
mixing by peristaltically pumping liquid around the ring-shaped reaction loop, and to create in situ 
an ion-exchange resin bed to concentrate the radionuclide. The gas-permeable nature of the 
PDMS material enabled (evaporative) solvent exchange steps to be performed. Even though the 
concentration of radionuclide was integrated on the chip, due to the small volume of the chip and 
the slow flow rates, the capability for this chip to produce larger quantities of tracers was very 
limited. 
 
 
Figure 1-1. Optical micrograph of the batch-based microfluidic system.  
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The various channels have been loaded with food dyes to help visualize the different components 
of the microfluidic chip. Green channels contain the reagents and reaction mixture. Red channels 
are microvalves. Yellow channels are triplets of microvalves used as peristaltic pumps. Inset: 
View of the whole device positioned beside a penny (diameter 18.9 mm) for scale comparison. 
The figure was adapted from reference [16]. 
 
A scaled-up version of this chip with a 5 μL cylindrical (“coin-shaped”) reaction chamber was 
later reported by Elizarov et al. to overcome the issue of small volume, enabling synthesis of 
[18F]FDG up to the mCi range [19] (Figure 1-2). This new version of chip also added an extra 
layer of channels compared to previous two-layer design (i.e., with a flow layer and a valve control 
layer): the new layer contained a dense array of channels just below the reaction chamber to 
which vacuum was applied. Due to the very thin layer of PDMS between the reaction chamber 
and these channels, gas transport across the membrane was accelerated, enabling quick removal 
of trapped gas when initially filling the chamber with reagents, and enabling rapid removal of 
solvent vapor during solvent evaporation steps. The vent channels could also be pressurized 
during reactions to significantly reduce unwanted evaporation. An additional change was that the 
radionuclide concentration was carried out on an off-chip column to enable a fast flow rate (2 
mL/min) for trapping more significant amounts of radionuclide before introduction into the chip. 
However, those layers were still made of PDMS elastomer, which is not chemically resistant to 
most organic solvents frequently used in radiosyntheses, thus limiting the variety of radiochemical 
reactions that can be performed in those chips. Also, a large amount of radioactivity remained 
unrecoverable from the chip due to suspected reaction between PDMS and [18F]fluoride under 
certain conditions[20]. Furthermore, the complicated fabrication processes of those chips 
(fabrication of the various layers individually which then had to be aligned and bonded) led to low 
device reliability. Zhang et al. recently developed a PDMS chip with a reaction chamber that can 
hold up to 500 μL, with manually-controlled vent port and manually-actuated valves (Figure 1-3) 
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[21]. The chip also contained an integrated resin bed for radionuclide concentration and another 
resin bed for purification of the crude product via solid-phase extraction. The synthesis of 
[18F]fallypride was demonstrated as a proof-of-concept, but the synthesis suffered significant 
radioactivity loss, likely due to the reaction between PDMS and [18F]fluoride described above.  
 
 
Figure 1-2. The coin-shaped reactor for scaled-up radiosynthesis.  
(A) Photograph of chip with off-chip ion exchange column controlled by on-chip valves. (B) 
Zoomed in photograph of the chip. The channels are filled with dyes for visualization: the fluid 
channel network is shown in green, control valves in red, and the vent channel in yellow. The 
figure was adapted from reference [19]. 
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Figure 1-3. The PDMS microfluidic chip developed by Zhang et al.  
(A) Photograph of the microfluidic chip with a US quarter for size comparison. (B) Schematic 
illustration of the microfluidic chip employed for [18F]fallypride production, including a [18F]fluoride 
concentration column, fluorination reaction cavity and [18F]fallypride purification column. (C) 
Photograph of anion exchange beads trapped inside a microchannel by PDMS pillars with 10 μm 
gap. (D) Photograph of reverse phase C18 microparticles trapped inside a microchannel by 
PDMS pillars with 40 μm gap. The figure was adapted from reference [21]. 
 
To overcome the chemical compatibility issue of PDMS, van Dam et al. developed a new 
generation of the 5 μL “coin-shaped” reactor made of polydicyclopentadiene (pDCPD), a rigid, 
transparent polymer [22]. The microfluidic chip (Figure 1-4) consisted of three layers - a flexible 
gasket layer (PDMS coated with an optimized perfluoropolyether) between a fluidic layer (pDCPD) 
and a vent layer (pDCPD). Compared to the previous version with a thin layer of PDMS between 
the reaction chamber and vent channels, the new composite material for the gasket layer provided 
both good vapor permeability and high chemical resistance. In this chip, the layers were not 
bonded together, requiring a different approach to implement on-chip diaphragm microvalves. 
Metal rods were linearly actuated to either allow membrane deflection (open valve) or prevent 
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membrane deflection (closed valve). With this reactor, a human dose (~16 mCi) of [18F]FDG was 
produced. Nonetheless, transport of vapor across the gasket layer was still a limiting factor in the 
operation speed.  
 
Figure 1-4: The new coin-shaped reactor fabricated from inert materials.   
Cross-section of microfluidic chip illustrating the main features in each layer and the architecture 
of the on-chip diaphragm valves. The figure was adapted from reference [22]. 
 
To address this limitation, Bejot et al. developed a modified microfluidic architecture and 
demonstrated the synthesis of N-succinimidyl-4-[18F]fluorobenzoate [23]. This microfluidic chip 
includes a 50 µL reaction vessel made of PEEK, a chemically inert lid made of pDCPD, seven 
on-chip plungers acting as valves for controlling the delivery of reagents into the reactor, the 
collection of crude product, and the release of vapor (by opening a vent) (Figure 1-5 and Figure 
1-6). The plunger positions were driven by two-way pneumatic actuators to switch between open 
and closed states. The ability to open a vent port rather than perform solvent evaporation through 
a membrane significantly sped up the synthesis process even though the volumes were 10x 
larger. The same setup was also used for producing [18F]FMISO with a good yield [24], and 
Lebedev et al. reported the production of [18F]fallypride for human use [25]. This work broadened 
the application of batch-based microfluidic device from preclinical to clinical use. Nevertheless, 
there was still some space left for the further improvement of this device, which ultimately used a 
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large external system of solenoids to actuate the plungers, required complex operation and 
required an extensive cleaning cycle (~45 min) after each synthesis.  
 
 
Figure 1-5. View of the chemically-inert 50 µL microfluidic batch reactor.  
The pDCPD lid, PEEK chip and PEEK interface base are visible. The figure was adapted from 
reference [23]. 
 
 
Figure 1-6. Schematic of 50 µL microfluidic batch reactor.  
Left: Cross-section schematic of the 50 µL reactor cavity, lid and interface base, showing some 
of the fluidic connections and the temperature control mechanism. Right: 3D rendering of the 
same parts. The figure was adapted from reference [25]. 
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More recently, our lab developed a droplet-based electrowetting-on-dielectric (EWOD) system, 
based on the principle of digital microfluidics or droplet microfluidics, for performing multistep 
radiochemistry [26–29]. The motivations of this work were to develop a more compact overall 
platform and to develop a means for the microfluidic component to be disposable and reduce or 
avoid the need for cleaning steps.  The EWOD chip (Figure 1-7) has a bottom plate that has a 
two-dimensional pattern of individually-addressable electrodes and can manipulate droplet 
movement by applying local electric fields via the ‘electrowetting’ phenomenon (reduction in 
contact angle between droplet and surface while electrical potential is applied), and a cover plate 
serves as the ground electrode. Both plates are coated with a conductor layer, a dielectric layer 
and a hydrophobic layer (Teflon), which facilitates the droplet movement and provides excellent 
chemical compatibility with various solvents needed for reactions. In the EWOD microfluidic chips, 
sequential electrode activations are used to transport reagent droplets (surrounded by air), as 
they are needed, from fixed reagent loading sites to a central, temperature-controlled zone where 
evaporation and reaction processes are carried out to perform multi-step radiosyntheses (Figure 
1-8). Multiple tracers have been successfully synthesized with the EWOD system and used for 
preclinical imaging, including [18F]fallypride, [18F]FDG, 3’-fluoro-3’-[18F]fluorodthymidine 
([18F]FLT), and [18F]SFB. Even starting with much less precursor material, the resulting 
radiochemical yields (RCYs) (i.e., 65 ± 6 % (n=7) for [18F]fallypride [28], 71.2 ± ? % (n=5) for 
[18F]FDG [30], 71.3 ± ? % (n=5) for [18F]FLT [31], and 19 ± 8 % (n=5) for [18F]SFB [27]) were 
comparable to the performance of conventional macroscale synthesis (i.e., 68 ± 2 % (n=42) for 
[18F]fallypride [32], 83 ± 17 % (n=40) for [18F]FDG [33], 60 ± 5 % (n=10) for [18F]FLT [34], 69 ± 8 
% (n=6) for [18F]SFB [35]).  
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Figure 1-7. Structure and operation of EWOD microfluidic chips.  
(A) Electronic control of the droplet interaction with the surface due to electrowetting effect. (B) In 
a typical EWOD device, the droplet is sandwiched between two plates with the electrode 
configuration as shown. The blue layer is an insulating dielectric layer and the green layer is a 
hydrophobic coating. (C) By applying a voltage to one end of a droplet with an actuation electrode, 
a force is generated, pulling the droplet toward the activated electrode, allowing linear transport, 
splitting, and other manipulations of droplets. The figure was adapted from reference [11]. 
 
 
Figure 1-8. Schematic of the EWOD radiosynthesis chip. 
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The schematic shows electrode pattern of the central reaction size (with concentric resistive 
heaters) and reagent pathways. A photograph of the actual device is shown at the top right of the 
figure. 
 
1.4. Structure of this dissertation 
Despite successful implementation, routine use of EWOD for radiochemical synthesis was 
limited by the complex fabrication of chemically-compatible chips (i.e. based on glass substrates). 
The fabrication of the two-layer chip required (a) coating the indium tin oxide (ITO) glass wafer 
with a conductive gold layer for the bottom chip, (b) patterning the electrodes (ITO), heaters (ITO), 
connection lines (gold) and contact pads (gold) on the conductive layer for the bottom plate; (c) 
depositing silicon nitride as the dielectric layer for one or both plates; (d) coating both plates with 
fluoropolymer to form the hydrophobic layer. The large number of processing steps makes the 
chips too expensive for disposable use, and the relatively large surface area (e.g., ~25 mm 
square) makes it challenging to produce the pinhole-free dielectric layers that are essential to 
avoid dielectric breakdown and electrolysis of droplets on the chip. Moreover, it has been 
observed during on-chip radiosynthesis of various tracers, that the Teflon layer can delaminate 
from the dielectric layer during hydrolysis or coupling step, resulting in adverse effects on the 
synthesis, e.g. trapping some of reaction mixture under the Teflon layer, which cannot be 
collected from the chip and reduces the collection efficiency and/or RCY. 
In the Chapter 2, I described efforts to optimize the fabrication of EWOD chips to decrease 
cost and improve their reliability. One aim of fabrication optimization was to increase the adhesion 
of the Teflon layer to the dielectric layer (silicon nitride) by treating the surface with an adhesion 
promotor. Also, optimization of the dielectric layer performed to lower the failure rate of the 
dielectric layer, so as to eliminate the electrolysis problem. With the improved chips, we 
demonstrated the successful production of several tracers, including [18F]fallypride and [18F]FDG. 
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Even after optimization, the fabrication cost remained high (> $200 per chip) and thus not 
suitable as a disposable consumable in a field where disposables on conventional synthesizers 
sell for $100 - $300. To further lower the production cost of PET tracers, in Chapter 3, I leveraged 
an alternative passive method of droplet manipulation method, that does not require electrodes, 
to implement a radiosynthesis on the chip [36]. This approach eliminated the need for the 
electrode layer and dielectric layer (and associated fabrication steps), thus greatly simplifying the 
chip fabrication process and reducing its cost. By utilizing the passive transport mechanism, I 
developed microfluidic chips and an automated droplet-based radiosynthesizer for multi-step 
chemical reactions based on the idea that reagents and solvents are sequentially loaded on the 
loading sites of pathways and transported to a central reaction zone spontaneously where 
reaction (heating) and evaporation steps were performed. In addition to the device design, I 
developed a new approach to fabricate surfaces with patterned wettability on silicon substrates. 
After optimization and characterization were performed, multi-step chemical reactions (including 
evaporative drying, fluorination and deprotection steps) were performed to synthesize two PET 
tracers:  [18F]fallypride and [18F]FDG. As a demonstration of the ability to produce useful amounts 
of these tracers, a batch of [18F]fallypride was prepared, purified, formulated, and used for 
preclinical imaging. 
With the passive transport-based radiosynthesizer I developed, reactions are performed at the 
scale of microliter volumes (and reagent masses in the 10s of microgram level). Even though the 
small reaction volume provides many advantages, such as reducing reagent cost, increasing 
molar activity, enabling high molar activity even from relatively small batches, reduction of system 
size and enabling safe operation with only small amounts of lead shielding, the amount of tracer 
can be produced on this platform was initially limited by the small reaction volume. Because the 
chip volume was much smaller than the volume in which the radionuclide is typically supplied, the 
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early radiochemistry performed in these droplet platforms was limited to 10s to 100s of MBq [0.27 
mCi to 2.7mCi] due to the small chip volume, even with the use of strategies such as sequentially 
loading and drying several droplets of [18F]fluoride to increase the starting activity. Thus, in 
Chapter 4, we integrated the chip with a fully-automated standalone [18F]fluoride concentrator, 
developed by my colleague, that can increase the radionuclide concentration by reducing the 
initial volume (1-5 mL) down to an output volume of 12.4 µL[37]. We described design and 
development of the integrated system, characterized the radionuclide concentration process, 
optimized the radionuclide transfer into the microreactor, and demonstrated the successful 
droplet-based synthesis of [18F]Fallypride using concentrated [18F]fluoride. The synthesis was 
demonstrated with starting activities up to 41 GBq [1.1 Ci] of activity and we explored the synthesis 
performance as a function of activity level. Finally, we demonstrated the successful production of 
clinical-grade tracer that passes all quality control (QC) tests. 
Due to differences between macroscale and microscale apparatus and synthesis conditions, 
performing synthesis on the passive transport-based microfluidic chip need to invest a significant 
amount of time to optimize conditions (e.g. volumes, timing of loading and heating steps), to 
achieve high-yield and to control the behavior of the droplets (i.e. to maintain the reagent within 
the reaction site without spreading to the reagent transport pathways). When the droplet is not 
well contained in the reaction site, the radioactivity recovery is lower because in later steps, the 
reagents do not get mixed with the full amount of the previous intermediate product, or the some 
of the final crude product cannot be collected from the chip during the last step of operation. Thus, 
I developed an innovative microdroplet reactor for automating tracer production in a more 
compact fashion in the Chapter 5. In this section, I designed a simplified chip with a single circular 
hydrophilic liquid trap to contain the reaction mixture. The circular reaction site was tolerant of a 
wide range of solvent types, reagent volumes, and temperatures, without overflow to undesired 
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chip locations. In addition, I developed a compact apparatus providing rotation of the chip (to 
enable loading of different reagents, or collection of the final product), feedback temperature 
control and a system to collect the final product from the chip for downstream purification and 
formulation. I demonstrated the successful automated synthesis of [18F]fallypride in high yield with 
this new platform. By addressing the droplet spreading issue, we noticed a significantly higher 
yield compared to the passive transport platform.  
Even in the microdroplet reactors described in Chapters 2-5, where several experiments can 
be performed in a day, adapting a macroscale synthesis protocol for a new radiotracer to 
microscale can still take weeks to months. Therefore, I also worked on developing some 
technologies to enable radiochemistry to be performed in a high-throughput fashion to relieve 
operators from tedious and repetitive work and to facilitate extensive optimization studies (of 
reaction conditions) for new tracers in a short time-frame in Chapter 6 and 7. 
To begin with, I developed an innovative high-throughput radio thin layer chromatography 
(radio-TLC) analysis method (Chapter 6) with my colleague by performing spotting of multiple 
radioactive samples on a single TLC plate followed by simultaneous developing of all samples in 
the mobile phase and simultaneous readout of the separated samples using Cerenkov 
luminescence imaging (CLI). Radio-TLC is commonly used to analyze purity of 
radiopharmaceuticals or to determine the reaction conversion when optimizing radiosynthesis 
processes. In applications where there are few radioactive species, radio-TLC is preferred over 
radio-high-performance liquid chromatography (radio-HPLC) due to its simplicity and relatively 
quick analysis time. However, with current radio-TLC methods, it remains cumbersome to analyze 
a large number of samples during reaction optimization or labelling libraries of compounds. With 
the method we developed, in addition to significant savings of time and effort to analyze a large 
number of samples resulting from parallelization, further time savings were achieved by 
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shortening the separation distances (by leveraging the high resolution of the CLI readout). We 
found the imaging-based readout also was advantageous for detection of minor impurity species 
or artifacts in the spotting or development processes that were not evident using a traditional 
radio-TLC scanner. 
To perform high-throughput radiochemical reactions for rapid radiochemistry optimization, I 
designed and fabricated the novel multi-reaction microfluidic chips in Chapter 7. The chip (25 mm 
x 27.5 mm) has multiple hydrophilic reaction sites (2 x 2 array or 4 x 4 array) surrounded by 
hydrophobic surface. And a thorough optimization study of [18F]fallypride was carried out on the 
multi-reaction microfluidic chips. With the high-throughput microfluidic chip, the cost of the 
optimization process can be significantly lower than for conventional setups since the amount of 
precursor consumed per reaction is extremely small (e.g. ~84 µg per data point compared to 4 
mg per data point in conventional reactions), and many reactions can be carried out using the 
same batch of radioisotope. Combined with the high-throughput radio-TLC analysis, the overall 
time needed for protocol optimization was further shortened. 
Chapter 8 describes an application of the high-throughput microfluidic chip described in 
Chapter 7 and the microdroplet reactor described in Chapter 5. In particular, I performed a high-
throughput optimization of the microscale synthesis of the PET tracer 3,4-dihydroxy-6-[18F]fluoro-
L-phenylalanine ([18F]FDOPA), and subsequently full automation of the optimized droplet-
synthesis process. Increasing interest in the [18F]FDOPA to image neuroendocrine tumors, brain 
tumors, and Parkinson’s disease,  has led to the demand for a simplified synthetic procedure for 
its production. Current macroscale synthesis methods either need a large amount of expensive 
precursors or have complicated and tedious synthesis procedures. By using the microdroplet 
reactor, I have demonstrated the feasibility of synthesis of [18F]FDOPA in microliter-sized droplets. 
The synthesis time was significantly shorter than the macroscale method (~37 min vs ~117 min) 
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[38], and used considerably less precursor (0.12 µmol versus 13.4 µmol). The isolated yield was 
comparable to the macroscale method (~10% vs ~14%). Impressively, by performing synthesis 
in the microdroplet, the tedious and complicated solid-phase extraction and drying steps (to 
perform intermediate purification between fluorination and deprotection) could be eliminated 
without any difficulty in the purification of the crude product. 
I conclude this dissertation with Chapter 9, where the future directions of these microfluidic-
based new technologies is discussed. In particular, I discuss (i) additional applications of the 
microdroplet reactor and challenges, (ii) further improvements needed to increase widespread 
use of the high-throughput technologies, and (iii) dissemination of these technologies to the 
community.  
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2. Chapter 2: Optimization of EWOD chip fabrication 
2.1. Introduction 
    The electrowetting-on-dielectric (EWOD) system, a promising digital microfluidic device, 
uses electric potentials to manipulate liquids without mechanical valves, pumps, or channels[39]. 
Recently, our group demonstrated synthesis of radiotracers using an EWOD microfluidic chip 
designed for multi-step radiochemistry in a batch format [27]. The programmable nature of 
EWOD-driven digital microfluidics has key advantages for radiochemistry as diverse multi-step 
tracer synthesis processes can be carried out using a “universal” chip design (shown in Figure 
2-1). The small reaction volume (1s – 10s of µL) also offers significant advantages in this field 
[10]. 
 
Figure 2-1. EWOD chip designed and fabricated for radiotracer synthesis.  
(A) Schematic of the chip, showing the actuation glass plate patterned with regular EWOD 
electrodes (blue), multifunctional electrodes to perform heating (orange and red), and electric 
contact pads along the two edges, as well as the electrical ground glass plate assembled on top. 
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(B) A picture of the fabricated chip, showing the EWOD and multifunctional electrodes (slightly 
darker) and gold connection lines and contact pads. The figure was adapted from reference [27]. 
 
EWOD microchips (shown in Figure 2-2) are typically composed of two plates, with a top 
electrical ground plate and a bottom plate with patterned actuation electrodes. Both the EWOD 
cover plate and base plate are diced from a glass wafer coated with indium tin oxide (ITO), a 
transparent electrode. Next, gold (with chromium adhesion layer) is deposited, and then the 
conductive layers are patterned to form droplet actuation electrodes, heater electrodes, 
connection lines and contact pads. Silicon nitride (SiNx) is deposited as dielectric layer for one or 
both plates. Finally a fluoropolymer (Cytop or Teflon AF 2400)  was utilized to form a hydrophobic 
layer as the last step of fabrication.  
 
Figure 2-2. A typical EWOD device. 
The droplet is sandwiched between two plates with the electrode configuration shown.  Applying 
a local field to one side of the droplet using a small control electrode (typically 1 or 2 mm square) 
can generate a force on the droplet in a direction toward the activated electrode. The figure was 
adapted from reference [26]. 
 
Unfortunately, it has been observed during on-chip radiosynthesis of various molecules, that 
the Teflon layer can delaminate from the dielectric layer during the hydrolysis step, resulting in 
adverse effects on the synthesis, e.g. trapping some of the reaction mixture under the Teflon 
layer, which cannot collected from the chip, reducing the collection efficiency and the RCY. 
Furthermore, the dielectric layer frequently has imperfections that can lead to electrical 
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breakdown, leading to increased current through the droplet when actuation voltage (~102 V) is 
applied. The current can cause mild to severe electrolysis (bubbling), heating and boiling of the 
liquid, and eventually electrical arcing that can damage the chip. Even mild electrolysis leads to 
local destruction of the hydrophobicity and can cause pinning, making it difficult to move droplets 
away from the affected site. 
In this chapter, I describe efforts to optimize the EWOD chip fabrication to provide a more 
reliable reaction platform and also demonstrate the ability of the optimized EWOD chip to 
synthesize multiple tracers, including [18F]fallypride and [18F]FDG. 
2.2. Methods 
2.2.1. Optimization of Teflon adhesion 
The mechanism by which Teflon adheres to dielectric layer is by van der Waals and other 
interactions rather than strong covalent bonding, which might be weak to withstand harsh 
conditions.  To address the delamination issue, the strategy we employed was to attempt to 
increase the adhesion of the Teflon layer to the dielectric layer via surface treatment with an 
adhesion promoter. 
A silane-based aheshion promoter, tridecafluoro-1,1,2,2-tetrahydrooctyltetrahydrooctyl) 
trichlorosilane (FTS, Gelest, Morrisville, PA, USA)was deposited on the substrate prior to Teflon 
coating [40]. The adhesion promoter provides long fluorocarbon chains to increase Teflon 
adhesion by physical polymer entanglement, as shown in Figure 2-3.  
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Figure 2-3. Mechanism of adhesion promotor. 
(Top) Chemical structure of Teflon and adhesion promoter. (Bottom) Process of deposition of 
adhesion promoter and Teflon layers. 
 
We explored the optimal deposition method for the saline, including dipping, spin-coating, and 
vapor deposition methods. Contact angles of the surface coated with different methods were 
measured with a contact-angle goniometer (VCA-3000S, AST, Billerica, MA, USA) by loading a 
DI water droplet (~5 µL) on the surface.  
Initial experiments were performed on glass slides (rather than SiNx coated substrates). Glass 
slides (25 mm x 25 mm) were first cleaned by sonication in acetone and then methanol (MeOH), 
and then Piranha (mixture of sulfuric acid and hydrogen peroxide, 3:1, v:v) cleaning was added 
to chip fabrication process to ensure clean initial surface [41] prior to deposition of the silane-
based adhesion promoter [42]. 
After optimization on glass, to translate the optimal saline deposition method to the EWOD 
chip fabrication, SiNx coated glass slides were used as the model chips. The slides coated with 
SiNx was etched for 20s with 12% HF, followed by oxidation for 15 min in 3:1 v/v H2SO4:H2O2 
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(Pirahna) to produce a surface with a high density of hydroxyl groups. FTS was then deposited in 
the exact same manner as for glass substrates. 
After saline deposition, the slides were baked on the hotplate at 115°C for 10 min. Then, the 
Teflon layer was deposited by spin-coating the slides with diluted Teflon®AF 2400 (1% solids), 
followed by baking and annealing (on hotplate at 160°C for 10 min, and 245°C for 10 min, and 
then annealed in the oven at 340°C for 3.5 h). The thickness of the resulting Teflon hydrophobic 
layer was ~100 nm. Chips were stored sealed in a cleanroom at room temperature until use.  
 
2.2.2. Evaluation method for Teflon adhesion 
Several methods were developed to quantitatively or semi-quantitatively evaluate Teflon 
adhesion to compare the effectiveness of different adhesion methods. 
The “tape test” is a widely used adhesion test method, which relies on measuring adhesion by 
applying and removing pressure-sensitive tape over a deposited film (after a grid of cross-cuts 
have been made). This approach is an industry standard test (Active Standard ASTM D3359). 
Among the diverse types of tape available in market, we chose an appropriate tape (Scotch 720 
Film Fiber Tape, 3M, Maplewood, MN, USA) sticky enough to partially pull up the Teflon layer 
(atop of the adhesion promotor), but not too sticky that it pulls up all of the applied layer. Prior to 
testing, the surfaces were cross-hatched (as shown in Figure 2-4) with the razor blade by making 
5 cuts through the Teflon layer (down to the substrate) at ~2 mm spacing in one direction and 
repeating in the perpendicular direction. Then, the center of a piece of tape was placed over the 
grid and smoothed onto the surface with a finger. Within 60 s of application, the tape was removed 
by seizing the free end and rapidly peeling the tape back upon itself at as close to an angle of 
180° as possible. After removal, the number of Teflon portions in the cross-hatched region were 
counted and the fraction remaining out of the initial number of grid squares was determined. Tape 
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tests were performed at different stages, i.e. immediately after fabrication, after heating, or after 
soaking in solvents to compare Teflon deposition methods and to try to ascertain the 
radiochemical process steps most contributing to the delamination problem.  
 
Figure 2-4. The tape test method.  
(A) First a cross-hatch pattern is cut into the Teflon coating. Next the sample is soaked in a heated 
chemical bath and the remaining fraction of the coating is quantified. (Here, 100% of the coating 
remains after soaking.) Finally, a tape test is performed, and the remaining fraction of the coating 
is quantified. (Here, some of the coating has been lost.) (B) Schematic of the procedure to perform 
a cross-hatch tape test. 
 
Nanoscratch tests (Nanovea Corp., Irvine, CA, USA), were also utilized to quantify the Teflon 
adhesion on the substrate. The nanoscratch system uses a stylus to makes scratches on the 
sample at a constant speed with increasing load, until the critical load (Lc) is found. The critical 
load corresponds to film delamination. However, it is difficult to determine adhesion strength 
quantitatively since the critical load depends not only on adhesion strength, but on several intrinsic 
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and extrinsic factors as well. Microscope observation during nanoscratch test provides the 
assistance to distinguish intrinsic (cohesive failure within the material) or extrinsic (adhesive 
failure between the material and the substrate) failures.  
To simulate chemistry-like conditions, adhesion was tested after heating the chip to various 
temperatures, after soaking in various solvents and reagents at room temperature, and after 
soaking at elevated temperatures. For the solvent soak tests, coated chips were soaked for 10 
min at 80°C in tetrapropylammonium hydroxide solution (TPAH), MeCN, or DI water, which were 
commonly used in radiochemistry syntheses on EWOD chips. Before the slides were immersed 
in solvents it was found necessary to cover their edges with Epoxy. If not covered, sometimes the 
entire Teflon layer would be delaminated.  
 
2.2.3. EWOD chip operation 
After optimization, EWOD chips were employed in radiochemical syntheses. During operation, 
the EWOD chip was clamped to a compact instrument (PHENYX, Sofie Biosciences, Culver City, 
CA, USA) to provide temperature control and electrode actuation (Figure 2-5). Active components 
were controlled with the PHENYX software. Reagents were, in most cases, pipetted manually into 
holes in a simplified chip cover to minimize variations in loaded volumes. The goal was eventually 
that the chip would be mounted in a reagent delivery cassette containing reservoirs, pumps, and 
valves to automatically deliver reagents to the chip as needed.  
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Figure 2-5. The EWOD chip clamped to the PHENXY instrument. 
(A) Side view of the EWOD chip clamped to the PHENXY instrument. The chip contacts the 
temperature-controlled heater (a heat transfer block that houses a thermocouple and a cartridge 
heater) on its bottom surface, and is clamped down by a cyclic olefin copolymer (COC) cover 
plate mediated by a gasket. The upper and lower plates of the EWOD chip are held at a fixed 
distance apart by spacers. (B) Photograph of EWOD chip installed on the PHENXY instrument. 
An electrical connector was affixed over the array of contact pads at the edge of the chip (closest 
to the bottom of the image). (C) Universal mapping of inlet and outlet holes in the chip for all PET 
tracers. EWOD actuation electrodes are shown in blue. Electrical contact pads and connection 
lines are omitted for clarity. 
 
2.2.4. Synthesis of [18F]fallypride 
We investigated the 1-step synthesis of [18F]fallypride from tosyl-fallypride precursor. Early 
stage optimization was explored on model chips with ~150µm gap between substrates [11,28]. 
Model chips (both the bottom and top chip) were prepared by applying adhesion promoter and 
Teflon coating to glass microscope slides, i.e. no electrodes or dielectric layer were created or 
patterned. Model chips have significantly lower cost than EWOD chips, which enabled a greater 
range of reaction conditions to be explored. Typically the first steps are performed with droplets 
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sitting atop the bottom substrate and no cover plate in place. The cover plate is then added at a 
later stage of the process. 
The synthesis began by loading a 8 μL solution of [18F]fluoride and TBAHCO3 (3.75 mM) on 
the bottom substrate and then evaporated at 105°C for 1 min, leaving a [18F]TBAF complex, which 
was then further azeotropically dried with 8μL MeCN at 105°C for 1 min to remove residual water. 
The activated complex was subsequently re-solubilized with 4 μL precursor solution (77 mM in 
1:1 v/v MeCN:thexyl alcohol). At this point, the cover chip (with ~150 µm spacer on two sides 
close to the edges) was added, and the gasket and COC were clamped down. The 2-layer model 
chip was then heated at 105 °C for 7 min. After cooling, the 2 halves of the chip were separated, 
20 μL collection solution (1:1 v/v mixture of DI water and MeOH) were loaded on each chip, and 
the diluted crude reaction mixture was extracted from both with a pipette. The collection steps 
were performed four times in total to achieve the maximum collection efficiency.  
Then, the protocol was transitioned to EWOD chips. In these tests, the electrodes were 
automatically activated by the PHENYX platform in an appropriate sequence to transport reagents 
from ports at the sides of the chip to the central reaction region.  The detailed on-chip procedure, 
detailing precisely which EWOD electrodes were activated at each step, is summarized in Figure 
2-6. 
 
 
 
 
26 
 
 
 
Figure 2-6. Schematic and representative micrographs of universal synthesis process for 
18F-labeled tracers on the EWOD chip. 
(A) Loading and drying of [18F]fluoride solution. (B) Loading and evaporation of MeCN for removal 
of residual water via azeotropic drying to leave a dry, activated [18F]fluoride residue. (C) Loading 
of precursor and radiofluorination reaction at elevated temperature. After the fluorination step, 
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some tracers require loading of hydrolysis solution and reaction at elevated temperature to 
remove protecting groups (not shown). (D) Loading of extraction solution to dissolve the crude 
product in a relatively large volume of solvent to facilitate efficient extraction from the chip with 
minimal residual liquid loss. 
 
2.2.5. Synthesis of [18F]FDG 
As with [18F]fallypride, we conducted our initial optimization studies on model chips and then 
progressed to EWOD chips. As a starting point, we mimicked reaction conditions previously 
developed for [18F]FDG synthesis on EWOD chips [26].  
A droplet containing a 4 μL mixture of [18F]fluoride, K2CO3 (14 mM) and Krytofix 222 (52 mM) 
was pipetted on the chip, evaporated at 105°C for 1 min, and then azeotropically dried at 105°C 
for 1 min by adding a 4 μL MeCN solution to form the activated [18F]KF/K2.2.2 complex. A 4 μL 
droplet of precursor solution (104 mM mannose triflate in DMSO), was added on the bottom chip, 
and the cover chip was positioned atop of it with the spacer, and the gasket and COC were 
clamped down. Then, the 2-layer chip was heated at 130°C for 7 min to perform the fluorination 
step. Afterwards, the chips were separated, and an 8 μL droplet of 0.3 N NaOH was added the 
chip to perform deprotection at room temperature for 100 s. Finally, the model chips were 
separated, and the crude reaction product was collected in the same fashion as for [18F]fallypride. 
Then, the protocol was transitioned to EWOD chips. Similar to the operations for [18F]fallypride 
synthesis, the electrodes are automatically activated by the PHENYX platform in an appropriate 
sequence to transport reagents to the central reaction region. 
 
2.2.6. Analytical methods 
Performance of synthesis of [18F]fallypride and  [18F]FDG was assessed via radioactivity 
measurements and radiochemical purity of the crude product. Radioactivity was measured with a 
calibrated dose calibrator (CRC-25R, Capintec, Florham Park, NJ, USA) at various times 
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throughout the synthesis process. Radioactivity recovery was defined as the collected 
radioactivity divided by the initial radioactivity. Radiochemical purity of one-step [18F]fallypride 
synthesis is same as fluorination efficiency, which was determined via radio thin layer 
chromatography (radio-TLC).  
To perform the radio-TLC, a 1 μL droplet was spotted on a silica TLC plate (JT4449-2, J.T. 
Baker, Center Valley, PA, USA) with a micropipette. The TLC plate was developed in an 
appropriate mobile phase and then analyzed with a scanner (MiniGITA star, Raytest, 
Straubenhardt, Germany). 
For [18F]fallypride, the TLC mobile phase was 60% MeCN in 25 mM NH4HCO2 with 1% TEA 
(v/v). In the resulting TLC chromatogram, two peaks are identified: unreacted [18F]fluoride (Rf=0.0) 
and [18F]Fallypride (Rf=0.9). RCP was calculated as the area under the [18F]fallypride peak divided 
by the area under both peaks. The decay-corrected crude radiochemical yield (crude RCY) of 
[18F]fallypride was defined as the radioactivity recovery times the fluorination efficiency.  
For analysis of only the fluorination reaction of [18F]FDG, the radio-TLC mobile phase was a 
mixture of  MeCN and DI water (95:5, v/v). The resulting chromatogram had two separate peaks, 
[18F]fluoride (Rf = 0.0) and intermediate [18F]fluoro-1,3,4,6-tetra-O-acetyl-D-glucose ([18F]FTAG, 
Rf = 0.77). Fluorination efficiency (i.e., conversion of [18F]fluoride to [18F]FTAG) was computed by 
dividing the area under the [18F]FTAG peak by the sum of the areas of both peaks. The fluorination 
yield was utilized to evaluate the performance of fluorination step, and calculated by multiplying 
fluorination efficiency by the radioactivity recovery. 
 For analysis of the [18F]FDG product, two radio-TLCs were performed to enable the efficiency 
of each reaction (fluorination and hydrolysis) to be inferred. One mobile phase was the same, i.e. 
a mixture of MeCN and DI water (95:5, v/v). The resulting chromatogram had one distinct peak 
for [18F]fluoride (Rf = 0.0) and several overlapping peaks (Rf > 0) corresponding to [18F]FTAG, 
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partially-hydrolyzed [18F]FTAG, and [18F]FDG. Fluorination efficiency could be calculated from this 
chromatogram by dividing the sum of the areas under all peaks except [18F]fluoride by the sum of 
the areas under all peaks. The second mobile phase was a mixture of ethanol and hexane (1:1, 
v/v). The first peak (Rf = 0.0) was a combination of unreacted [18F]fluoride and [18F]FDG, while 
the other overlapping peaks represented a mixture of [18F]FTAG and partially-hydrolyzed 
[18F]FTAG. The radiochemical purity of [18F]FDG could be computed as the area under the first 
peak divided by the area under all peaks, and then subtracting the fraction of unreacted 
[18F]fluoride (i.e. 1 – fluorination efficiency) from the first radio-TLC chromatogram. The crude 
RCY of [18F]FDG could be determined by multiplying this radiochemical purity by the radioactivity 
recovery. The hydrolysis efficiency could be determined by dividing the radiochemical purity of 
[18F]FDG by the fluorination efficiency.  
2.3. Results and discussion 
2.3.1. Optimization of Teflon adhesion 
To simplify the optimization procedure and reduce cost, initial experiments were performed on 
model chips (glass slides) rather than EWOD chips. (Tridecafluoro-1,1,2,2-tetrahydrooctyl) 
trichlorosilane (FTS) was selected as the adhesion promoter. 
Vapor deposition was found to be the most effective way to apply the adhesion promoter. 
Measurements after FTS deposition showed consistent and high (~120°) contact angle. To 
perform this deposition, Piranha-cleaned chips were dried with nitrogen gun to remove the water 
residue, and then positioned in the vacuum chamber horizontally. A total of 200 µL FTS was 
loaded in an aluminum tray and positioned in the chamber next to the chips. Then, the vacuum 
chamber was evacuated and FTS was vaporized in the chamber, and then sealed for 18-24 hours. 
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Afterwards, the chips were baked on a hotplate at 115°C for 10 min to facilitate molecular cross-
linking and to remove any residual water prior to Teflon coating. 
Other FTS deposition methods tested include dipping deposition and spin-coating deposition. 
For dipping deposition, the cleaned glass slides were dipped in a 3% FTS (dissolved in 
isopropanol) for 5 min and dried on the hotplate at 115°C for 10 min. For spin-coating deposition, 
FTS was loaded on the cleaned chips and spun at 500 rpm for 30 s. However, these approaches 
showed lower contact angle (~90°) of the prepared surface, indicating perhaps lower density of 
FTS molecules bound to the surface.  
Using the adhesion promoter was found to have a dramatic influence on the Teflon adhesion 
(Figure 2-7). After soaking Teflon-coated glass for 10 min in DI water or TPAH at 80°C, all Teflon 
was removed in a subsequent tape test if no adhesion promoter was used (“no silane group”). In 
contrast, when the FTS adhesion promoter was applied (“silane group”), most of the Teflon 
remains adhered to the substrate, indicating significantly improved adhesion under these 
conditions. 
 
 
Figure 2-7. Comparison of Teflon adhesion on glass with and without adhesion promoter. 
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(A) Adhesion of Teflon to glass with silane and without silane after soaking in DI water at 80°C; 
(B) Adhesion of Teflon to glass with silane and without silane after soaking in TPAH at 80°C. 
 
In an actual EWOD chip, it is SiNx that is located immediately beneath the Teflon layer. We 
proposed to increase Teflon adhesion on SiNx in the same manner as for glass, i.e. by using a 
silane treatment. Before silane deposition, the chips were treated with 12% HF etching and 
Piranha cleaning as described in the methods to clean the surface and oxidize the resulting 
functional groups to produce high density of hydroxyl groups, which in principle should be 
amenable to silane treatment according to the same method as used for glass [43]. 
Tests were performed on SiNx-coated glass samples. Figure 2-8 shows that Teflon adhesion 
after exposure to TPAH was improved when the silane adhesion promoter was used. Solvents 
didn’t go underneath the Teflon due to the hydrophobicity provided by the silane. (Note this 
observation is made of the chip immediately after solvent exposure, before any tape test was 
performed.) When no silane was used, the edges of Teflon peeled up slightly from the substrate 
along the cross-hatched pattern, whereas the peeling did not occur when the silane adhesion 
promoter was used. However, when measuring the adhesion using a tape test (after the solvent 
exposure), the results seemed almost reversed. In the chip with no adhesion promoter, a visible 
fraction of the Teflon was removed during the tape test; however, when the adhesion promoter 
was used, nearly all of the Teflon was removed during the tape test, suggesting the adhesion is 
worse when the adhesion promoter is used.  
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Figure 2-8. Comparison of Teflon adhesion with or without silane adhesion promoter on 
SiNx.  
(A) Result after TPAH exposure (but before tape test) when no silane was used. (B) Result of 
tape test after solvent exposure when no silane was used. (C) Result after TPAH exposure (but 
before tape test) when silane was used. (D) Result of tape test after solvent exposure when silane 
was used.  
 
To make sense of these ambiguous results, several samples were sent out for Nanoscratch 
analysis. This approach is expensive, but provides more quantitative testing of different samples 
by direct comparison of scratch patterns made in the materials under identical conditions. The 
results of Nanoscratch adhesion test showed that Teflon layer after silane pre-treatment of SiNx 
surface has weaker adhesion (0.0033 mN/µm2 delamination pressure) than Teflon deposited on 
the SiNx surface directly (0.0139 mN/µm2 delamination pressure), or the Teflon coating on silane-
treated glass (0.0067 mN/µm2 delamination pressure). These results appear to confirm that the 
Teflon adhesion is weaker on SiNx when the adhesion promoter is used. 
Further study would be needed to understand the underlying cause of reduced adhesion in the 
presence of adhesion promoter, or to determine if strength could be improved by depositing a thin 
SiO2 layer over the SiNx prior to silane treatment or by using a different dielectric material 
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altogether. However, these studies were not performed since the adhesion strength of Teflon 
directly to SiNx was already strong than the adhesion to glass (with adhesion promoter). 
Overall, we showed that various tests can be used to compare Teflon adhesion to the substrate 
under different fabrication conditions, or different exposure conditions. The results showed that 
the use of FTS adhesion promoter allowed Teflon-coating of glass that could withstand solvent 
exposure at elevated temperatures without significant delamination, and that Teflon-coating of 
SiNx (without adhesion promotoer) could also withstand such conditions. 
  
2.3.2. Optimization of dielectric layer 
In EWOD chips we previously had frequently observed signs of electrolysis (e.g. formation of 
small gas bubbles) when actuation electrodes were activated, indicating dielectric breakdown or 
defects in the dielectric layer. In parallel with my Teflon adhesion studies, Sofie Biosciences 
pursued a study of dielectric deposition methods and materials.  
Sofie Bioscience developed methods for quality control (QC) testing of the dielectric layer. A 
simple test chip was designed with several large electrodes that were coated with various 
dielectric materials and Teflon. The chip was immersed in liquid and the current was measured 
as an increasing voltage was applied. The voltage at which the dielectric layer failed (either due 
to sudden increase in current or due to onset of bubble formation) was recorded. Both the 
magnitude of this voltage, and the consistency of this voltage across a batch of coatings were 
evaluated. 
 With the developed QC methods, test chips coated with various dielectric layers, such as SiNx 
layers deposited with different PECVD parameters, SiNx layers deposited in small increments 
with sample rotation between depositions, composite dielectrics (e.g. SiO2 and SiNx, SiNx and 
parylene), etc.  
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Ultimately a SiNx / parylene composite was found to give the most reliable performance at the 
desired actuation voltage. 
 
2.3.3. Synthesis of [18F]fallypride 
Syntheses were carried out on model chips first and then translated to EWOD chips fabricated 
with optimal dielectric layer and Teflon adhesion method. 
The decay-corrected crude RCY of [18F]fallypride synthesized on the model chips was 54 ± 
14% (n=12). Though it was assumed that conditions would be directly translatable from the model 
chips to EWOD chips, in practice, a reduction in yield was observed during this process. We 
suspected the more confined nature of the chip (due to clamping with the COC cover plate, and 
presence of gasket around the chip boundary) may alter the temperature distribution, evaporation 
rate, or vapor removal properties. Thus, we performed a temperature optimization of reaction 
conditions directly on the EWOD chips (rather than model chips). As a result of this optimization, 
an increase in fluorination temperature (from 120 °C to 135 °C) was found to restore yields close 
to that obtained on the model chips. 
Using a 1:1 (v:v) mixture of DI water and MeOH, the crude product could be collected from the 
chip with an efficiency of 66 ± 6% (n=7) of the total activity after 4 rinsing cycles. Very little residual 
activity was found in the COC cover plate. Much of the remaining activity was stuck on the EWOD 
chip (bottom substrate and cover chip) in a form that doesn’t seem removable even with extensive 
soaking of the chips in solvent. Some residual activity was also found on pipette tips that were 
used for extraction of the product from the output port of the cover plate. A small amount of 
radioactivity was not accounted for, presumably lost as a volatile by-product. The residual activity 
is summarized in Table 2-1. With an average fluorination efficiency of 62 ± 12% (n=7) and 
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radioactivity recovery of 66 ± 6% (n=7), the overall crude RCY was 40 ± 9% (n=7).  A sample 
radio-TLC chromatogram of the extracted crude product is shown in Figure 2-9. 
 
Table 2-1. Reaction performance of [18F]fallypride on EWOD chips. 
Reaction performance and distribution of residual radioactivity measured after the synthesis of 
[18F]fallypride on EWOD chips (n=7). Values are decay-corrected. 
Radioactivity measurement Value (%) 
Radioactivity recovery (%) 66 ± 6 
Residual activity on gasket between chip and cover plate (% of initial activity) 2 ± 1 
Residual activity on top and bottom chips (% of initial activity) 11 ± 5 
Residual activity on COC cover plate (% of initial activity) 3 ± 2 
Residual activity on pipette tips for extraction (% of initial activity) 10 ± 3 
Residual activity in vacuum trap (%) 1 ± 2 
Fluorination efficiency (%) 62 ± 12 
Crude RCY (%) 40 ± 9 
 
 
 
Figure 2-9. Example of radio-TLC chromatogram of crude [18F]fallypride produced on 
EWOD chip. 
The crude [18F]fallypride product was produced on an EWOD chip. In this example, the fluorination 
efficiency was determined to be 78%. 
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While the performance on the EWOD chips was slightly lower than the result obtained from 
model chips, this value was sufficiently high and consistent that we decided to postpone further 
optimization of the fluorination reaction until the PHENYX system with integrated reagent loading 
was ready. It was expected that automated extraction would improve yield since there will not be 
any losses on pipette tips.  
 
2.3.4. Synthesis of [18F]FDG 
Initially, the temperature of the first (fluorination) reaction step was optimized on model chips. 
Of temperatures in the range 110 – 140 °C, the highest fluorination efficiency of 78 ± 3% (n=4) 
was observed at 130 °C. The radioactivity recovery in this case was 58 ± 5% (n=4), but this was 
not further optimized since during the real synthesis it is not necessary to remove the intermediate 
from the chip. 
Next, we investigated the second step of the [18F]FDG synthesis, i.e., hydrolysis of the 
[18F]FTAG intermediate. Acidic hydrolysis conditions appeared to damage the Teflon surface of 
the model chips, affecting hydrophobicity and impeding the ability to move droplets across the 
surface. Perhaps because of this, hydrolysis yields were variable (84 ± 23%, n=4). In comparison, 
basic hydrolysis conditions (8 µL of 0.3N NaOH, room temperature, 100s) gave reproducibly 
quantitative conversion of [18F]FTAG to [18F]FDG, and caused no noticeable degradation of the 
model chips. Reaction efficiency of the hydrolysis reaction was determined by performing two 
radio-TLC analyses of the crude product (Figure 2-10). The performance of [18F]FDG synthesis 
on model chips is summarized in Table 2-2. 
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Figure 2-10. Examples of radio-TLC chromatograms of crude [18F]FDG. 
The crude [18F]FDG produced on a model chip using basic hydrolysis conditions. (A) Development 
of TLC plate in hexane:EtOAc (1:1) separates unreacted [18F]fluoride and [18F]FDG (Rf = 0) from 
intermediates (Rf > 0). (B) Development of TLC plate in MeCN:water (95:5) separates unreacted 
[18F]fluoride from other radiofluorinated species. [18F]FDG and [18F]FTAG sometimes appear as 
overlapping peaks under these conditions, and poor hydrolysis can leave multiple partially 
hydrolyzed intermediates, making quantitation difficult. Thus the combination of conditions 
provides a reliable means to differentiate all species to calculate reaction efficiencies.  
 
Table 2-2. Reaction performance of [18F]FDG on model chips. 
Reaction performance and distribution of residual radioactivity measured after the synthesis of 
[18F]FDG on model chips using basic hydrolysis (n=2). Values are decay-corrected. 
Radioactivity measurement Value (%) 
Activity of crude product extracted from chip (% of initial activity) 67 ± 11 
Residual activity on top chip (% of initial activity) 6 ± 5 
Residual activity on bottom chip (% of initial activity) 8 ± 5 
Residual activity on pipette tips for extraction (% of initial activity) 11 ± 1 
Fluorination efficiency (%) 77 ± 14 
Hydrolysis efficiency (%) 100 ± 0 
Crude RCY (%) 50 ± 1 
 
With optimized conditions from the model chips, we transitioned to [18F]FDG syntheses on 
EWOD chips. Due to the larger reaction volumes during hydrolysis step (8 µL, compared to 4 µL 
reaction volume during fluorination step), we noticed that the edges of droplets, after introduction 
into the chip, were too close to the inlet ports of the chip and could potentially be affected by 
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cross-contamination from previously used reagents. Thus, the chip gap height was increased 
from ~150 µm to 300 µm by doubling the spacer to decrease the diameter of loaded droplets, 
eliminating the issue of cross-contamination and allowing large volumes to be used. Since gap 
height affects thermal distribution, the temperature of the droplets in the new chips was 
characterized. To adjust the temperature difference, a thermocouple was positioned inside the 4 
µL DMSO droplet sitting between EWOD chips (i.e. with 150 µm or 300 µm spacer), and the 
temperature inside the droplet was recorded with a data acquisition device (DAQ) while the 
EWOD chips was heated to 130°C. Specifically, temperature of the droplet was found to be ~5°C 
lower with the larger gap height, and thus reaction temperatures were therefore increased by 5°C. 
Initial results have shown comparable radioactivity recovery (71 ± 10%, n=2) as observed on the 
model chips (i.e., 67 ± 11%, n=2), and comparable hydrolysis efficiency (100%, n=2), but 
fluorination efficiency was lower and less reliable (40 ± 18%, n=2) compared to that on the model 
chips (77 ± 14%, n=2). We expect increased temperature, concentration, reaction time, or drying 
time would improve the overall crude RCY but we decided to postpone further optimization until 
the PHENYX system with integrated reagent loading was ready.  
2.4. Conclusion 
With the EWOD chip fabricated with the optimal dielectric layer and Teflon adhesion method, 
the syntheses of [18F]fallypride and [18F]FDG were successfully performed. Even though the crude 
RCYs were slightly lower than previously reported [27], the robustness of the EWOD chips was 
significantly improved. Notably, almost no failures due to Teflon delamination or electrolysis were 
observed during droplet movements and reactions. 
However, despite the improved performance and reliability of the chips presented here, the 
improvements actually increased the complexity (and therefore cost) of EWOD chip fabrication. 
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Even in cost models based on modest scales of mass production by a commercial microfluidic 
foundry, the cost was expected to be prohibitive for use as a disposable component. 
Subsequent chapters explore efforts to develop other droplet-based systems to produce 
tracers with low cost by continuing to leverage the fundamental benefits of microscale synthesis 
(e.g. low reagent consumption) but by also minimizing the cost of the microfluidic chip itself. 
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3. Chapter 3: Passive transport-based droplet radiosynthesizer 
3.1. Introduction 
Due to the ability to monitor specific in vivo biochemical processes with positron emission 
tomography (PET), this imaging technology is widely used as a research tool in fundamental 
studies of disease and the development of new drugs and therapies. It is also an indispensable 
clinical tool for diagnosis and staging of disease, monitoring a patient’s response to therapy, and 
streamlining clinical trials through patient stratification [1–4]. Though the majority of scans are 
performed with the glucose analog 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) to detect abnormal 
glucose metabolism, there is increasing interest in monitoring other biochemical process using 
other PET tracers that can provide more disease-specific information in many cases. Though 
many other tracers are being used in preclinical research and some in clinical trials [5,6], the cost 
of these tracers compared to [18F]FDG is prohibitive for many studies because there is insufficient 
demand and coordination of schedules for centralized production and distribution of these short-
lived compounds, which is the key to the low cost of [18F]FDG [7]. To increase accessibility to 
diverse PET tracers, advances are needed in radiosynthesis technology that make it possible to 
produce smaller batches on demand at an affordable cost. 
In recent years there has been significant development of microfluidic devices to perform 
radiochemical synthesis of PET tracers [8,9]. Among the various approaches that have been 
explored, droplet-based systems have perhaps the most potential for cost reductions [10,11]. By 
performing reactions at the microliter scale, amounts of expensive reagents such as precursor 
can be reduced by 2-3 orders of magnitude compared to conventional approaches. In addition, 
miniaturization of the overall synthesizer can significantly reduce the cost of equipment and 
radiation-shielded facilities. Furthermore, the small volume scale reduces contamination, and 18F-
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labeled tracers can be produced in much higher molar radioactivity due to the reduction of fluorine-
19 from reagents and other sources. We have previously shown automated droplet-based 
radiosynthesis of several PET tracers using electrowetting-on-dielectric (EWOD) systems [26–
29]. In EWOD microfluidic chips, electrodes are used to transport reagents, as they are needed, 
from fixed reagent loading sites to a central, temperature-controlled zone where evaporation and 
reaction processes are carried out to perform multi-step radiosyntheses. Despite successful 
implementation, routine use of EWOD for radiochemical synthesis is limited by the complex 
fabrication of chemically-compatible chips (i.e. based on glass substrates). The large number of 
processing steps makes the chips expensive and the relatively large surface area (e.g., ~25 mm 
square) makes it challenging to produce the pinhole-free dielectric layers that are essential to 
avoid dielectric breakdown and electrolysis of droplets on the chip. 
To address these issues, we investigated the use of microfluidic devices relying on passive 
droplet manipulation to provide the same function of moving reagent droplets from fixed loading 
sites to a central reaction region. Passive devices do not use electrodes or other active means of 
actuation, but rather rely on gradients in geometry or surface tension to transport droplets [44]. 
Xing et al. reported a capillary micropumping technique in which droplets could be pumped along 
superhydrophilic pathways toward a pre-existing larger droplet [45]. Yeh et al. reported a method 
to generate a gradient in the density of hydrophobic decyltrichlorosilane (DTS) molecules on a 
substrate and observed that droplets moved toward the more hydrophilic side [46]. Similarly, Liu 
et al. reported spontaneous droplet motion on a surface patterned with a gradient in the density 
of superhydrophilic pillars fabricated within a hydrophobic background [47].   Ng et al. reported a 
method to move droplets using the Marangoni force. An ethanol (EtOH) droplet was positioned 
next to the water droplet to be actuated. Evaporation of ethanol formed a vapor gradient that 
dissolved into the surface of the water droplet, and caused the water droplet to move away from 
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the highest ethanol concentration [48].  Droplets can also be made to move spontaneously due 
to a height gradient between two non-parallel substrates. Whether the droplet is wetting or non-
wetting determines whether it moves toward the side with narrowest or widest height, respectively 
[49–51]. In another geometric approach, a gradient in the width of a superhydrophilic path on a 
superhydrophobic surface was reported by Ghosh et al. to generate spontaneous motion of a 
droplet [52]. As seen in Figure 3-1B, a droplet on such a track experiences an imbalance in 
surface tension forces along the leading and trailing boundaries of the liquid footprint, leading to 
a net force on the droplet toward the wider end of the track. Not only is droplet transport possible, 
but multiple tracks can be merged, or droplets can be held in position until they accumulate 
enough volume to be further transported.  
While these techniques provide a wide range of possible transport mechanisms, not all would 
be suitable for loading reagents for performing multi-step chemical reactions. For example, 
capillary pumping relies on the presence of droplets at both the source and destination, but the 
reaction zone is often completely dried in one or more steps of the synthesis process. In 
approaches that rely on chemical gradients, the presence of solvents or surface-bound molecules 
could potentially interfere with, or be affected by, the intended chemical reactions on the chip. 
Certain geometric gradients (e.g. variation in DTS density on surface or variation in height 
between two substrates) do not appear to lend themselves to the creation of sophisticated 
channel networks for multi-step reactions. We therefore elected to work with the approach of 
Ghosh et al., for which the “channels” can be routed in any direction via simple photolithographic 
fabrication processes.  
We hypothesized that this latter passive transport mechanism could be used to develop a chip 
for multi-step chemical reactions based on the idea that reagents and solvents are sequentially 
delivered to a central reaction zone with intervening reaction (heating) and evaporation steps. To 
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pattern the surface, Ghosh et al. used a mixture of TiO2 powder and hydrophobic polymer, and 
then activated the TiO2 with UV light in specific regions to catalyze destruction of the polymer [52]. 
However, TiO2 has reactive properties [53] that may cause interference with the desired 
radiochemical reactions, and thus, in this report, we developed an alternative implementation that 
avoids the use of TiO2 to generate similar patterned surfaces. In this chapter, we discuss the 
fabrication technique, characterize the movement of several important solvents on patterned 
surfaces, and design a chip for multi-step reactions. Finally, the multi-step radiosynthesis of two 
PET tracers, (S)-N-((1-Allyl-2-pyrrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2,3-
dimethoxybenzamide ([18F]fallypride) and  [18F]FDG are demonstrated and then the syntheses 
are automated by implementation of reagent delivery and product collection mechanisms. 
Compared to EWOD microsystems, it is expected that passive microfluidic devices will have 
advantages of significantly reduced chip cost and enhanced reliability (since the need for a 
dielectric layer, sensitive to defects, is eliminated entirely). In addition, the overall system should 
be simpler and less expensive since many droplet operations do not require actively-controlled 
actuators. Although the idea and mechanism of passive droplet manipulation has been studied 
for several years, to the best of our knowledge, it has not yet been used as a means to deliver 
reagents for chemical reactions. 
3.2. Materials and Methods 
3.2.1. Materials 
1% Teflon AF 2400 solution was purchased from Chemours.  Positive photoresist 
(MEGAPOSIT SPR 220-7.0) and developer (MEGAPOSIT MF-26A) were purchased from 
MicroChem (Westborough, USA). Additional solvents and chemicals used for microfluidic chip 
fabrication, including methanol (MeOH, Cleanroom LP grade), acetone (Cleanroom LP grade),  
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isopropanol (IPA, Cleanroom LP grade), sulfuric acid (96%, Cleanroom MB grade) and hydrogen 
peroxide (30%, Cleanroom LP grade), were purchased from KMG Chemicals (Fort Worth, USA). 
Potassium carbonate (K2CO3, 99%), 2,3-dimethyl-2-butanol (thexyl alcohol, 98%), anhydrous 
hexane (95%), anhydrous ethyl acetate (EtOAc, 99.8%), anhydrous dimethyl sulfoxide (DMSO, 
99.9%), methanol (MeOH), EtOH (99.5%), anhydrous acetonitrile (MeCN, 99.8%), ammonium 
formate (NH4HCO2; 97%), 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (K222, 
98%), trimethylamine (TEA, 99%) and sodium hydroxide (NaOH, 1N) were purchased from 
Sigma-Aldrich. Tetrabutylammounium bicarbonate (TBAHCO3, 75mM), tosyl fallypride (fallypride 
precursor, >90%), fallypride (reference standard for [18F]fallypride, >95%) and mannose triflate 
(FDG precursor, >99%) were purchased from ABX Advanced Biochemical Compounds 
(Radeberg, Germany). Dulbecco's phosphate-buffered saline (PBS, 1X) was purchased from 
Mediatech (Manassas, VA, USA). Food dye was purchased from Kroger (Cincinnati, OH, USA) 
and diluted with deionized (DI) water in the ratio of 1:100 (v/v).  DI water was obtained from a 
Milli-Q water purification system (EMD Millipore Corporation, Berlin, Germany). No-carrier-added 
[18F]fluoride in [18O]H2O was obtained from the UCLA Ahmanson Biomedical Cyclotron Facility.   
 
3.2.2. Design and fabrication of microfluidic droplet reactor 
Batches of microfluidic chips were fabricated in the Integrated NanoSystems Cleanrooom 
(California NanoSystems Institute, UCLA) from 4” silicon wafers using standard lithographic 
processes. A diagram of the process is shown in Figure 3-10 of the Appendix. The wafer was 
spin-coated with Teflon AF 2400 solution at 1000 rpm for 30 s and then heated on a hotplate at 
160°C for 10 min, 245°C for 10 min, and then annealed in an oven (HTCR 6 28, Carbolite, UK) at 
340°C for 3.5 h under nitrogen atmosphere. The final thickness of the Teflon layer was ~150 nm 
as measured by surface profilometry (Dektak 150, Veeco, Plainview, NY, USA). The Teflon layer 
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was patterned via dry etching [54]. A positive photoresist (SPR 220-7) layer was spin-coated at 
3000 rpm for 30 s on top of the Teflon and then soft baked at 115°C for 3 min. After that, the 
photoresist layer was patterned by UV exposure (MA6 mask aligner, Karl Suss, Garching, 
Germany) and developed according to the manufacturer’s recommended protocol. The exposed 
Teflon regions were then etched away via 30s exposure to oxygen plasma (PlasmaLab system 
80 RIE plus, Oxford Instruments, UK) at 100 mTorr pressure, 200 W power and 50 sccm oxygen 
flow. The wafer was then diced into individual 25.0 x 27.5 mm microfluidic chips manually with a 
silicon wafer cutter. Afterwards, chips were dipped into acetone for 1 min to remove photoresist, 
rinsed in IPA for 1 min, and dried with nitrogen. To further increase the hydrophilicity of the 
patterned surface, the microfluidic chips were cleaned with Piranha cleaning solution (96% 
sulfuric acid; 30% hydrogen peroxide, 3:1 v/v mixture) prior to use. Contact angles of the surface 
at different steps was measured with a contact-angle goniometer (VCA-3000S, AST, Billerica, 
MA, USA).  
The microfluidic chip comprises a hydrophobic surface with a circular hydrophilic reaction zone 
in the center (3.0 mm diameter), and six inward-leading tapered hydrophilic pathways for reagent 
transport (Figure 3-1A). Liquid reagent droplets are transported passively from reagent loading 
sites to the central reaction region by the patterned wettability mechanism reported by Ghosh et 
al. [52] (Figure 3-1B).  A simple chip of varied taper angles (α) was also designed to investigate 
the behavior and droplets of aqueous and organic solvents on the pathway (see Figure 3-11). 
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Figure 3-1. Photograph and mechanism of fabricated passive microfluidic chip (top view).  
(A) The star pattern is a hydrophilic surface (silicon); the remainder is hydrophobic (Teflon). The 
diameter of the central circular reaction zone is 3.0 mm. The taper angle α of each delivery 
channel is 5°, and length from the narrow end to center is 9.7 mm. The width of the narrow end 
of each delivery channel is 0.17 mm. (B) Illustration of passive transport mechanism of a droplet 
on a wedge-shaped pathway. Fnet is the net force due to the larger contact line at the leading 
(right) edge of the liquid footprint compared to the trailing (left) edge, driving the liquid in the 
direction of the wider track. 
 
3.2.3. Automation of microdroplet reactions 
Operations on the microfluidic chip were automated by a custom-built temperature control 
platform, reagent dispensing subsystem and solution collection subsystem. 
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Heating was provided by placing the chip in direct contact with a ceramic heater (Ultramic 
CER-1-01-00098, Watlow, St. Louis, MO, USA). The heater was affixed atop a 40 cm x 40 cm 
thermoelectric device (Peltier, VT-199-1.4-0.8, TE Technology, Traverse City, MI, USA) mounted 
to a heatsink and cooling fan (AFB0512VHD, Delta Electronics, Taipei, Taiwan). A custom plastic 
frame above the Peltier (and bolted to the heatsink) helped keep the heater in place while also 
providing two flat vertical edges for rapidly positioning one corner of the microfluidic chip. The 
signal from a K-type thermocouple embedded in the heater was amplified through a K-type 
thermocouple amplifier (AD595CQ, Analog Devices, Norwood, MA, USA) and connected into a 
data acquisition device (DAQ; NI USB-6211, National Instruments, Austin, TX, USA). A digital 
output of the DAQ was used to drive a solid-state relay (SSR, Model 120D25, Opto 22, Temecula, 
CA, USA) to control the supply of 120 VAC to the heater. An on-off temperature controller was 
programmed in LabView (National Instruments). To cool the heater, the Peltier was driven by a 
24V power supply (TDK-Lambda Americas, National City, CA, USA) operated through another 
SSR controlled by the LabView program. A power step down module (2596 SDC, Model 180057, 
DROK, Guangzhou, China) was connected to the 24V power supply to provide 12V for the cooling 
fan, which was switched on during cooling via an electromechanical relay (SRD-05VDC-SL-C, 
Songle Relay, Yuyao city, Zhejiang, China) controlled by the LabView program. 
Droplets were loaded onto the microfluidic chip at reagent loading sites through miniature, 
solenoid-based, non-contact dispensers (INKX0514300A and INKX0514100A, Lee Company, 
Westbrook, CT, USA). A different dispenser (INKX0514100A) with seal material made of FFKM 
was used to dispense the fallypride precursor solution. Other solutions were loaded through 
dispensers (INKX0514300A) with seal material EPDM.  Basically, each dispenser is connected 
to a pressurized source of a reagent, and the internal solenoid valve is opened momentarily to 
dispense liquid; the amount of liquid dispensed is related to the duration the valve is open. The 
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inlet of each dispenser was connected to a 1 mL glass V-vial (03-410-024, V Vial™ with Open-
Top Screw Cap, Wheaton, Millville, NJ, USA) sealed with a septum (224100-072, Wheaton) via 
ETFE tubing (1/16" OD, 0.010" ID, 1529L, IDEX Health & Science, Oak Harbor, WA, USA). The 
septum was pre-punched with a 1 mm OD biopsy punch (Integra Miltex, York, PA, USA). A bevel 
was cut on the end of the tubing and positioned at the bottom of the vial. Nitrogen pressure was 
supplied to the headspace of the vial via a 25G needle (Beckton Dickinson, Franklin Lakes, NJ, 
USA) inserted directly through the septum. The needle was connected via 1/8” OD tubing to the 
output of an electronic pressure regulator (ITV0030-3UBL, SMC Corporation, Noblesville, IN, 
USA) controlled by the LabView program. The reagent stock solutions were pipetted directly into 
the vial. For precursor solution and [18F]fluoride solution, the smaller volume (30-50 µL) was 
loaded into a 250 µL vial insert (5181-1270, Agilent Technologies, Santa Clarita, CA, USA) 
installed into the V-vial. The outlet of each dispenser was fitted with a nozzle (ID 0.005”, 
INZA4650935K, Lee Company), which is recommended for generation of droplets with volume in 
the range of 100s of nL to several µL. Each dispenser was powered via a dedicated driver circuit 
(IECX0501350A, Lee Company) and controlled via the LabView program. Note that because the 
dispensing rate depends on the driving pressure, viscosity of solvent, tubing size, and nozzle site, 
a calibration was performed for each type of liquid to determine the valve opening time that should 
be used to dispense a particular volume (Figure 3-13). Before use, each dispenser was manually 
primed (using 3 psi nitrogen) to ensure all air ahead of the liquid was eliminated. 
A fixture (Figure 3-2C) was built to hold 6 dispensers with nozzles ~2 mm above the 6 loading 
sites of the microfluidic chip. Each dispenser was secured within a hole by an O-ring (ORBN005, 
Buna-N size 005, Sur-Seal Corporation, Cincinnati, OH, USA). After completing the multi-step 
reaction, each dispenser was flushed with 1 mL of DI water and MeOH sequentially at 69 kPa 
(~10 psi), and dried with nitrogen for 2 min. 
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A liquid collection subsystem was implemented to transfer the final crude reaction product 
droplet from the microfluidic chip to the collection vial. A 23G hypodermic metal tubing 
(304H23XX, MicroGroup, Medway, MA, USA) was inserted through a hole in the center of the 
dispenser fixture. The height of this tube was controlled by mounting it on a single-acting 
pneumatic cylinder (6498K511, McMaster-Carr, Santa Fe Springs, CA, USA). The pneumatic 
cylinder was activated by applying 138 kPa (~20 psi) pressure from an electronic pressure 
regulator (ITV0030-3UBL, SMC Corporation) controlled by the LabView program.  In its non-active 
position, the end of the tubing was ~ 55.5 mm above the chip surface (Figure 3-2A). The droplet 
was collected by making close contact (~0.5 mm) to the chip (Figure 3-2B), and applying vacuum 
to the headspace of the collection vial using a compact vacuum pump (0-16" Hg vacuum range, 
D2028, Airpon, Ningbo, China) connected via a vacuum regulator (ITV0090-3UBL, SMC 
Corporation). Vacuum pressure was ramped from 0 to 21 kPa (~3 psi, 0.01 psi increment every 
100 ms) over 30 s to collect the crude product droplet. 
After collecting the crude product, the collecting tubing was cleaned by flushing with a 1 mL 
mixture of MeOH and DI water (1:1, v/v). 
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Figure 3-2. Schematics and photograph of the microfluidic platform. 
(A) Schematic of droplet microreactor system, including reagent dispensing system, crude 
product collection system, and heating and cooling system. (B) Schematic showing configuration 
for product collection, i.e. with collection tubing lowered into the droplet. The pneumatic cylinder 
used to lower the tubing is omitted for clarity. (C) Photograph of the microfluidic platform. 
 
3.2.4. On-chip radiosynthesis 
As a demonstration of the ability to perform multi-step reactions with this microfluidic platform, 
we performed the synthesis of two PET tracers: [18F]Fallypride and [18F]FDG. The synthesis of 
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[18F]Fallypride requires activation of the cyclotron-produced [18F]fluoride via evaporative drying, 
followed by a fluorination reaction. For [18F]FDG, an initial [18F]fluoride activation step is followed 
by a fluorination reaction and then a deprotection (hydrolysis) reaction. 
3.2.4.1. Radiosynthesis of [18F]fallypride 
The synthesis conditions of [18F]fallypride (Figure 3-3A) were adapted and further optimized 
from our previous work synthesizing this compound using EWOD chips [28]. 
 
Figure 3-3. Synthesis schemes for the example PET radiotracers.  
(A) Radiosynthesis of [18F]fallypride, illustrating [18F]fluoride drying step followed by 
radiofluorination of precursor. (B) Radiosynthesis of [18F]FDG, showing the [18F]fluoride drying 
step, followed by radiofluorination of the precursor and the deprotection (hydrolysis) reaction. 
 
A [18F]fluoride stock solution was prepared by mixing [18F]fluoride/[18O]H2O (100 μL, ~370 MBq; 
~10 mCi) with 75 mM TBAHCO3  solution (5 μL). Precursor stock solution was prepared by 
dissolving fallypride precursor (4 mg) in a mixture of MeCN and thexyl alcohol (1:1 v/v, 100 μL). 
A stock solution for dilution of the crude product prior to collection was prepared from a mixture 
of MeOH and DI water (9:1, v/v, 500 µL). These solutions were loaded into individual reagent vials 
connected to dispensers. 
 
 
 
52 
 
 
To perform the on-chip synthesis, a 2 μL droplet of [18F]fluoride solution (~7.4 MBq; ~0.2 mCi) 
was first loaded onto the chip and spontaneously transported to the reaction site. The microfluidic 
chip was heated to 105°C for 1 min to evaporate the solvent and leave a dried residue of the 
[18F]tetrabutylammonium fluoride ([18F]TBAF) complex at the reaction site. It was found that the 
typical azeotropic distillation process (i.e. addition and evaporation of MeCN) to remove residual 
moisture was not needed. 
Next, a 1 μL droplet of fallypride precursor solution was deposited at another loading site and 
was spontaneously transported to the reaction site, where it dissolved the dried residue. Then, 
another 1 μL droplet of fallypride precursor solution was deposited and transported the same way. 
The chip was heated to 110°C and held for 7 min to accomplish the radiofluorination reaction. 
Then, ten 1 μL droplets of collection solution were sequentially deposited at a different reagent 
loading site and spontaneously moved to reaction site to dilute the resulting crude reaction 
mixture. Afterwards, the diluted droplet was transferred into the collection vial. The collection 
process was repeated 5x to minimize residue on the chip. A schematic of the on-chip process is 
shown in Figure 3-4.  
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Figure 3-4. Schematic of [18F]fallypride synthesis on the passive microfluidic chip.  
(A) [18F]fluoride solution is loaded and dried. (B) Precursor solution is loaded and fluorination 
reaction is performed. (C) Collection solution is loaded to dilute the crude product, which is then 
collected. Note that each reagent is loaded from a dedicated dispenser and reagent pathway. The 
synthesis of [18F]FDG is quite similar but there is an additional reaction step between steps B and 
C. After the fluorination reaction, the deprotection agent (NaOH) is added, transported to the 
center, and the room temperature hydrolysis reaction is performed. 
 
3.2.4.2. On-chip radiosynthesis of [18F]FDG 
The on-chip synthesis conditions for [18F]FDG (Figure 3-3B) were adapted from the work 
completed by Gomzina et al. [55][55][27][30,55]. 
A K222/K2CO3 stock solution was prepared by dissolving Kryptofix K2.2.2 (9 mg) and K2CO3 (1.8 
mg) in DI water (60 μL). To produce a [18F]fluoride stock solution, 5 µL of this first solution were 
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mixed with [18F]fluoride/[18O]H2O (45 μL, ~185 MBq; ~5 mCi). A precursor stock solution was 
prepared by dissolving mannose triflate (2.5 mg) in DMSO (100 μL). For the deprotection step, a 
NaOH solution (0.3N, 100 μL) was prepared. A stock solution for dilution of the crude product for 
collection was prepared from a mixture of MeOH and DI water (3:2 v/v, 500 μL). These solutions 
were loaded into individual reagent vials connected to dispensers. 
For the synthesis, a droplet (2 μL) of [18F]fluoride stock solution (~7.4 MBq ; ~0.2 mCi) was 
first dispensed onto the chip and spontaneously transported to the reaction site. The heater was 
set to 105°C for 1 min to remove the solvent and leave a dried residue of the [18F]KF/K222 
complex. Two droplets of FDG precursor solution (each 1 μL) were sequentially dispensed at 
another site and moved to the reaction zone. The temperature was raised to 80°C for 5 min to 
perform the fluorination reaction. Subsequently, a droplet of NaOH solution (3 μL) was dispensed 
and transported to the reaction site, and the hydrolysis reaction was performed at room 
temperature for 100 s. Finally, 20 droplets (0.5 μL each) of the collection solution were loaded on 
the chip sequentially and the resulting diluted crude product was transferred to the collection vial. 
This collection was repeated four more times. 
 
3.2.5. Analytical methods 
Performance of the chip-based reaction was assessed via measurements of radioactivity and 
radiochemical purity (RCP).  
Radioactivity was measured with a calibrated dose calibrator (CRC-25R, Capintec, Florham 
Park, NJ, USA) at various times throughout the synthesis process (including starting radioactivity 
on the chip after loading of [18F]fluoride stock solution). Radioactivity recovery was calculated as 
the activity of the collected crude product divided by the starting radioactivity, corrected for decay. 
Collection efficiency was calculated as the activity of the collected crude product divided by the 
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activity on chip after synthesis, corrected for radioactive decay. To gain further insights into the 
synthesis process, residual activity on the chip was measured after collection of the crude product. 
We report this as a fraction of the activity on chip just prior to the collection step, corrected for 
radioactive decay. Similarly, the residual activity in the collection system was measured and 
expressed as a fraction of the activity on chip just prior to collection, corrected for radioactive 
decay. In manual syntheses, the residual activity on the pipette tips used for collection was 
measured in a dose calibrator. In automated syntheses, the residual activity in the collection 
tubing was determined by measuring the activity of the cleaning solution (1:1 v/v MeOH/water, 1 
mL) in a dose calibrator. 
RCP of the crude compound collected from the chip was determined via radio thin layer 
chromatography (radio-TLC). A 1 μL droplet was spotted on a silica TLC plate (JT4449-2, J.T. 
Baker, Center Valley, PA, USA) with a micropipette. The TLC plate was developed in an 
appropriate mobile phase and then analyzed with a scanner (MiniGITA star, Raytest, 
Straubenhardt, Germany). 
For [18F]fallypride, the TLC mobile phase was 60% MeCN in 25 mM NH4HCO2 with 1% TEA 
(v/v). In the resulting TLC chromatogram, two peaks are identified: unreacted [18F]fluoride (Rf=0.0) 
and [18F]Fallypride (Rf=0.9). RCP was calculated as the area under the [18F]fallypride peak divided 
by the area under both peaks. Fluorination efficiency (conversion of [18F]fluoride to product) was 
the same as RCP. The decay-corrected crude radiochemical yield (crude RCY) of [18F]fallypride 
was defined as the radioactivity recovery times the RCP.  
In a few experiments, we also performed radio-HPLC purification of the crude [18F]fallypride 
mixture and analysis of the purified and formulated [18F]fallypride using a Smartline HPLC system 
(Knauer, Berlin, Germany) equipped with a degasser (Model 5050), pump (Model 1000), a UV 
(254nm) detector (Eckert & Ziegler, Berlin, Germany) and a gamma-radiation detector and 
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counter (B-FC- 4100 and BFC-1000; Bioscan, Inc., Poway, CA, USA). Separation was performed 
using a C18 column (Kinetex, 250 x 4.6 mm, 5 µm, Phenomenex, Torrance, CA, USA). The mobile 
phase was 60% MeCN in 25 mM NH4HCO2 with 1% TEA (v/v) and flow rate was 1.5 mL/min. The 
retention time of fallypride was 4.5 min. The crude [18F]fallypride mixture collected from the chip 
was manually injected into the HPLC system, and the [18F]fallypride fraction (~2 mL) was 
collected. Chromatograms were collected using a GinaStar analog-to-digital converter (raytest 
USA, Inc., Wilmington, NC, USA) and GinaStar software (raytest USA, Inc.) running on a PC. The 
chromatogram of crude [18F]fallypride had two peaks, [18F]fluoride (tR = 1.6 min) and [18F]fallypride 
(tR = 4.4 min) (e.g., Figure 3-5A).  
 
 
Figure 3-5. Examples of radio-HPLC chromatograms of [18F]fallypride synthesis on the 
microfluidic reaction chip.  
(A) Analysis of crude product. Note that the apparent double peak of [18F]Fallypride is an artifact 
due to saturation of the radiation detector. (B) Analysis of formulated product. The RCP was 99%.  
 
For analysis of only the fluorination reaction of [18F]FDG, the radio-TLC mobile phase was a 
mixture of  MeCN and DI water (95:5, v/v). The resulting chromatogram had two separate peaks, 
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[18F]fluoride (Rf = 0.0) and intermediate [18F]fluoro-1,3,4,6-tetra-O-acetyl-D-glucose ([18F]FTAG, 
Rf = 0.77). Fluorination efficiency (i.e., conversion of [18F]fluoride to [18F]FTAG) was computed by 
dividing the area under the [18F]FTAG peak by the sum of the areas of both peaks. For analysis 
of the [18F]FDG product, two radio-TLCs were performed to enable the efficiency of each reaction 
(fluorination and hydrolysis) to be inferred [26]. One mobile phase was the same, i.e. a mixture of 
MeCN and DI water (95:5, v/v). The resulting chromatogram had one distinct peak for [18F]fluoride 
(Rf = 0.0) and several overlapping peaks corresponding to [18F]FTAG, partially-hydrolyzed 
[18F]FTAG, and [18F]FDG (Rf > 0) (e.g., Figure 3-6A). Fluorination efficiency could be calculated 
from this chromatogram by dividing the sum of the areas under all peaks except [18F]fluoride by 
the sum of the areas under all peaks. The second mobile phase was a mixture of EtOAc and 
hexane (1:1, v/v). The first peak (Rf = 0.0) was a combination of unreacted [18F]fluoride and 
[18F]FDG, while the other overlapping peaks represented a mixture of [18F]FTAG and partially-
hydrolyzed [18F]FTAG (e.g., Figure 3-6B). The RCP of [18F]FDG could be computed as the area 
under the first peak divided by the area under all peaks, and then subtracting the fraction of 
unreacted [18F]fluoride (i.e. 1 – fluorination efficiency) from the first radio-TLC chromatogram. The 
crude RCY of [18F]FDG could be determined by multiplying this RCP by the radioactivity recovery. 
The hydrolysis efficiency could be determined by dividing the RCP of [18F]FDG by the fluorination 
efficiency.  
 
 
 
58 
 
 
 
Figure 3-6. Examples of radio-TLC chromatograms of [18F]FDG synthesis on the 
microfluidic reaction chip.  
(A) Analysis of crude product using 95:5 MeCN/water mobile phase. (B) Analysis of the same 
sample but using the 50:50 EtOAc/hexane mobile phase. The peak represents both unreacted 
[18F]fluoride and [18F]FDG, and the absence of a second peak indicates no residual [18F]FTAG or 
partially hydrolyzed [18F]FTAG. (C) Analysis of purified [18F]FDG using 95:5 MeCN/water mobile 
phase. The RCP was >99%. (D) Analysis of the same sample, but using the 50:50 EtOAc/hexane 
mobile phase.  
 
[18F]FDG was further purified with a custom miniaturized cartridge[26] adapted from a 
commercially available FDG Purification cartridge for the base hydrolysis (Chromabond Set V, 
ABX). The commercial cartridge was designed for macroscale purification of [18F]FDG [35] and 
would result in too much dilution of the purified product when making small amounts of the tracer. 
Instead, custom cartridges were made by repacking the resin beads (18.4 mg cation exchange 
resin (PS-H+), 18.2 mg anion exchange resin (PS-HCO3), 30.4 mg neutral alumina (ALOX N) and 
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15.6 mg reversed-phase resin (HR-P)) inside a 0.063’’ ID perfluoroalkoxy alkane (PFA) tubing 
(ZEUS, Orangeburg, SC, USA). The resins were sandwiched and separated with ~1.5 mm 
diameter frits (FRPE1CC, OROCHEM, Naperville, IL, USA). Before use, the cartridge was pre-
conditioned with 0.5 mL EtOH and then 1 mL DI water. During purification, the ~100 µL diluted 
crude product was manually passed through the cartridge, then an additional 300 µL DI water 
were used to collect the pure product. The resulting radio-TLC chromatograms using both mobile 
phases showed only one [18F]FDG peak. Isolated RCY was calculated by diving the eluted 
radioactivity ([18F]FDG) by the starting radioactivity ([18F]fluoride). Purification efficiency was 
calculated as the isolated RCY divided by the crude RCY. After purification, radio-TLC analysis 
was performed with 95:5 v/v MeCN/H2O to determine the purity (e.g., Figure 3-6C). Since the 
[18F]FTAG and [18F]FDG peaks can partially overlap, radio-TLC analysis using 50:50 v/v 
EtOAc/hexane was also performed to confirm completion of hydrolysis (e.g., Figure 3-6D). It 
should be noted that, due to the small reaction volume, removal of samples for radio-TLC from 
the crude reaction mixture causes a slight reduction in the total amount of radioactivity. Thus the 
measurements of isolated product and the estimate of purification efficiency are ~2% lower than 
they would be if the radio-TLC samples were not taken. 
Finally, we also used the technique of Cerenkov imaging [56] to visualize the distribution of 
radioactivity on the microfluidic chip after different steps. To obtain an image, a glass microscope 
slide (1mm thick) was placed on top of the chemical reaction chip prior to placing it in the imaging 
chamber. The Cerenkov imaging setup was described previously [57]. Exposure time was set to 
300 s. In addition to performing image corrections (dark mask, flat mask and median mask) 
described previously, we also performed a background subtraction and a decay correction (to the 
starting time of the first image). For purposes of analysis, regions of interest (ROIs) were drawn. 
The background correction used an ROI drawn in an area of the chip not exposed to radioactive 
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solutions; the background level was the average pixel value in this region. Other ROIs analyzed 
include the total chip, the reaction region, and the reagent pathways. For each experiment trial, 
images were taken after the evaporation step, the fluorination step and the collection step.   
 
3.2.6. Micro PET/CT imaging protocol 
For in vivo imaging, the synthesis was started by preparing a 5x more concentrated 
[18F]fluoride stock solution consisting of 100 µL [18F]fluoride/[18O]H2O (i.e. 1850 MBq, 50 mCi) and 
5 µL TBAHCO3  solution (75 mM). A 2 µL droplet (~37 MBq; ~1 mCi) was used for the synthesis.  
The collected (diluted) crude [18F]fallypride product from the chip was purified via analytical-scale 
HPLC (identical conditions as for analysis described above). The product fraction was dried by 
evaporation of solvent in an oil bath at 110°C for 8 min with nitrogen flow, and then redissolved 
in PBS. The amount of PBS was adjusted to ensure 2.6- 3.0 MBq (~70– 80 µCi) of the tracer in 
200 µL PBS for one mouse injection. The formulated [18F]fallypride was analyzed via radio-HPLC 
to confirm purity and determine molar activity according to typical procedures [35]. Isolated RCY 
was calculated as activity of formulated [18F]fallypride divided by the starting activity. 
The in vivo imaging study was conducted with a 10 week-old female C57Bl/6J mice (Jackson 
Laboratory, Bar Harbor, ME) in accordance with UCLA Animal Research Committee approved 
protocols and guidelines. For static PET imaging, the mouse was pre-warmed, anesthetized (2% 
isoflurane in oxygen), and injected via tail vein with ~2.6 MBq (~70 µCi) [18F]Fallypride, followed 
by  60 min uptake period under anesthesia and a 10 min static PET acquisition (G8 PET/CT, Sofie 
Biosciences, Culver City, CA, USA) with an energy window of 150-650 keV. Images were 
reconstructed using maximum-likelihood expectation maximization as recommended by the 
vendor, and corrected for CT-based photon attenuation, detector normalization and radioisotope 
decay (scatter correction was not applied), and converted to units of percent injected dose per 
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gram (%ID/g). PET scans were followed by a 50 sec CT scan for anatomical co-registration and 
attenuation correction with a 50 kVp, 200 µA X-ray source and reconstructed using a Feldkamp 
algorithm. PET/CT images were analyzed using AMIDE version 1.0.5 [58]. 
3.3. Results and discussion 
3.3.1. Development of fabrication method 
To prepare surfaces with patterned wettability, Ghosh et al. [52] deposited a mixture of 
hydrophobic fluoroacrylic copolymer (PMC), TiO2 nanoparticles and EtOH onto a substrate, and 
then used UV irradiation to activate the TiO2 to catalyze the local destruction of PMC. Because it 
has been shown the TiO2 nanoparticles can catalyze a variety of chemical and radiochemical 
reactions [53], they could therefore potentially interfere with the reactions we wanted to perform 
on the chip, and thus we avoided the use of nanoparticles. Instead, the patterned surface was 
prepared by dry-etching of a Teflon coating on a silicon substrate. 
Contact angle measurements (Appendix, Table 3-4), made using DI water droplets, showed 
that the patterned regions (i.e. uncovered silicon surface) were very hydrophilic (θ=7±3°, n=3), 
while the remaining Teflon regions were very hydrophobic (θ=122±1°, n=3). Importantly, the 
hydrophobic layer maintained its integrity and adhesion to the substrate throughout the full 
patterning process. 
 
3.3.2. Feasibility studies and characterization 
First, we assessed whether the passive transport mechanism was compatible with the various 
solvents and solvent mixtures used in the desired reactions. The simple chip was fabricated to 
study the behavior of droplets of solvents as a function of taper angle (Appendix, Figure 3-11). 
We found that all solvents (DI water, MeOH, MeCN, DMSO) could be spontaneously transported 
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for taper angles of 4° or larger (Appendix, Figure 3-12). To provide a safety margin, we used an 
angle of 5° for subsequent experiments.  
We then designed the chemical reaction chip in Figure 3-1A, consisting of a 3mm diameter 
hydrophilic reaction zone and six radially-oriented reagent droplet transport ‘channels’. We 
observed that the droplets behaved differently depending on the type of solvent and the volume. 
For example, some droplets moved to the central reaction zone and remained confined to this 
zone, while others would wet the reaction zone and then ‘overflow’ along the radial channels. We 
suspect that surface tension and density (i.e. gravity) may play a role in determining this behavior. 
We empirically explored the behavior of different droplet volumes of each solvent on the 6-inlet 
chip (Appendix, Figure 3-14) to determine the maximum volume that could be loaded while 
avoiding the overflow issue. The maximum volumes for DI water, MeOH, MeCN and DMSO were 
1, 1, 1, and less than 0.5 µL, respectively. Thus, we adjusted reagent concentrations so the 
desired absolute amount of reagents could be efficiently loaded without exceeding the maximum 
droplet volume. To determine a suitable dilution solution for product collection, different 
combinations of MeOH and DI water were tested after performing mock syntheses. For 
[18F]fallypride, a ratio of 9:1 (v/v) was used, and for [18F]FDG, a ratio of 6:4 (v/v) was used. These 
ratios exhibited sufficient mobility to reach the reaction zone, yet avoided overflow of the reaction 
site (when 1 µL was loaded). 
 
3.3.3. Mock radiosyntheses 
Next, we performed a mock synthesis of [18F]fallypride replacing [18F]fluoride solution with 
TBAHCO3 solution and precursor solution with just the solvent. Diluted food dyes were added in 
each solution.  A series of photographs of the whole process is shown in Figure 3-7. Movements 
of different droplets were fast and smooth. Evaporations proceeded smoothly without bubbling or 
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bursting of droplets. Surprisingly, 2 µL droplets of mock precursor solution remained confined to 
the reaction site, even though such volume of MeCN caused ‘overflow’, perhaps due to the 
presence of dried salts (TBAHCO3) and food dye from the evaporation step, or altered the surface 
properties. The collection process seemed effective, with no visible residue apparent at the 
reaction site after collection. 
 
 
Figure 3-7. Sequence of photographs of the microfluidic chip during the mock synthesis 
of [18F]fallypride. 
(A) A DI water droplet (2μL, dyed yellow) containing TBAHCO3 (77mM) was loaded, 
spontaneously transported to the reaction site, and then the chip was heated to 105°C to remove 
the solvent. (B) Next, two droplets of a 1:1 v/v mixture of MeCN and thexyl alcohol (1μL, dyed 
red) were loaded from a separate inlet and transported to the reaction site in sequence, after 
which the droplet was heated to 110°C to simulate fluorination reaction. Note that loading in two 
separate portions instead of a single larger droplet helped to prevent over-flowing of the reaction 
site. (C) Next, two droplets of collection solution (9:1 v/v MeOH/water) (5 μL each, dyed blue) 
were loaded from a third inlet and transported to the center to dilute the reaction mixture. Finally 
the collection tubing was lowered and the droplet was collected into a vial with the aid of vacuum. 
Very little residue was apparent on the chip after collection. 
 
The mock synthesis of [18F]FDG was conducted on the chip as well with similar findings. 
Surprisingly, about 2 μL of the precursor solution could be loaded, even though DMSO volumes 
>0.5 μL caused overflow.  
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3.3.4. Multi-step radiosyntheses 
Subsequently, we attempted the radiosyntheses of [18F]fallypride and [18F]FDG. Cerenkov 
images, showing distribution of radioactivity on the chip at different stages of the syntheses, are 
shown in Figure 3-8. Images after the [18F]fluoride drying process showed all the radioactivity 
confined to the reaction zone, as did images after the fluorination reaction, and images after the 
collection process showed very little activity remained on the chip. The amount of radioactivity on 
the whole chip as determined by Cerenkov imaging correlated well with radioactivity 
measurements made via dose calibrator (data not shown). The [18F]FDG synthesis required some 
optimization of the [18F]fluoride loading process to ensure radioactivity was well confined 
(Appendix, Figure 3-15). 
 
Figure 3-8. Distribution of radioactivity visualized using Cerenkov imaging after different 
steps of radiosyntheses.  
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(Top) [18F]Fallypride: (A) after [18F]fluoride drying step; (B) after fluorination reaction; (C) residual 
radioactivity on chip after collection of product. (Bottom) [18F]FDG:  (D) after [18F]fluoride drying 
step; (E) after fluorination step; (F) residual radioactivity on chip after collection of product. Images 
are corrected for radioactive decay. 
 
Initially, reactions were performed with manual pipetting of reagents to the reagent loading 
sites and manual collection of the crude product via pipette. Then, fully automated syntheses 
were performed on the chip, including automated dispensing of reagents and automated 
collection of the crude product. 
The performance of [18F]fallypride synthesis is summarized in Table 3-1.  With manual 
operations, the fluorination efficiency was 74 ± 8 % (n=4), collection efficiency was 90 ± 4 % (n=4), 
and the crude RCY was 59 ± 9% (n=4). Analysis of radioactivity measurements during the 
synthesis on passive chips showed negligible losses (-3 ± 1%, n=4, relative to the starting 
radioactivity) during drying of [18F]fluoride, but slightly higher losses of 15 ± 2% (n=4) during 
fluorination and 9 ± 4% (n=4) residual activity on chip and pipette tips after collection. Note that 
the negative evaporation loss is likely due to measurement error in the dose calibrator. The crude 
RCY was slightly lower than we previously reported for the droplet-based synthesis using EWOD 
chips, i.e. 84 ± 7% (n=6) [27]. The reported fluorination and collection efficiencies on EWOD were 
90 ± 9 % (n=6) and 94 ± 3 % (n=6), respectively, suggesting the current platform and reaction 
conditions give slightly lower fluorination efficiency. We plan to perform further optimization of 
conditions and investigation of additional substrate materials in the future. The synthesis time (up 
to the end of the collection process) for [18F]fallypride was ~25 min.  
 
Table 3-1. Performance of [18F]fallypride synthesis using manual or automated reagent 
loading and product collection.  
All measurements were repeated n=4 times. Starting radioactivity was 7.4 MBq (0.2 mCi). 
Fluorination efficiency, radioactivity recovery, crude RCY, and isolated RCY are expressed with 
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respect to starting [18F]fluoride activity, while collection efficiency and residual activities are 
expressed with respect to activity on chip just prior to the collection step. 
 Parameter Manual synthesis 
Automated 
synthesis 
Fluorination efficiency (%) 74 ± 8 76 ± 4 
Radioactivity recovery (%) 79 ± 4 84 ± 4 
Collection efficiency (%) 90 ± 4 93 ± 2 
Synthesis time (min) 25 ± 3 20 ± 1 
Crude RCY (%) 59 ± 9 64 ± 6 
Isolated RCY (%) N/A 46 ± 4 
Residual activity on chip (%) 12 ± 3 5 ± 2 
Residual activity on collection tip/tubing (%) 2 ± 1 2 ± 0 
 
 
Automated loading and collection provided a marginal increase in the crude RCY of 
[18F]fallypride to 64 ± 6 % (n=4). This increase can be explained by the improved radioactivity 
recovery (84 ± 4 % (n=4) compared to 79 ± 4 % (n=4) for manual operation), which was due to 
lower residual activity on chip and collection tubing (7 ± 2 % (n=4) of the activity on chip before 
the collection step, compared to 14 ± 3 % (n=4) for the manual setup). The isolated RCY was 46 
± 4 % (n=4). Typically, in macroscale synthesis, about 5-10% of the radioactivity of the crude 
product can be lost during purification and formulation. Here we lost about 28% of the activity, 
suggesting that significant improvements can still be made, perhaps in injection of the small 
volume of collected product into the HPLC system. The synthesis time was reduced to ~20 min  
(~12 min for drying and fluorination steps and ~8 min for collection) due to elimination of manual 
steps. This time is slightly shorter than reported for EWOD-based synthesis (i.e., ~31 min for 
[18F]fallypride) [27]. The synthesis time is also somewhat shorter than macroscale processes (~29 
min for [18F]fallypride) [35,59]. The total time of purification and formulation (~ 13 min) is shorter 
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than macroscale processes as well (20 min) [59]. It should be pointed out that the formulation 
step was not yet optimized; it is expected that this process could be performed more quickly by 
using a cartridge based method rather than evaporation. The time for collection can possibly be 
further condensed by optimizing the speed of the product droplet collection process. 
The performance of [18F]FDG synthesis is shown in Table 3-2. With manual handling, the 
fluorination efficiency, collection efficiency and crude RCY were 84 ± 4 % (n=4), 70 ± 15 % (n=4) 
and 40 ± 8 % (n=4), respectively. The intermediate [18F]FTAG was completely hydrolyzed into 
[18F]FDG as determined by radio-TLC with EtOAc and hexane (1:1, v:v) mobile phase. 
Evaporation loss (1 ± 2 %, n=4) was minimal, but significant radioactivity losses were observed 
during fluorination (30 ± 3%, n=4), and there was significant residual radioactivity on the chip and 
pipette tips after collection (20 ± 9%, n=4). These losses were comparable to the losses reported 
on EWOD platform (48 ± 3 %, n=2). The crude RCY was marginally lower than crude RCY on 
EWOD platform (45 ± 10 %, n=2), which was mainly due to lower fluorination efficiency compared 
to that on EWOD platform (93 ± 3 %, n=2) [27]. The lower fluorination efficiency might due to 
incomplete dissolution of the [18F]TBAF residue into the precursor droplet. After fluorination, the 
radioactivity would ideally be uniformly distributed through the reaction droplet, but in fact is 
confined to a smaller region corresponding to the location of the [18F]TBAF residue after the initial 
[18F]fluoride drying step. Further optimizations will focus on improving fluorination efficiency by 
adding external means to facilitate mixing and dissolution processes, and by carefully controlling 
volume of solution in reaction site. 
 
Table 3-2. Performance of [18F]FDG synthesis using manual or automated reagent loading 
and product collection.  
All measurements were repeated n=4 times. Starting radioactivity was 7.4 MBq (0.2 mCi). 
Fluorination efficiency, radioactivity recovery, crude RCY, and isolated RCY are expressed with 
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respect to starting [18F]fluoride activity, while collection efficiency and residual activities are 
expressed with respect to activity on chip just prior to the collection step. 
 Parameter Manual synthesis 
Automated 
synthesis 
Fluorination efficiency (%) 84 ± 4 72 ± 7 
Hydrolysis efficiency (%) 100 ± 0 100 ± 0 
Radioactivity recovery (%) 49 ± 12 69 ± 5 
Collection efficiency (%) 70 ± 15 96 ± 2 
Synthesis time (min) 18 ± 1  21  ± 2 
Crude RCY (%) 40 ± 8 50 ± 8  
Isolated RCY (%) N/A 36 ± 6 
Residual activity on chip (%) 33 ± 16 4 ± 2 
Residual activity on collection tip/tubing (%) 2 ± 0 Not measured 
 
 
As expected, after implementation of automated reagent loading and product collection for 
[18F]FDG synthesis, the crude RCY was enhanced to 50 ± 8 % (n=4). Higher radioactivity recovery 
(69 ± 5%, n=4) compared to manual synthesis (49 ± 12 %, n=4) dominated the increase of crude 
RCY. The collection efficiency for the automated synthesis was 96 ± 2 % (n=4), indicating very 
little residual activity on the chip or in the collection tubing. (Additional losses of activity occur 
during the radiofluorination step.) In comparison, for the manual synthesis, the collection 
efficiency was only 70 ± 15 % (n=4), due primarily to residual activity on the chip (35 ± 16% (n=4) 
of the activity on the chip prior to the collection step). Isolated RCY was 36 ± 6 % (n=4). 
Purification efficiency of the custom cartridge was 72 ± 9 % (n=4) and can likely be improved by 
optimization of the custom purification cartridges and purification process. The synthesis time (up 
to the end of the collection process) for [18F]FDG was ~21 min, which is much shorter than 
reported for EWOD-based synthesis (~50 min). The synthesis time including manual purification 
(11 min) was ~32 min, which is a little bit longer than the macroscale synthesis time (~22 min, 
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including time for purification and sterile filtration) [33]. It should be noted that the purification 
process was not yet optimized, and it may be possible to reduce the synthesis time further. 
 
3.3.5. Scaling up the amount of radioactivity 
The starting activity of [18F]fallypride and [18F]FDG synthesis was minimized in preliminary 
experiments for safety reasons to ~7.4 MBq (~0.2 mCi) by loading a 2 μL droplet (radioactivity 
concentration ~0.1 mCi/µL). 
Though sufficient radioactivity was recovered for small animal imaging, it will be desirable in 
the future to scale this up to enable tracer production for multiple animal studies or for clinical 
doses.  One way to scale up activity is by pre-concentrating the [18F]fluoride solution from the 
cyclotron using a miniaturized anion exchange cartridges [60]. Another approach is to repeatedly 
load droplets of [18F]fluoride solution before drying.  
Preliminary experiments were conducted to test the feasibility of the latter approach with 
manual loading and collecting (see Table 3-3). To ensure the same ratio of precursor to TBAHCO3 
in the fluorination reaction, multiple 2 µL droplets of [18F]fluoride/[18O]H2O solution (i.e. no 
TBAHCO3) were first loaded, followed by a single 2 µL droplet of TBAHCO3 solution (3.6 mM). 
The mixture was dried at 105°C for 1 min. In a preliminary experiment, loading of 2, 4, or 8 µL of 
[18F]fluoride/[18O]H2O solution resulted in crude RCYs was 58% (n=1), 54% (n=1), and 50% (n=1). 
This apparent reduction in crude RCY as a function of [18F]fluoride/[18O]H2O volume could be a 
mixing issue as it may become increasingly difficult to dissolve the increasing amount of residue 
in the precursor solution droplet prior to fluorination. Instead of loading a large volume and drying 
it once, each droplet of [18F]fluoride/[18O]H2O could be dried after loading, perhaps limiting the 
lateral extent of the initial residue. For the 8 µL case, the starting activity was 2.34 MBq (~ 0.63 
mCi).  
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Table 3-3. Performance of [18F]fallypride synthesis with scaled-up starting radioactivity.  
Addition of [18F]fluoride/[18O]H2O solutions was followed in all cases by the same amount of 
TBAHCO3 solution (2 µL, 3.6 mM). All experiments were performed n=1 times. 
Parameter Trial 1 Trial 2 Trial 3 Trial 4 
 [18F]fluoride/ [18O]H2O solution volume (µL) 2 4 6 8 
Starting radioactivity (MBq) 9 15 21 23 
Radioactivity recovery (%) 83 72 76 79 
Fluorination efficiency (%) 70 76 57 63 
Crude RCY (%) 58 55 43 50 
 
3.3.6. Preclinical Imaging 
Using [18F]fallypride synthesized automatically on the chip,  in vivo small-animal PET/CT 
imaging was performed after purification (purity > 99%) and reformulation. Separation via radio-
HPLC revealed no additional radioactive impurities. Molar activity was 185 GBq/µmol (~5. 0 
Ci/µmol) at the end of synthesis. The biodistribution, showing high uptake of [18F]fallylpride in the 
striatum (Figure 3-9), was similar to literature reports [61].  
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Figure 3-9. Small-animal PET/CT images from the static scan after 60 min uptake of 
[18F]fallypride.  
(A) Maximum intensity projection (MIP) image of whole mouse; (B) Transverse slice highlighting 
uptake in striata in the brain. 
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3.4. Conclusions 
An automated microfluidic platform for droplet-based reactions was developed based on 
passive droplet transport using patterned wettability. A new approach to fabricating such 
patterned surfaces was developed and implemented on silicon substrates. After optimization and 
characterization were performed to determine optimal taper angle of the pathways and optimal 
droplet volumes for various solvents, multi-step chemical reactions (including evaporative drying, 
fluorination and deprotection steps) were performed to synthesize two PET tracers,  [18F]fallypride 
and [18F]FDG. As a demonstration of the ability to produce useful amounts of these tracers, a 
batch of [18F]fallypride was prepared, purified, formulated, and used for preclinical imaging. 
Cerenkov imaging revealed the distribution of radioactivity after various synthesis steps. As 
desired, the majority of radioactivity was confined in the reaction site during fluoride drying and 
reaction steps, and minimal residual radioactivity remained on chip after the collection step. More 
detailed analysis of Cerenkov images may be helpful in further optimization of aspects of the on-
chip synthesis such as droplet mixing and redissolution of dried residues. 
Though synthesis performance was slightly lower than on EWOD chips, the cost of the passive 
chips is significantly lower due to the very simple fabrication process. Furthermore, the overall 
system for connecting reagent sources and collecting the crude product is significantly less 
complicated. Synthesis times were also shorter than on EWOD chips, potentially enabling the 
production of more batches of tracers in one day. 
By combining with a [18F]fluoride concentrator, or sequentially loading [18F]fluoride droplets, 
the system can be scaled up to higher amounts of radioactivity. Other than PET imaging, our 
automated platform has the potential to be applied for small scale chemical reactions or assays 
as well. 
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3.5. Appendix 
3.5.1. Microfluidic chip fabrication 
 
 
Figure 3-10. Schematic of microfluidic chip fabrication process.  
A silicon wafer is first spin-coated with Teflon® AF 2400. The Teflon is patterned by first spin-
coating and patterning photoresist as an etch mask, and then removing exposed Teflon via dry-
etching. Finally the water is diced into individual chips and each chip is subject to photoresist 
removal and treatment with Piranha solution to increase hydrophilicity of patterned pathways. 
 
Table 3-4. Contact angle measurements of a droplet of DI water (~2 µL) on the microfluidic 
chip at different stages during the fabrication process. 
Treatment Contact angle (°) (n=3) 
Initial Si wafer 41 ± 4 
Hydrophobic region before patterning 122 ± 2 
Hydrophilic region (after acetone wash) 57 ± 10 
Hydrophilic region (after Piranha clean) 7 ± 3 
 
 
3.5.2. Characterization of droplet transport rate 
A simple chip design, consisting of a single delivery channel connected to a circular reaction 
zone, was fabricated to evaluate suitability of passive transport for various aqueous and organic 
solvents (Figure 3-11A). Taper angles α were varied in 1° increments from 1° to 10° to investigate 
the droplet movement behavior. Video of droplet movement on the chip was recorded with an 
iPhone 7 camera at 60 fps (1080p HD). Transporting time was calculated by subtracting starting 
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frame number (droplet just loaded on the pathway, Figure 3-11B) from ending frame number 
(droplet just reached the reaction zone, Figure 3-11C). 
 
 
Figure 3-11. Photograph of the simple passive microfluidic chip for characterizing droplet 
movement (top view).  
(A) The taper angle of the pathway in this particular chip was 4°.  (B) Video frame from video 
recording of 1 µL DI water on the pathway. Note that for practical reasons, the video was taken 
at a slightly oblique angle above the chip. The frame shows the droplet has just been deposited 
at the start of the pathway and was defined as starting frame. (C) Video frame showing the same 
droplet at the time it reached the reaction site (defined as the ending frame). The number of 
intervening frames could be used to compute the transport time. 
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Figure 3-12. Moving rate of different solvents as a function of taper angle of the reagent 
delivery pathway.  
(A) 1 µL droplet of DI water (n=4). (B) 1 µL droplet of MeOH (n=4). (C) 1 µL droplet of MeCN (n=4 
for 1-5°; n=2 for 6-10°). (D) 1 µL droplet of DMSO (n=3). Note that if the time to reach the reaction 
site exceeded 1000 frames, the transport speed was considered to be zero and the data was 
omitted from the graph (i.e. 1° taper angle for MeOH and MeCN). All solvents were deposited via 
non-contact dispensers (INKX0514300A for DI water, MeOH and MeCN; INKX0514100A for 
DMSO). 
 
3.5.3. Characterization of dispensing volumes 
Dispense volumes by the non-contact dispensers were measured by averaging the weight of 
dispensed solutions. The dispenser was opened for a certain duration at 5 psi and the dispensed 
solution was collected in an empty PCR tube. After n=10 such droplets were dispensed, the total 
mass of the dispensed liquid was determined on an analytical balance. Using the known density 
of the solution at room temperature, the total volume was determined. The average volume of an 
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individual droplet was determined by dividing by n=10. Plots of dispensed volume versus valve 
opening time are shown in Figure 3-13. The relationship was approximately linear for times > 10 
ms. The curves could be used to determine the necessary time to dispense a particular volume.  
 
 
Figure 3-13.Calibration curves for dispensed droplet volume.  
(A) Various solvent mixtures using INKX0514300A dispensers with solvent reservoir pressurized 
to 5 psi. Trend lines are linear fits with R2 values of 0.9999 for DI water (H2O), 0.9999 for 60:40 
v/v MeOH / H2O, 0.9995 for 50:50 v/v thexyl alcohol / MeCN, and 0.9998 for 90:10 v/v MeOH / 
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H2O. (B) DMSO dispensed with INKX0514100A dispenser and reservoir pressurized to 7 psi.  R2 
for the linear fit was 1.0000. 
 
 
3.5.4. Characterization of capacity of reaction site 
Passive transport chips of six pathways and one reaction site were fabricated as described in 
the main chapter. Droplets of various sizes (0.5 µL, 1 µL, 1.5 µL, 2 µL, 5 µL) were manually loaded 
on the narrow end of bottom pathway (Figure 3-14). Photos were taken at the moment when 
solvents stopped moving. For DI water, the majority of the droplet maintained in the reaction site 
for droplet volumes smaller than 2 µL. MeOH and MeCN behaved similarly to DI water. The higher 
evaporation rate may help to prevent overflow of the reaction site. DMSO easily overflowed even 
with the lowest (0.5 µL) droplet volume. 
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Figure 3-14. Behavior of solvents droplets of different volumes after reaching the reaction 
site.  
(A) DI water; (B) MeOH; (C) MeCN; (D) DMSO. 
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3.5.5. Optimization of protocol for [18F]FDG synthesis using Cerenkov imaging 
To find conditions that avoided overflowing of the reaction site when loading 2 µL of this 
radioisotope solution, different loading methods were explored. [18F]fluoride/[18O]H2O was 
premixed with K2.2.2  (133 mM)/K2CO3 (33 mM). This solution was then loaded and dried by various 
methods. Cerenkov images were taken and processed as described in the main chapter.   
When a single 2 µL droplet was loaded on the pathway and dried at 105°C for 1 min, we 
observed significant spreading of the solution along reagent pathways during evaporation, leading 
to significant radioactive residue outside the reaction site (Figure 3-15A). For smaller droplets 
(0.5 µL, 1 µL), heating was applied to the chip after first droplet was loaded, and subsequent 
droplets were loaded sequentially while the chip was heated until a total of 2 µL had been loaded. 
For the 1 µL droplets, the Cerenkov image after completion of this step showed that the 
radioactivity remained confined within the reaction site (Figure 3-15B). For the 0.5 µL droplets, 
the first droplet exhibited spreading along the reagent pathways, and the following droplets dried 
on the pathway before getting to the reaction site because of rapid evaporation (Figure 3-15C). 
Due to the reliable confinement of radioactivity using two 1 µL droplets, subsequent experiments 
were performed in this manner.  
Next, the concentrations were varied to optimize the yield. Optimal results were obtained when 
the [18F]fluoride/[18O]H2O was premixed with K2.2.2  (40 mM)/K2CO3 (22 mM). Cerenkov imaging 
revealed that the residue remained confined to the reaction site with this new composition (Figure 
3-15D).  
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Figure 3-15. Distribution of radioactivity after [18F]fluoride drying step of [18F]FDG 
synthesis visualized using Cerenkov imaging.  
(A) A single 2 µL droplet of [18F]fluoride solution (with 133 mM K2.2.2  and 33 mM K2CO3) was 
loaded and dried; (B) Two 1 µL droplets were loaded and dried sequentially; (C) Four 0.5 µL 
droplets were loaded and dried sequentially; (D) A single 2 µL droplet of [18F]fluoride solution (with 
40 mM K2.2.2  and 22 mM K2CO3) was loaded and dried.  
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4. Chapter 4: Curie-level radiochemical reactions in a 
microdroplet radiosynthesizer 
4.1. Introduction  
For more than a decade, there has been interest in microreactors for preparation of 
radiolabeled probes for positron emission tomography (PET). By performing radiochemical 
reactions in microliter scale, the substantial cost of tracer production can be greatly reduced 
through lower consumption of expensive reagents (e.g. precursor) and small system footprint that 
can reduce amount of needed shielding or can enable many synthesizers to be installed in a 
single hot cell. Furthermore, yields can be increased due to the higher concentration of 
radionuclide, rapid mixing of reagents, fast heat transfer and short evaporation times [62].  
Several prototypes of microreactors leveraging those advantages have been reported for 
preclinical tracer production [19,21,27,63,64] but only a few systems were shown to produce 
doses of both sufficient quantity and quality for clinical use. For example, Lebedev et al. reported 
a batch-type microfluidic reactor (volume 50 µL) and showed rapid reaction times and high yields 
for several 18F-labeled tracers [23,25]. A concentrator subsystem was incorporated to increase 
the amount of activity that could be loaded into the 50 µL reactor, and production of [18F]fallypride 
for clinical imaging was demonstrated. Volume reduction not only reduced the amount of 
expensive reagents used but also reduced times needed for heating, evaporations, etc. Another 
microfluidic system (NanoTek, Advion, Inc.) is based on reagents flowing through a pre-heated 
capillary. Zheng et al. and Liang et al. demonstrated the successful syntheses of [18F]FMISO and 
[18F]T807, respectively, for clinical use [65,66]. This “flow-through” reactor design allows scaling 
of reaction volumes to adjust the batch size (e.g. changing the volume of radionuclide solution 
scales the amount of activity), enabling production of small batches for optimization or large 
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batches for clinical doses. However, the large scale reactions (required for producing clinical 
doses) use similar volumes as conventional systems, generally minimizing reagent savings [65].  
Our group has been developing droplet-based platforms for the synthesis of PET tracers based 
on electro-wetting on dielectric (EWOD) [11,26–28] or passive droplet transport [36]. These 
technologies enable reaction volumes to be scaled down to the microliter range (and reagent 
masses to the 10s of microgram level). The small reaction volume is also advantageous for 
increasing molar activity, enabling high molar activity even from relatively small batches, 
something that is not possible with conventional synthesizers [13], and enabling high molar 
activity in isotopic exchange reactions [67]. Furthermore, by removing bulky reagent delivery 
systems, system size is drastically reduced, enabling safe operation with only small amounts of 
lead shielding [11] or potentially enabling multiple systems to be operated within a single hot-cell.  
While earlier radiochemistry performed in these droplet platforms was limited to 10s to 100s of 
MBq [0.27 mCi to 2.7mCi] due to the small chip volume, our lab recently developed a fully-
automated standalone [18F]fluoride concentrator, relying on a miniaturized strong anion exchange 
(SAX) cartridge, that can increase the radionuclide concentration by reducing the initial volume 
(1-5 mL) down to an output volume of 12.4µL [37]. 
In this work, we leverage this technology to enable increased activity to be loaded into the 
micro-droplet synthesizer.  We describe design and development of an integrated system 
comprising the concentrator and passive transport-based microreactor, characterize the 
radionuclide concentration process, optimize the radionuclide transfer into the microreactor, and 
demonstrate the successful droplet-based synthesis of [18F]fallypride using concentrated 
[18F]fluoride. The synthesis is demonstrated with starting activities up to 41 GBq [1.1 Ci] of activity 
and we explore the synthesis performance as a function of activity level. Finally, we demonstrate 
the successful production of clinical-grade tracer that passes all quality control (QC) tests.  
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4.2. Materials and Methods 
4.2.1. Materials 
Anhydrous methanol (MeOH, 99.8%), ethanol (EtOH, 99.5%), anhydrous acetonitrile (MeCN, 
99.8%), 2,3-dimethyl-2-butanol (thexyl alcohol, 98%), ammonium formate (NH4HCO2, 97%) and 
trimethylamine (TEA, 99%) sodium hydroxide (NaOH, 1N) were purchased from Sigma-Aldrich. 
Tetrabutylammounium bicarbonate (TBAHCO3, 75mM), tosyl fallypride (fallypride precursor, 
>90%) and fallypride (reference standard for [18F]fallypride, >95%) were purchased from ABX 
Advanced Biochemical Compounds (Radeberg, Germany). DI water was obtained from a Milli-Q 
water purification system (EMD Millipore Corporation, Berlin, Germany). No-carrier-added 
[18F]fluoride in [18O]H2O was obtained from the UCLA Ahmanson Biomedical Cyclotron Facility.   
 
4.2.2. Apparatus  
An integrated system (Figure 4-1) was developed comprising an automated radionuclide 
concentrator (Figure 4-2C) coupled to an automated micro-droplet synthesis platform (Figure 
4-2A). 
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Figure 4-1: Tracer production scheme using the integrated radionuclide concentrator and 
microfluidic radiosynthesizer.  
Radionuclide (e.g. [18F]fluoride) is produced in a cyclotron (1-5mL) and is concentrated down to 
25μL and then transferred to the droplet-based microfluidic system to perform the radiosynthesis.  
 
 
 
Figure 4-2: Photographs of components of the integrated system. 
(A) Photograph of the microfluidic radiosynthesis platform. (B) Photograph of the microfluidic chip. 
(C) Photograph of the radionuclide concentrator.  
 
A detailed report of the design and operation of the [18F]fluoride concentrator, operated here 
in the “direct loading” configuration, was recently published [37]. Briefly, the system relies on a 
miniature strong anion exchange (SAX) cartridge. The [18F]fluoride in [18O]H2O from the cyclotron 
is passed through this cartridge to trap the [18F]fluoride, while the [18O]H2O is collected in a waste 
vial. The trapped [18F]fluoride is then released into a small volume of eluent solution. 
Upstream of the concentrator, we incorporated a simple module for strong cation exchange 
(SCX) cartridge filtration of the initial [18F]fluoride solution to eliminate contaminants and small 
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particles that could potentially interfere with trapping on the micro-cartridge. Details of this module 
are described in the Appendix.  
The design and operation of the microfluidic chips and microdroplet reaction system were 
previously published [36]. Each microfluidic chip (25.0 x 27.5 mm2) comprises a hydrophobic 
Teflon-coated silicon surface with a circular hydrophilic (silicon) reaction zone in the center (3 mm 
diameter), and six tapered hydrophilic pathways for reagent transport from reagent loading sites 
to reaction zone (Figure 4-2B). The chip is affixed atop a heater for temperature control. Reagents 
are delivered by non-contact liquid dispensers to the reagent loading sites. The crude product is 
collected from the reaction zone into an evacuated V-vial via a metal collection tubing inserted 
into the droplet. 
The design and evaluation of the interface between the concentrator and droplet synthesis 
platform is described in detail below. 
To prepare for each high activity run, [18F]fluoride solution is loaded in the source vial, reagents 
needed for elution and reaction are loaded in the corresponding V-vials in the concentrator and 
droplet synthesizer, and a clean V-vial is installed in the droplet synthesizer for product collection. 
 
4.2.3. Micro-cartridge fabrication  
The micro-cartridges for the radionuclide concentrator were fabricated by a different method 
than our previous report [37]. Due to the high cost and limited re-usability of commercially-packed 
cartridges (with ~4 µL bed volume and ~2 mg of resin), we opted to pack the resin ourselves into 
short segments of tubing. Doing so allowed convenient exploration of different resin types, resin 
masses, and cartridge geometries. Cartridges were packed with one of several different resins: 
Bio-Rad AG-MP1 (200-400 mesh size; Bio Rad, Hercules, CA, USA), resin from Sep-Pak Plus 
QMA Light Cartridges (37-55 µm particle size; Waters Corporation, Milford, MA, USA), or resin 
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from Oasis MAX Plus short cartridges (30 µm particle size; Waters Corporation). Throughout this 
manuscript, resin type will be referred to by the cartridge name from which they are extracted 
(e.g. Bio-Rad AG-MP1, Sep-Pak QMA, and Oasis MAX).  All resin types rely on quaternary 
ammonium functionality for trapping anionic species. Different resin masses ranging from 2-7mg 
were explored. Resin was packed into ETFE tubing with 1/16” outer diameter (OD) and different 
inner diameter (ID): 0.02” (1516L; IDEX Health and Sciences, Wallingford, CT, USA), 0.03” 
(1528L; IDEX) or 0.04” (1517L; IDEX). Complete details of the cartridge fabrication process are 
in the Appendix.  
After cartridge fabrication, we evaluated the flow rate of water (as described in Appendix). 
This was performed to compare different cartridge geometries (i.e. was the flow rate sufficiently 
fast to trap the radionuclide in a reasonable time), and to monitor the cartridge-to-cartridge 
variation.  
 
4.2.4. Optimization and evaluation of concentrator performance 
Prior to use, cartridges were preconditioned with 0.5mL of KHCO3 followed by 10 mL of 
deionized (DI) water. Insufficient rinsing was found to adversely impact trapping efficiency 
(Appendix). Resin remained hydrated after the preconditioning step and was not air dried before 
use. 
The input source vial was loaded with [18F]fluoride in [18O]H2O from the cyclotron, diluted with 
DI water if needed to ensure the volume was in the range 0.5-1.0 mL. These starting solutions 
contained activities ranging from 0.011 – 41 GBq [0.3mCi – 1.1 Ci]. For most experiments, 
[18F]fluoride was first pushed through an SCX filtration module prior to trapping on the SAX 
cartridge (described in detail in Appendix). Following SCX filtration, trapping was performed by 
the radionuclide concentrator by flowing this solution at 20 psi through the pre-conditioned micro-
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cartridge. Water was collected in the [18O]H2O recovery vial. After the initial trapping of [18F]fluoride 
was completed, 0.5mL of DI water was passed through the system and cartridge to the [18O]H2O 
recovery vial to recover any residual [18F]fluoride.  
Elution efficiency was tested as a function of eluent composition and eluent volume. Three 
different elution compositions of TBAHCO3 were tested: 3.8mM, 10.mM, and 25mM. The 
performance for different eluent concentrations was explored in order to find the best tradeoff 
between the amount of TBAHCO3 needed for the elution versus the amount needed for the 
downstream droplet synthesis. In these experiments, a total of 6 elutions were performed (6.2 µL 
of eluent per elution), with elution efficiency measured after each pair of elutions (i.e., elutions 1 
and 2 together, elutions 3 and 4 together, etc.).   
To characterize trapping and elution efficiency, various radioactivity measurements were made 
with a calibrated dose calibrator (CRC-25 PET, Capintec, Inc., Ramsey, NJ). For the purposes of 
calculations, all radioactivity measurements were decay-corrected to a common timepoint. 
Measurements were made of the activity in the [18F]fluoride source vial before trapping (A0source), 
activity in the source vial after trapping (Asource), activity in the [18O]H2O recovery vial after trapping 
(Awaste), and the collected activity after elution (Acollect). The activity on the cartridge after trapping 
(Acartridge) was determined indirectly (i.e. calculated as A0source – (Awaste + Asource)) to minimize 
radiation exposure. This method also proved to be significantly more accurate than directly 
measuring the cartridge in the dose calibrator, presumably due the differing geometry of the 
cartridge compared to the vials, which can affect dose calibrator measurements. Trapping 
efficiency (%) was computed as Acartridge / (A0source – Asource). Elution efficiency (%) was calculated 
as Acollect / (Acartridge). Recovery efficiency (%), defined as the amount of activity recovered following 
elution relative to starting activity, was calculated as trapping efficiency x elution efficiency. 
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Starting activity was defined as A0source – Asource which can be approximated as A0source since we 
found Asource < ~0.1% of A0source.  
 
4.2.5. Interface between concentrator and droplet synthesizer 
In our previous work, we showed that multiple 2 µL droplets of the initial [18F]fluoride solution 
could be sequentially loaded onto the chip, each one spontaneously moving to the reaction site 
[36]. Though synthesis scale of [18F]fallypride was modestly increased in this manner (up to 4x 
more activity, i.e. 8 µL loaded), we observed a reduction in reaction efficiency as activity 
increased. We suspect that after drying of the larger radionuclide volumes, the residue was 
spread over a larger surface area of the chip, making it difficult to efficiently redissolve into the 
precursor solution for the subsequent reaction. Because the concentrator output volume in this 
chapter (~25 µL after optimization) was significantly greater than 8 µL, we suspected even larger 
impact on reaction efficiency. 
We thus compared several methods of loading and drying larger volumes of [18F]fluoride onto 
the reaction chip, and used Cerenkov luminescence imaging (CLI; further described below) to 
visualize the distribution of activity on the chip after drying. 
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Figure 4-3: Two different designs of the interface and the resulting distribution of 
radioactivity on the chip.  
(A) Concentrated activity is directly dispensed onto the reaction chip. (B) Concentrated activity is 
first transferred to an intermediate vial (to merge the liquid from individual elution steps into a 
single liquid plug), and then transfer the contents to the chip as a series of small droplets using a 
piezoelectric dispenser. (C) Top view of the reaction chip showing both the reaction site and the 
reagent loading site (highlighted by dotted lines). (D) Concentrated [18F]TBAF (12.4 µL) + water 
rinse of the cartridge (12.4  µL) were loaded via the “aliquotting” method as a series of small 
droplets (~0.5 µL) that were dried as they arrived at the reaction site; (E) Concentrated [18F]TBAF 
loaded all at once (12.4 µL) and then dried followed by water rinse of the cartridge (12.4 µL) 
loaded then dried. The white line indicates the boundary of the hydrophilic pattern on the chip. 
 
In the “direct” method (Figure 4-3A), the concentrator output tubing (ETFE, 0.01′’ ID, 1/16″ 
OD; 1529L; IDEX) was mounted such that the outlet terminated just above the loading site of the 
chip. Each ~6 µL eluent plug was delivered to the chip immediately after it passed through the 
cartridge and the resulting droplet was spontaneously transported to the reaction zone. After two 
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eluent plus were loaded onto the chip, the droplets were dried. The elution process could then be 
repeated to load more eluent onto the chip.   
In the “dispenser” method (Figure 4-3B), the eluent plugs from the concentrator were first 
transferred via ETFE tubing (0.02” ID, 1/16” OD; 1516L; IDEX) to an intermediate vial, and then 
the combined volume of concentrated [18F]fluoride solution was connected to the input of a 
piezoelectric reagent dispenser (INKX0514300A, Lee Company, Westbrook, CT, USA) in the 
droplet synthesis platform via ETFE tubing (0.01′’ ID, 1/16″ OD; 1529L; IDEX). The intermediate 
vial was then pressurized (7.5 psi) and concentrated [18F]fluoride was delivered to the reagent 
loading site as a series of smaller droplets. We also explored the development of a specialized 
droplet merging chip as an alternative to the intermediate vial. In this chip, air gaps between eluent 
plugs are removed through a porous PTFE membrane (see Appendix). However, the 
intermediate vial method was ultimately used due to simplicity of operation and higher reliability. 
Detailed fluidic connections for each droplet merging technique to the dispenser can be seen in 
Appendix.  
 
4.2.6. [18F]fallypride synthesis on chip  
4.2.6.1. Optimization of synthesis conditions 
The synthesis conditions of [18F]fallypride (Figure 4-4) were adapted from our previous work 
synthesizing this compound with the droplet radiosynthesizer setup [36].  
 
 
 
 
91 
 
 
 
Figure 4-4: Microdroplet synthesis of [18F]fallypride.  
 
To facilitate the integration with the upstream [18F]fluoride concentrator, further optimization of 
the synthesis protocol was performed due to the higher salt amount (TBAHCO3) required for 
efficiently eluting [18F]fluoride from the micro-cartridge. Different [18F]fluoride/TBAHCO3 stock 
solutions were prepared by mixing [18F]fluoride/[18O]H2O (11~22 MBq [0.3-0.6mCi]) with different 
amounts of 75 mM TBAHCO3 solution to produce final concentrations in the range 0.51 – 71 mM. 
For each, a 12.4 µL droplet of [18F]fluoride/TBAHCO3 solution was manually loaded on the 
reaction site of the chip and dried at 105°C for 1 min. Then, a droplet of precursor solution (77 
mM, tosyl fallypride dissolved in a 1:1 (v:v) mixture of MeCN and thexyl alcohol) was loaded and 
moved to the reaction site automatically, and the chip was heated at 110°C for 7 min to perform 
the fluorination step. Different volumes (2-8 µL) of precursor solution were tested. Afterwards, 
twenty 1 μL droplets of collection solution (9:1 (v:v) mixture of MeOH and DI water) were 
sequentially deposited at a different reagent loading site and spontaneously moved to the reaction 
site to dilute the resulting crude reaction mixture. After automatically lowering the collection tubing 
into the droplet, the diluted droplet was then transferred into the collection vial via negative 
pressure. The collection process was repeated 4x to maximize recovery of the crude product. 
4.2.6.2. Synthesis using integrated platform 
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For synthesis performed with the integrated systems, up to 41 GBq [1.1 Ci] of activity was 
loaded in the source vial and concentrated into ~25 μL (i.e. 4 elution steps) comprised of 25 mM 
TBAHCO3 (12.4 μL) and DI water (12.4 μL). The concentrated activity was loaded on the loading 
site of the chip as a series of ~0.5 µL droplets. During the loading process, each droplet 
spontaneously moved toward the reaction site. The chip was heated to 100 °C and the interval 
between droplets adjusted (to about 4 s) such that each droplet dried soon after reaching the 
reaction site. The full amount of concentrated activity could be delivered in ~3 min. To ensure 
efficient delivery of activity to the chip, the concentrator fluid paths (minus the SAX cartridge) were 
further rinsed with a total of 25 μL of DI water (i.e. 4 elution steps) and delivered to the chip and 
dried in the same fashion. After ~3 min additional time for loading and drying the rinse solution, 
the chip was heated an extra 30s at 105 °C. Next, eight 1 µL droplets of fallypride precursor 
solution were then loaded sequentially on the chip, and the fluorination was performed at 110°C 
for 7 min. Afterwards, the crude product was collected via ~80 µL of collection solution into the 
collection vial as described above. 
For [18F]fallypride synthesis of GBq level, we waited several hours for the activity to first decay 
before taking detailed measurements. To prevent radiolysis during this time, the crude 
[18F]fallypride was collected into a vial pre-loaded with 2 mL of EtOH. 
 
4.2.7. Evaluation of synthesis performance 
Performance of the on-chip [18F]fallypride synthesis was assessed via measurements of 
radioactivity and fluorination efficiency (conversion of [18F]fluoride to product). Radioactivity was 
measured with a calibrated dose calibrator (CRC-25R, Capintec) at various times throughout the 
synthesis process. 
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Radioactivity recovery was calculated as the collected crude product divided by the starting 
radioactivity, corrected for decay. Fluorination efficiency of the collected crude product was 
determined via radio thin layer chromatography (radio-TLC). A 1 μL droplet of crude product was 
spotted on a silica TLC plate (JT4449-2, J.T. Baker, Center Valley, PA, USA) with a micropipette. 
The TLC plate was developed in the mobile phase (60% MeCN in 25 mM NH4HCO2 with 1% TEA 
(v/v)) and then analyzed with a scanner (MiniGITA star, Raytest, Straubenhardt, Germany). In the 
resulting TLC chromatogram, two peaks were identified: unreacted [18F]fluoride (Rf=0.0) and 
[18F]fallypride (Rf=0.9). Fluorination efficiency was calculated as the area under the [18F]fallypride 
peak divided by the area under both peaks. The decay-corrected crude radiochemical yield (crude 
RCY) of [18F]fallypride was defined as the radioactivity recovery times the fluorination efficiency.  
Cerenkov Luminescence Imaging (CLI) [57] was utilized to visualize the distribution of 
radioactivity on the chip after drying the [18F]fluoride solution as previously described [36]. Briefly, 
to obtain an image, a glass microscope slide (1mm thick) was placed on top of the chip prior to 
placing it in the light-tight imaging chamber. An image was then collected (exposure time 300 s) 
and then image corrections and background subtraction were applied. 
 
4.2.8. Purification and formulation  
For some batches of [18F]Fallypride produced at the 15 MBq [0.41mCi] and 1 GBq [27mCi] 
scale, we also performed radio-HPLC purification of the crude product, and analysis of the pure 
product, both using an analytical scale Smartline HPLC system (Knauer, Berlin, Germany) 
equipped with a degasser (Model 5050), pump (Model 1000), a 200 μL injection loop, a UV 
(254nm) detector (Eckert & Ziegler, Berlin, Germany) and a gamma-radiation detector and 
counter (B-FC- 4100 and BFC-1000; Bioscan, Inc., Poway, CA, USA). Separation was performed 
using a C18 column (Kinetex, 250 x 4.6 mm, 5 µm, Phenomenex, Torrance, CA, USA). The mobile 
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phase was 60% MeCN in 25 mM NH4HCO2 with 1% TEA (v/v) and flow rate was 1.5 mL/min. The 
retention time of fallypride was 4.5 min. Chromatograms were collected using a GinaStar analog-
to-digital converter (raytest USA, Inc., Wilmington, NC, USA) and GinaStar software (raytest USA, 
Inc.) running on a PC. Based on the chromatograms, molar activity of [18F]fallypride was 
calculated as described previously [13]. 
For purification, the crude [18F]fallypride mixture collected from the chip (80 μL) was diluted 
with 90 μL mobile phase and manually injected into the HPLC system, and the pure [18F]fallypride 
fraction (~2 mL) was collected through a selector valve (Cheminert, Valco Instrument Co. Inc. ) 
based on the gamma detector signal. The product fraction was dried by evaporation of solvent in 
an oil bath at 110°C for 8 min with nitrogen flow, and then dissolved in PBS. 
4.3. Results and Discussion  
4.3.1. [18F]fluoride concentrator cartridge optimization  
First, due to the change in cartridge fabrication, we performed optimization of the cartridge 
design and [18F]fluoride concentration process. 
Initially, we compared flow rates (of DI water) through the different cartridge designs (resin 
type, resin mass, tubing inner diameter). The results are tabulated in Table 4-1. We consider flow 
rates ≥ 0.5mL/min to be acceptable, which ensures trapping of [18F]fluoride can be completed in 
a short time. We also found that flow rates in this range gave reliable, repeatable elution compared 
to cartridges with slow flow rates. For the Bio-Rad AG-MP1 resin, both 2 mg and 3 mg cartridges 
had suitable flow rates. For the Sep-Pak QMA resin, cartridges with sufficient flow included 3mg 
resin in 0.03” ID tubing and 5 mg resin in 0.04” ID tubing. Lastly, flow rates were adequate for all 
tested Oasis MAX cartridges (3 mg or 5 mg in 0.03” ID tubing and 7 mg in 0.04” ID tubing).  
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Table 4-1: Flow rates of water (driven at 20 psi) through different SAX cartridges (resin type 
and mass).  
 
Resin Type Bio-Rad AG-MP1 Sep-Pak QMA Oasis MAX 
Resin Mass 
(mg) 2 3 4 3 5 5 7 3 5 7 
Tubing inner 
diameter 
(inch) 
0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.03 0.03 0.04 
Flow Rate 
(mL/min) 
0.92 ± 
0.11 
(n=3) 
0.84 ± 
0.06 
(n=4) 
0.47 ±  
0.04 
(n=3) 
0.68 ± 
0.11 
(n=4) 
0.28 ± 
0.11 
(n = 2) 
0.56 ± 
0.08 
(n = 2) 
0.23 ± 
0.07 
(n = 2) 
0.70 ± 
0.03 
(n = 2) 
0.50 ± 
0.04 
(n = 2) 
0.92 ± 
0.08 
(n = 2) 
 
It should be noted that these resin masses are all equal to or higher than literature reports 
where efficient trapping of up to 110 GBq [3Ci] [18F]fluoride was achieved using 2 mg of various 
SAX resins [19,25].  
 
4.3.2. Optimization of [18F]fluoride concentration process 
Trapping and elution performance was first compared between the 3 resin types, using 
cartridges containing 3 mg of resin (Table 4-2). Eluent composition was arbitrarily chosen to be 
25mM TBAHCO3  as a starting point.  
 
Table 4-2: Effect of resin type on trapping and elution performance (for 3 mg cartridges).  
Values are presented as average ± standard deviation, calculated from the indicated number of 
repeats (n). Each of the 6 eluent plugs (E1, E2, … E6) contains 6.2 µL of 25mM TBAHCO3. Eluted 
percentages are relative to activity that is initially trapped on the cartridge. All measurements are 
decay corrected.   
 Resin type 
 Sep-Pak QMA AG-MP1 Oasis MAX 
Number of repeats (n) 2 2 1 
Trapping efficiency (%) 99.4 ± 0.8 96± 4 99 
Partial elution efficiency (E1+E2) (%) 92 ± 5 21± 3 65 
Partial elution efficiency (E3+E4) (%) 6 ± 4 68± 6 34 
Partial elution efficiency (E5+E6) (%) 0.9 ± 0.4 12± 8 3 
Overall elution efficiency (E1 to E4) (%) 98± 1 89 ± 9 100 
Overall elution efficiency (E1 to E6) (%) 98.9 ± 0.2 101 ± 1 103 
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Trapping of fluoride was high for all resins: 99.4 ± 0.8% (n = 2) for the Sep-Pak QMA resin, 96 
± 4% (n = 2) for the Bio-Rad AG-MP1 resin, and 99% for the Oasis MAX resin. However, 
differences were observed among elution efficiencies. Sep-Pak QMA cartridges released 92 ± 
5% (n = 2) of the activity in the first two elutions, while the Bio-Rad AG-MP1 and Oasis MAX 
cartridges released only 21 ± 3% (n = 2) and 65% (n = 1), respectively. After four elution steps, 
all cartridges had high cumulative elution efficiencies, i.e. 98 ± 1% (n=2) and 100% (n=1) for the 
Sep-Pak QMA and Oasis MCX resins, respectively, and 89 ± 9% (n=2) for the Bio-Rad AG-MP1 
resin. Due to the high elution efficiency using minimal eluent volume (only 2 elution steps) using 
the Sep-Pak QMA resin, further experiments focused on this resin. 
In order to explore if eluent concentration could be decreased to reduce the amount of 
TBAHCO3 that enters the downstream reaction, we explored the effect of eluent concentration 
(Table 4-3) using the 3 mg Sep-Pak QMA cartridges. Consistent with the previous experiment, 
trapping of [18F]fluoride was nearly quantitative for all trials (≥93%). Increasing concentration of 
TBAHCO3 was found to increase the amount of activity eluted, especially in the first two elution 
steps. For 3.8 mM TBAHCO3, the efficiency was only 5 ± 1% (n=3) in the first 2 elutions and only 
reached 64 ± 4 (n=3) after 6 elution steps.  In the case of 10 mM TBAHCO3, elution efficiency 
after 2 steps was also low (17 ± 9, n=3), but increased to ~89% (n=3) after 4 elution steps. For 
additional repeats of 25 mM TBAHCO3, we again observed reliable and high recovery (95 ± 2%; 
n=4) within the first two elution steps (12.4 µL). We hypothesized that the missing ~5% of activity 
had likely been released from the cartridge but was lost as residual liquid left behind in the system. 
We explored using eluting with two plugs of 25mM TBAHCO3 followed by two plugs of DI water 
(12.4 µL; to rinse this residual activity to the concentrator outlet), and found that all of the activity 
(100. ± 1%, n=3) was recovered.  Because this approach resulted in a total salt amount lower 
than using 4 elutions of 10 mM eluent, we focused on this approach for further experiments.  
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Table 4-3: Effect of eluent concentration on trapping and elution performance (for 3 mg 
Sep-Pak QMA cartridges).  
Values are presented as average ± standard deviation, from the indicated number of repeats (n). 
Each elution plug was 6.2µL. Eluted percentages are relative to activity that is trapped on the 
cartridge. All measurements are decay corrected. * In the final column, eluent plugs 1 and 2 were 
25 mM TBAHCO3, eluent plugs 3 and 4 were DI water. No further elution steps were performed. 
 TBAHCO3 concentration (mM) 
 3.8 10. 25 25* 
Number of repeats (n) 3 3 4 3 
Trapping efficiency (%) 99.8 ± 0.4 99.8 ± 0.2 93 ± 5 99.6 ± 0.3 
Elution 1+2 efficiency (%) 5 ± 1 17 ± 9 95 ± 2 94 ± 3 
Elution 3+4 efficiency (%) 18 ± 1 72 ± 3 2.9 ± 0.4 5 ± 1 
Elution 5+6 efficiency (%) 41 ± 3 12 ± 7 0.8 ± 0.3 N/A 
Elutions 1 to 6 efficiency (%) 64 ± 4 101 ± 1 99 ± 2 100. ± 1 
 
4.3.3. Optimization of [18F]fallypride synthesis conditions  
First, the effect of TBAHCO3 amount on fluorination efficiency of [18F]fallypride was 
investigated (Table 4-4). Across all conditions, the radioactivity recovery was relatively constant 
(85-93%), but the fluorination efficiency varied significantly, with a maximum value (99% 
conversion; 90% crude RCY) for a concentration of 10 mM. With higher concentration, we 
observed the formation of a radioactive side-product, perhaps due to the base-sensitivity of the 
precursor.  With lower concentration, we did not observe the side product, but the conversion 
decreased. 
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Table 4-4: Effect of different TBAHCO3 concentrations on the performance of the droplet 
synthesis of [18F]fallypride (n=1).  
In each case, the volume of this initial solution was 12.4 µL. After drying, the fluorination was 
performed by adding 2 µL of precursor solution (77 mM; in a mixture of MeCN and thexyl alcohol 
(1:1, v/v)).All reported efficiencies and yields are decay-corrected. 
 
Concentration of TBAHCO3 (mM) 
71 25 10. 3.6 1.2 0.51 
Radioactivity recovery (%) 88 86 91 93 85 86 
Fluorination efficiency (%) 12 65 99 47 32 39 
Crude radiochemical yield (%) 11 56 90. 44 27 33 
Residual on chip (%) 5 10. 5 4 4 3 
 
However, as described above, the elution efficiency of the micro-cartridge with two elutions 
(12.4 µL) of 10 mM TBAHCO3 was very low (17 ± 9%, n=2). Thus even with an optimal synthesis, 
the overall performance (concentrator efficiency and synthesis efficiency) would be expected to 
be very low (~17% x 90% = 15%). Comparing instead the elution procedure with 12.4 µL of 25 
mM TBAHCO3 followed by 12.4 µL of DI water, the concentrator efficiency was much higher (100. 
± 1%, n=3).  Even with the reduced synthesis efficiency with 25 mM TBAHCO3 (65% conversion; 
56% crude RCY), the overall performance would be expected to be good (~100% x 56% = 56%).  
Using the condition of 25 mM TBAHCO3 mixed with the [18F]fluoride solution (12.4 µL), we then 
studied the effect of the amount of precursor (Table 4-5). Increasing the volume of precursor 
solution (77 mM) was found to increase the fluorination efficiency and crude RCY. Increasing from 
2 µL to 4 µL resulted in a significant improvement (from 57 ± 1%, n=2 to 91%, n = 1) in crude 
RCY.  Little difference was observed upon further increasing the precursor solution volume from 
4 µL to 8 µL, but we elected to use the higher amount to provide a safety factor. 
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Table 4-5: Optimization of precursor volume for [18F]fallypride synthesis.  
Concentration of TBAHCO3 solution for all reactions was 25 mM. Precursor concentration was 77 
mM in a mixture of MeCN and thexyl alcohol (1:1, v/v) for all reactions. Note: all reported 
efficiencies and yields are decay-corrected. 
 
Precursor volume (µL) 
2 (n=2) 4 8 
Radioactivity recovery (%) 88 ± 2 93 92 
Fluorination efficiency (%) 65 ± 0 98 99 
Crude radiochemical yield (%) 57 ± 1 91 92 
Residual on chip (%) 10 ± 1 3 6 
 
One factor to consider is whether the DI water rinse during the radionuclide concentration 
phase was important, as this resulted in only a modest increase in activity recovered from the 
concentrator (94 ± 3%, n=3 to 100. ± 1%, n=3), but took additional time for elution (~1min) and 
drying (~1.5 min). Radioactive decay during this added time is less than the gains from the rinsing 
step and thus the rinsing step has an overall benefit process efficiency.  
 
4.3.4. Performance of transfer method between systems  
First the “direct” loading method was tested. The output volume of two elutions (12.4 µL) from 
the concentrator was loaded on the microfluidic chip as two sequential 6.2 µL droplets and dried. 
The micro-cartridge was then rinsed with two 6.2μL DI water plugs and this rinse volume was also 
loaded onto the chip and dried.  In this direct loading method, however, the droplet did not remain 
confined to the reaction zone and spread out along all of the reagent delivery paths. Indeed, CLI 
imaging of the chip after drying confirmed that radioactivity was distributed across all hydrophilic 
areas of the chip after the [18F]fluoride drying process (Figure 4-3D). This is undesirable as much 
of the dried [18F]TBAF complex would not be dissolved into the precursor droplet loaded for the 
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subsequent fluorination step. The problem was likely due to the mismatch between the volume 
(12.4 µL) output from the concentrator and the capacity of the chip (2 µL).  
Next, the “dispenser” loading method was evaluated. The concentrator output was connected 
to the dispenser through an intermediate vial, which first collected the full volume of concentrated 
activity from the 2 eluent plugs and 2 DI water plugs (total 25 µL), and then delivered this volume 
to the reagent loading site via the dispenser as a series of ~0.5 µL droplets while the chip was 
heated at 100°C. We observed that only 48% of the eluted activity was found to be loaded on the 
chip – an additional 26% and 20% of the eluted radioactivity were found as residual activity in the 
dispenser and intermediate vial, respectively. To recover the radioactivity left in the dispenser and 
the intermediate vial, another 4 plugs of DI water (25 µL total) were rinsed through the 
concentrator (without passing through the cartridge), into the intermediate vial, and then 
dispensed as a series of ~0.5 μL droplets and dried in the same manner as described above. 
With this modification, a total of 96% of the eluted radioactivity was loaded onto the chip, with only 
4% of eluted radioactivity found as residual activity in other parts of the system (Table 4-10).  In 
stark contrast to the above method where the full volume was loaded, the CLI image taken after 
the droplet-by-droplet loading and drying step confirmed that all of the radioactivity was confined 
within the reaction zone (Figure 4-3E), suggesting that it would be efficiently solvated when the 
precursor solution was added.  
 
4.3.5. Low activity [18F]fallypride synthesis  
Using the optimal [18F]fluoride concentration and transfer method, [18F]fallypride synthesis was 
initially performed on the integrated system with low overall starting activity to verify the 
functionality of the system and assess its performance (Table 4-6). Starting with 11 – 170 MBq 
[0.3 – 4.5 mCi] [18F]fluoride solution, the trapping efficiency of the micro-cartridge was consistent 
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at 100 ± 0 % (n = 6), followed by high elution of trapped activity (91 ± 7 % ; n = 6) from the 
cartridge. The concentration process followed by the “dispenser” transfer method as described 
above resulted in 89 ± 7 % (n = 6) of overall starting activity loaded onto the chip. The fluorination 
efficiency was 89 ± 5 % (n = 6) and the radioactivity recovery was 81 ± 9 % (n = 6), resulting in a 
crude RCY of 72 ± 8 % (n = 6). After collection of the crude product, only 7 ± 3 % (n = 6) of the 
initially-loaded radioactivity remained stuck to the chip. The crude RCY was slightly higher than 
we previously reported for the droplet-based synthesis using passive transport chips with low 
starting activity [36], i.e. 64 ± 6% (n=4). The previously reported fluorination efficiency and 
radioactivity recovery were 76 ± 4 % (n=4) and 84 ± 4 % (n=4) [36], respectively, suggesting that 
the current synthesis protocol with increased salt concentration and optimized precursor volume 
resulted in substantial improvement in fluorination efficiency. The integrated system had slightly 
lower radioactivity recovery due to the ~6% activity loss from the concentration step.   
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Table 4-6: Detailed performance of integrated process of radionuclide concentration and 
droplet synthesis of [18F]fallypride.  
All reported losses, efficiencies, and yields are decay-corrected. Values are presented as average 
± standard deviation, computed from n=6 repeats. Except where otherwise indicated, losses and 
recovery efficiencies are computed with respect to the starting activity. 
Radionuclide Concentration Steps  
Starting activity (MBq [mCi]) 11-170 [0.3 - 4.5] 
Trapping efficiency (%) 100 ± 0 
Elution efficiency (%) (relative to trapped activity) 91 ± 7 
Waste vial (%) 0 ± 0 
Activity on cartridge after elution (%) 6 ± 6 
Activity on chip after elution (%) 89 ± 7 
Activity in the intermediate vial after dispensing (%) 2 ± 1 
Droplet Radiosynthesis Steps  
Fluorination efficiency (%) 89 ± 5 
Radioactivity recovery (%) 81 ± 9 
Crude RCY (%) 72 ± 8 
Residual activity on chip after collection (%) 7 ± 3 
 
4.3.6. High activity [18F]fallypride synthesis  
Next, syntheses were performed starting with higher activities (ranging from 3.7 GBq to 41 
GBq [0.10 Ci to 1.1 Ci]). While the synthesis was successful at all scales, we observed the crude 
RCY to decrease from 65 % to 25 % as the overall starting activity increased (Figure 4-5A). To 
better understand the effect, we looked at the performance of different factors individually.  In the 
radionuclide concentration module, the elution efficiency of [18F]fluoride was high and consistent 
(96 ± 4%, n=11) across all experimental runs, but the overall performance was adversely 
impacted by the trapping efficiency, which decreased from ~94% to ~63% as the starting activity 
was increased (Figure 4-5B). The decreased trapping performance of the micro-cartridge 
suggests the capacity of the cartridge was insufficient to trap all of the [18F]fluoride. This was 
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surprising as several reports have indicated trapping of high amounts of [18F]fluoride (up to 110 
GBq [3 Ci]) using cartridges packed with only ~2 mg of resin [19,25]. After some investigation, we 
discovered there may be impurities in our source of [18F]fluoride that reduce the trapping efficiency 
far below the capacity as measured by spiking KF solutions with [18F]fluoride (See Appendix).  
Further studies, such as investigation of cartridges with higher resin mass, could potentially 
improve the trapping performance at high activity levels. 
 
Figure 4-5: Performance of synthesis on integrated system at higher activity levels (3.7 – 
41 GBq [0.10 – 1.1 Ci]).  
(A) Overall crude RCY (including radionuclide concentration and crude synthesis) as a function 
of starting activity. (B) Trapping efficiency within the cartridge as a function of starting activity. The 
elution efficiency remained consistent (96 ± 4%, n=11) across all experimental runs and is not 
shown here. (C) Fluorination efficiency as a function of concentrated activity loaded onto the chip.  
 
Looking at the performance of the droplet synthesis process, we observed that the fluorination 
efficiency decreased from around 90% to 40% as the amount of starting activity on the chip 
increased (Figure 4-5C). One potential explanation is that the reaction conditions may move out 
of the optimal range as the precursor to fluoride ratio decreased due to increased starting activity. 
Based on the molar activity of [18F]fluoride at EOB previously reported as 740 GBq/µmol (20 
Ci/µmol)[13], the molar ratio of precursor to fluoride at low starting activity (11 to 170 MBq) ranged 
from 41000 to 2700 while the ratio of that at high starting activity (3.7 to 41 GBq) ranged from only 
100 to 11. Potentially at the higher activity levels the reduced excess of precursor adversely 
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impacts the yield during the short fluorination reaction. Further studies at high activity scales, e.g. 
using different amounts of precursor, could help to determine whether this is a factor. The 
decrease in fluorination efficiency when using high activities might also be due to radiolysis during 
the fluorination step. At the beginning of the reaction, the activity concentration in the reaction 
droplet is quite high, ranging from 460 to 5100 GBq/mL [13 to 140Ci/mL] at the start of the reaction 
(assuming 8 μL precursor solution is added) and increasing somewhat during the fluorination 
reaction as the reaction solvent partially evaporates. Although EtOH was preloaded in the 
collection vial to prevent radiolysis after the collection step (by dilution and because EtOH acts as 
a radical scavenger), some radiofluorinated impurities were observed in the HPLC 
chromatograms of the crude products when starting activity was higher than 8.0 GBq [0.22Ci] 
(Figure 4-11) and the number and quantity of radioactive impurities increased with increased 
starting activity. In contrast, the HPLC chromatogram from a batch starting with 0.20 GBq [5.4mCi] 
of activity showed only two peaks, [18F]fluoride and [18F]fallypride. Further studies would be 
needed to confirm exactly when radiolysis is happening, which would guide potential methods to 
reduce it such as addition of radical scavengers at other stages of the synthesis, or attempting to 
change the droplet geometry (i.e. make it flatter) to reduce radiolysis by geometric effects [68]. 
Another potential approach could be to divide the activity into a few smaller batches (e.g., < 8 
GBq [0.22Ci], where no radiolysis was evident in chromatograms), performing several smaller-
scale syntheses in parallel, and then combining the batches in the presence of a radiolysis 
quenching agent. At <8 GBq [0.22Ci] activity level, the crude RCY was still ~60 %, not far from 
the value 72 % at low activities, potentially enabling overall conversion of 60 % for much larger 
batch sizes. 
Even though the crude RCY was only 25% with 41 GBq [1.1Ci] starting activity, a total of 7.2 
GBq [0.19 Ci] [18F]fallypride product (not decay corrected) was produced after 35 min synthesis, 
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5 min purification via analytical-scale HPLC, and 10 min formulation. The resulting amount of 
[18F]fallypride could easily supply multiple human doses (each needing ~0.37 GBq [10mCi] at the 
time of injection), even if they were scheduled throughout the day (i.e. product loss due to 
radioactive decay).   
The overall crude synthesis took ~35 min. This is 15 min longer than our previously reported 
microdroplet synthesis method [36], due to the extra time needed for concentration of [18F]fluoride 
(~10 min) and transfer, loading, and drying of the [18F]fluoride onto the chip (~7 min), compared 
to only ~1 min in our previous synthesis method [36]. However, the previous method was limited 
to using only ~74 MBq [2 mCi] of activity (2 μL; assuming 37 GBq/mL [1Ci/mL]), and scaling up 
by the methods reported therein would have required sequential loading and drying of 1000 μL to 
load 37 GBq [1Ci] of activity, a process that would have taken ~170 min. 
The molar activity (81-270 GBq/µmol [2.2 – 7.3 Ci/µmol], at the end of formulation) of all 
experimental runs carried out on the integrated system was up to 5 times higher than previously 
reported molar activity for [18F]fallypride synthesis in the macroscale (15 – 78 GBq/µmol [0.4 – 
2.1 Ci/µmol]) [35]. Although 140 – 192 GBq/µmol [3.8 – 5.2 Ci/µmol] was reported by Moon et al, 
relative high starting activity (8.1 – 26 GBq [0.22 – 0.70 Ci]) was needed while the similar molar 
activity was able to be produced on the integration platform using 3.7 GBq (0.1 Ci) starting activity. 
4.4. Conclusions  
In this chapter we successfully integrated an automated [18F]fluoride concentrator with a 
microfluidic droplet-based radiosynthesis platform. We presented a thorough characterization and 
optimization of the concentration parameters, the transfer of concentrated [18F]fluoride between 
the two components, and the synthesis of [18F]fallypride as a model compound. Integration of the 
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two platforms followed by complete automation of the overall process enabled fast, safe, reliable, 
and high-yielding radiosynthesis of [18F]fallypride of clinical quality. 
Repeatable and reliable concentration of [18F]fluoride followed by radiosynthesis of 
[18F]fallypride was performed 17 times with starting activities ranging from 11MBq – 41GBq 
[0.3mCi – 1.1Ci]. Complete concentration and synthesis could be performed in 35 min. For “low 
activity” syntheses starting with 11-170 MBq [0.3 – 4.6mCi], fluorination efficiency and crude RCY 
were 89 ± 5% (n = 6) and 72 ± 8% (n = 6), respectively. As starting activity was increased (4.5 – 
41 GBq [0.12 – 1.1 Ci]), the overall crude RCY dropped significantly, primarily due to the a 
decreasing in the trapping efficiency of [18F]fluoride during the concentration process, which can 
likely be addressed through further cartridge optimization. We also observed some reduction in 
fluorination efficiency as the starting activity was increased, potentially due to mismatched 
stoichiometry or radiolysis effects at higher activities. Future studies will further investigate these 
factors and potential solutions. 
This study shows that despite a small reaction volume (2-8 μL here), it is possible to load 
significant quantities of the radionuclide into microdroplet reactors. In this study, starting activity 
was scaled up to 41 GBq [1.1 Ci], limited only by the capacity of our cyclotron facility. We also 
found the chips to be compatible with the high activity levels and no disruption to the droplet-
based processes was observed. 
This integrated platform enables production of clinical grade PET tracers in large quantities to 
enable imaging of several patients or imaging over several radionuclide half-lives (e.g. 4-5 half-
lives). Production is reliable and can be completed in a short time enabling ease of use within 
research facilities and radio-pharmacies. We are currently exploring the synthesis of additional 
18F-labeled tracers (e.g. [18F]FDOPA, [18F]FET, etc.) and molecules labeled with different 
isotopes. In fact, with small modifications of the concentrator module, we believe that tracers 
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labelled with different radionuclides, such as gallium-68, could also be synthesized at clinically-
relevant scales using the integrated platform. 
4.5.  Appendix 
4.5.1. Cartridge Fabrication  
Loose resin was weighed on a balance (Excellence Plus, Mettler Toledo, Columbus, OH, USA) 
and placed within a 0.2 mL PCR tube (Fisherbrand, Fisher Scientific, Pittsburg, PA, USA). Tubing 
with desired inner diameter was cut to a length of 11 cm. A small polyethylene frit (1/8’’ thick, 20 
micron pore size) was punched out of a larger disk (FT20751P, UCT, Inc., Bristol, PA USA) and 
was inserted into the tubing segment. Depending on tubing inner diameter (0.02’’, 0.03’’ or 0.04’’), 
the frit was cut with a 0.5mm (504528, World Precision Instruments, Sarasota, FL, USA), 0.70mm 
(504529, World Precision Instruments), or 1.0mm (504646, World Precision Instruments) biopsy 
punch. Once the frit was inserted into the tubing, it was pushed down 4cm using the needle 
clearing rod from a spinal needle (Quincke Spinal Needle, BD Biosciences, San Jose, CA, USA) 
and secured within the tubing by pinching the tube to plastically deform the tube near the frit. The 
deformation was performed on the side of the frit closest to the opening in which the frit was 
loaded. Next, the same end of the tubing was connected to vacuum (-12 psi). For the Bio-Rad 
AG-MP1 and Sep-Pak QMA resins, slurries were made by adding 0.2mL of MeOH into the PCR 
tube with the measured resin. For Oasis MAX resin, a slurry was made with 0.2mL of DI water. 
Compared to DI water, the MeOH slurry was loaded into the cartridge tubing more smoothly with 
less fluidic resistance; however, for the Oasis MAX resin, there was no difference between 
solvents. Next, the other end of the tubing was inserted into the bottom of the PCR tube to aspirate 
the slurry into the tubing. The frit served to trap the resin beads within the tubing. The PCR tube 
was then refilled with 0.2mL of the same solvent and aspiration repeated. Rinsing of the PCR 
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tubing was performed a total of 2 times after the initial slurry loading. For cartridges packed with 
MeOH slurries, the cartridge was rinsed an additional time using 0.2mL DI water. After complete 
loading and rinsing, a second frit was punched, placed into the tubing, and is pushed right up to 
the resin bed. Finally, the tubing near this second frit was pinched to secure the frit and resin bed 
in place.  
 
4.5.2. Cartridge Testing  
Cartridge packing was assessed by flowing DI water through cartridges and measuring the 
flow rate. A sample reservoir (Falcon 15 mL conical tube, BD Biosciences, San Jose, CA, USA), 
flow sensor (SLI-2000, Sensirion Westlake Village, CA, USA), a cartridge to be tested, and a 
waste reservoir (Falcon 15 mL conical tube, BD Biosciences, San Jose, CA, USA) were 
connected in series with tubing (0.03’’ID 1/16’’ OD ; 1528L, IDEX). 3mL of DI water was loaded 
into the sample reservoir. The sample reservoir was pressurized to 20 psi with a manual pressure 
regulator (ARX21-N01, SMC Corporation, Japan) connected to a nitrogen source. Flow rates of 
DI water through the cartridge was recorded (at 74 ms intervals) until the 3mL in the sample 
reservoir was depleted. An average flow rate and standard deviation was determined by 
averaging the last 500 samples taken.  
 
4.5.3. Cartridge Preconditioning  
We anticipated eluting the trapped [18F]fluoride with TBAHCO3) the phase transfer catalyst we 
used in our previous work synthesizing [18F]fallypride in micro-droplets [36]. To avoid introducing 
additional types of anions during elution, which could affect the downstream synthesis, we 
performed preconditioning with the same bicarbonate anion, choosing 1M potassium bicarbonate 
(KHCO3) as the preconditioning solution. 
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In order to develop a preconditioning protocol, we fabricated cartridges using 0.03’’ ID tubing 
filled with 3mg of either Bio-Rad AG-MP1, Sep-Pak QMA resin, or Oasis MAX resin. Examining 
first the Bio-Rad AG-MP1 cartridges, we first flowed 0.5mL of preconditioning solution through 
the cartridge at 20 psi. Next, the cartridge was rinsed with DI water of different volumes. (The 
cartridge was left wetted after the rinse; no air drying was implemented.) Finally, we performed 
trapping of [18F]fluoride on the cartridge as described in the main paper to determine the impact 
of rinsing volume (Table 4-7). All solutions were flowed through the cartridge in the same 
direction. If a rinse volume of 8.0 or 10. mL was used, trapping on the cartridge was quantitative.  
Lower amounts of rinse solution (4.0 or 6.0 mL) resulted in significantly worse trapping (i.e. 75% 
or 90%, respectively), perhaps due to small amounts of residual preconditioning solution that 
compete with [18F]fluoride for binding. We elected to use 10mL of DI water for the rinse after 
preconditioning for the Bio-Rad AG-MP1 resin. We tried the same conditions with the other resins 
and found the trapping to be quantitative as well (Table 4-7). 
Note that the preconditioning step can be performed during setup (prior to the introduction of 
the radioisotope) and thus the time needed does not adversely impact the overall radiochemical 
yield. 
 
Table 4-7: Trapping efficiency of [18F]fluoride in cartridges. 
The microcartridges packed with 3mg of varying resin as a function of volume of DI water rinse 
used during preconditioning Unless otherwise noted, data points represent n=1. 
 Resin type 
 Bio-Rad AG-MP1 Sep-Pak QMA Oasis MAX 
Water rinse volume 
(mL) 4.0 6.0 8.0 10. 10. 10. 
Trapping 
Efficiency (%) 75 90 99 99 99.8 ± 0.3 (n = 2) 99 
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4.5.4. Droplet Merging Methods  
4.5.4.1. Overview 
Since the concentrated activity is eluted from the micro-cartridge as a series of 6.2µL plugs, 
the plugs are separated by air gaps. The initial plugs contain most of the concentrated activity, 
while lower amounts of activity are contained in later plugs. We were concerned that these gaps 
between plugs could impede efficient transfer to the downstream piezoelectric dispenser and/or 
adversely affect the dispenser performance. We therefore explored two methods to remove these 
air gaps; one involved the use of an intermediate vial and the other relied on the use of a 
microfluidic droplet merging chip.  
  
 
Figure 4-6: Illustration of droplet merging methods used between the radionuclide 
concentrator and downstream dispenser.  
(A) Intermediate vial setup. (B) Droplet merging chip setup.   
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4.5.5. Intermediate Vial Approach  
One approach to combine the sequential eluent plugs was to first collect them in a small 
intermediate vial, and then transfer the contents of the vial as a contiguous liquid plug to the 
reagent dispenser of the droplet-based synthesizer (Figure 4-6A). 
The intermediate vial was comprised of a 250μL glass insert (5181-1270, Agilent, Santa Clara, 
CA, USA) positioned within a septum-capped 1mL v-vial (W986284NG, Wheaton, Millville, NJ, 
USA). The output of the concentrator was connected to the headspace of this vial via ETFE tubing 
(0.02” ID, 1/16” OD; 1516L; IDEX). An ETFE dip tube (0.01′’ ID, 1/16″ OD; 1529L; IDEX) was 
inserted to the bottom of the intermediate vial and connected to the piezoelectric dispenser of the 
droplet synthesis platform. The end of the dip tube was cut at an angle to minimize dead volume 
at the bottom of the vial during fluid transfer. The dispenser was positioned ~ 5mm above the 
radioisotope loading site of the reaction chip. To allow venting of the vial, we also inserted a 
needle (1” long, 25 gauge; 305125; BD Biosciences, San Jose, CA, USA) and connected this the 
common port of an electronic 3-way valve (LVM105R, SMC Corporation, Japan) via 1/8” OD 
polyurethane tubing (TIUB01, SMC Corporation, Japan). One output of the valve was plugged 
and the other was vented to atmosphere. 
During elution from the concentrator, this valve is vented to allow trapped air to escape from 
the intermediate vial. After completion of elution, this valve is closed (switched to the plugged 
output), and inert gas of the desired dispensing pressure is supplied by the concentrator to drive 
the vial contents toward the dispenser. 
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4.5.6. Microfluidic Chip Approach  
To avoid potential losses due to splashing from the intermediate vial approach, we also 
explored the development of a microfluidic droplet merging chip to remove the air gaps (Figure 
4-6B). 
4.5.6.1. Chip design and operation 
The chip (Figure 4-7) is comprised of three layers. The top layer (“fluid layer”) was fabricated 
out of polyether ether ketone (PEEK) and has a fluid channel machined into it (1.6 mm wide, 0.63 
mm deep, 30.3 mm long) along with two threaded inlet and outlet ports which can be interfaced 
to standard ¼-28 fittings. The middle layer is a Teflon membrane with small (0.22μm) pores which 
serves as a gas-permeable membrane allowing air in between droplets to pass through to the 
other side while preventing the passage of aqueous liquids. The bottom layer (“vent layer”) was 
machined out of acrylic and contains a channel matching the fluid layer (except depth was 
increased to 2.0 mm). The three layers were clamped together by eight M3 machine screws to 
form a liquid-tight seal. 
Connections to and from the droplet merging chip are shown in Figure 4-7D. The output of the 
[18F]fluoride concentrator is connected to the fluid inlet port of the chip via ETFE tubing (0.01′’ ID, 
1/16″ OD; 1529L, IDEX). The fluid outlet port of the chip is connected via silicone tubing (1/32’’ID, 
1/16’’OD; 05-14, Automate Scientific, Berkeley CA, USA) to a piezoelectric dispenser positioned 
in the synthesis platform. The dispenser was positioned ~ 5mm above the radioisotope loading 
site of the reaction chip (Figure 4-3). Near the outlet of the droplet merging chip, the silicone tubing 
passed through a pinch valve (ASCO251866, ASCO Valves, Florham Park, NJ, USA). A pinch 
valve was chosen here due to the negligible dead volume compared to other valve types. In the 
vent layer, one vent port is plugged while the other vent port is connected to the common port of 
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a 3-way valve (LVM105R, SMC Corporation, Japan) to enable switching between vented or 
plugged states. 
During operation, the pinch valve is initially closed, and the vent layer is vented to atmosphere. 
The first liquid plug from the concentrator enters the chip (as trapped air escapes through the vent 
layer) but cannot travel to the outlet port. The elution process of the [18F]fluoride concentrator 
proceeds normally. As each plug is eluted, the eluent enters the fluid channel of the droplet 
merging chip and merges with the existing liquid as air in the air gap is pushed through the 
membrane layer. After all of the elution steps are complete and the elution plugs are merged, the 
pinch valve is opened and the vent outlet is plugged using the 3-way valve. Pressure is applied 
from the concentrator to push the merged eluent plug toward the reagent dispenser of the reactor 
chip.   
 
 
   
Figure 4-7: Droplet merging chip.  
(A) Structure of assembled chip. (B) Photograph of assembled chip. (C) Bottom view of fluid layer, 
top view of membrane layer, and top view of vent layer, showing channel, inlet and outlet ports, 
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and holes for securing screws. (D) Side view showing the three layers (with securing screws 
omitted for clarity) and connections of the chip to upstream radioisotope concentrator and 
downstream radiosynthesis platform.  
 
4.5.6.2. Chip Performance  
We characterized the residual activity (dead volume) of the droplet merging chip as a function 
of the number of elution plugs. A mock eluent solution was made containing [18F]fluoride at a 
known concentration and plugs of this mock eluent solution (each 6.2 μL) were loaded into the 
droplet merging chip and merged using the procedure described above. The merged plug was 
collected in a small vial, and the recovered activity measured. Following each experiment, the 
chip was disassembled and cleaned to remove the possibility of carryover activity into subsequent 
experiments. The results are shown in Figure 4-8. When only one elution plug was passed 
through the chip, only 70 ± 6% (n = 3) of the activity was recovered. As the number of elution 
plugs was increased, the total amount of activity that was recovered increased. For 3 or 4 elution 
plugs, the activity recovery was high, i.e. 92.1 ± 5.1% (n=3) and 94.2 ± 1.9 (n=3), respectively. 
It should be noted that these experiments were performed using plugs of uniform activity 
concentration. In real operation of the [18F]fluoride concentrator, later plugs would be more dilute 
and the loss of activity may in fact be lower than measured in these experiments. 
 
 
 
 
115 
 
 
 
Figure 4-8: Activity recovery from the droplet merging chip.  
Each data point represents an average of 3 repeats with error bars representing standard 
deviation.  
 
Ultimately, we found the performance of the droplet merging chip to be comparable to the 
intermediate vial, and thus opted to use the intermediate vial. The complicated operation 
(compared to the vial) and susceptibility for membrane breakthrough (if fluid pressure is too high 
or if fluid has too high an organic solvent content) reduce its practicality.  
 
4.5.7. Simulating higher activity levels 
When performing trap and elute experiments, we saw some limitations with the 3mg cartridge 
at higher activity levels, and therefore performed experimentation to explore what factors may be 
influencing trapping capacity in our cartridges. 
4.5.7.1. KF Spiking 
To simulate high starting activities (i.e., 37 GBq), we tried performing trapping experiments 
with low amounts of [18F]fluoride spiked into a potassium fluoride (KF) solution. Estimating the 
molar activity of [18F]fluoride from our cyclotron to be 740 GBq/μmol (based on prior 
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measurements), the total amount of fluoride ion (both F-18 and F-19 forms) expected for 37 GBq 
[1 Ci] should be 0.05 μmol. Mock solutions were prepared using different concentrations of KF 
(1.0 mL volume) chosen from 50 – 5000 μM, which were expected to correspond to simulated 
activity ranges of 37 GBq to 3.7 TBq. These solutions were spiked with 50 μL of [18F]fluoride (15 
- 37MBq [0.4 - 1mCi]), an amount of activity sufficient for accurate activity measurements, but 
contributing negligible fluorine ion compared to the KF content. The measured trapping efficiency 
for each of these solutions is shown in Figure 4-9. 
 
 
 
 
Figure 4-9: Trapping efficiency of a solution containing KF of various concentrations. 
The solution is spiked with a small amount of [18F]fluoride. All trapping experiments were 
performed with micro-cartridges packed with 3 mg of Sep-Pak QMA resin. Each condition was 
tried once (n=1). Dotted line represents a logarithmic fit and has an R2 = 0.9922.  
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Trapping efficiency of the mock 37 GBq [1 Ci] sample (i.e. 50 μM KF) was 100% suggesting 
the cartridge should be able to trap 37Gbq [1Ci] of radioactivity, but the trapping was observed to 
fall off rapidly as the amount of KF increased. For example, at a mock activity level of 740 GBq 
[20 Ci] (i.e., 1 mM KF), we can interpolate the measurements and estimate a trapping efficiency 
of ~40%. 
4.5.7.2. Decayed, bombarded [18O]H2O Spiking 
We performed additional experiments using decayed, bombarded [18O]H2O to evaluate 
whether the KF spiking measurements would be predictive of actual performance. We took 1.0 
mL of decayed bombarded [18O]H2O (taken from a bombardment when the activity at end of 
bombardment was ~37Gbq [1.0 Ci]). Though the [18F]fluoride had decayed, the total fluoride 
content was not expected to have significantly changed since the amount of [19F]fluoride right 
after bombardment far exceeds the amount of [18F]fluoride produced. We spiked in a small amount 
of activity (~19 MBq [0.5 mCi]) and performed a trapping experiment. Surprising, the trapping 
efficiency was found to be only 42%. 
While we believe this experiment to be predictive of the results using 37 GBq of freshly 
produced [18F]fluoride, this result suggested that KF solution is not a good substitute for 
performing mock experiments. Furthermore, it suggests that there may be a high concentration 
of a competing species (e.g. anion, metals) present in bombarded [18O]H2O that may also be 
interacting with the cartridge and limiting the capacity available for trapping fluoride. 
Further study is needed to determine the impurities and how they may be hindering trapping. 
As mentioned earlier, other groups have reported efficient trapping of up to 110 GBq (3 Ci) using 
cartridges with only 2 mg of resin (Our cartridges used 3 mg of resin). 
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In the next section, we explore whether larger resin mass can improve the trapping capacity, 
and in the subsequent section, we explore the use of SCX cartridges to filter the bombarded 
[18O]H2O to remove interfering species. 
4.5.8. Trap and Elute with Larger Resin Mass  
To attempt to increase trapping capacity, we explored cartridges packed with higher resin 
masses, i.e. 5mg of either Sep-Pak QMA or Oasis MAX resin. 
Due to limited supply of high levels of [18F]fluoride or corresponding amounts of bombarded 
[18O]H2O, we performed initial experiments with low amounts of activity spiked into a 1 mM KF 
solution (as described above). This KF concentration (corresponding to 740 GBq [20 Ci]) was 
chosen because the trapping efficiency in spiking experiments was ~40%, which matched the 
trapping efficiency in spiking experiments using 1.0 mL of decayed [18O]H2O from 37 GBq [1 Ci] 
bombardment. We are aware that the low trapping efficiency from the bombarded [18O]H2O 
spiking experiments may not entirely be due anion contamination, but, nonetheless, this 
experiment could still give us some insight on the trapping capacity of cartridges with larger resin 
amounts. 
Detailed trapping and elution behavior can be seen in Table 4-8.  Compared to 42% trapping 
for the 3mg Sep-Pak QMA cartridge reported above, trapping efficiency was 71± 1% (n = 2) for 5 
mg Sep-Pak QMA cartridges and 68± 5% (n = 2) for 5 mg Oasis MAX cartridges. For 7 mg of 
Oasis MAX resin, trapping efficiency increased to 84% (n = 1), indicating that more resin mass 
can indeed improve the trapping. 
One drawback of the larger resin mass is decreased elution efficiency.  For the 5 mg cartridges, 
even after four elution steps, the elution efficiencies were 78± 1% (n = 2) and 78± 1% (n = 2) for 
Sep-Pak QMA and Oasis MAX resin, respectively. For the 7 mg Oasis MAX cartridge, elution 
efficiency was only 47% (n=1) after four elution steps. Comparing the overall recovery efficiency 
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(i.e. trapping efficiency x elution efficiency (4 elutions)), the 5 mg Sep-Pak QMA cartridges 
performed the best (55.5 ± 0.4%, n = 2) compared to 5mg Oasis MAX (53 ± 4%, n = 2), and 7mg 
Oasis MAX (39%, n = 1).   
 
Table 4-8: Trapping and elution performance.  
A [18F]fluoride solution spiked with 1mM KF using cartridges with increased resin mass. Values 
represent average ± standard deviation, calculated from the indicated number of repeats (n).  
 Resin type 
 Sep-Pak QMA Oasis MAX Oasis MAX 
Cartridge Mass (mg) 5 5 7 
Tubing ID (inch) 0.03 0.03 0.04 
Number of repeats (n) 2 2 1 
Trapping efficiency (%) 71 ± 1 68 ± 5 84 
Elution 1+2 Efficiency (%) 30 ± 2 27± 1 11 
Elution 3+4 Efficiency (%) 49 ± 1 50.3 ± 0.3 36 
Elution 5+6 Efficiency (%) 19.3 ± 0.1 21 ± 3 39 
Elution efficiency (4 elutions) (%) 78 ± 1 78± 1 47 
Recovery Efficiency (4 elutions) (%) 55.5 ± 0.4 53 ± 4 39 
Elution efficiency (6 elutions) (%) 98 ± 1 98± 3 86 
 
 
4.5.9. SCX filtration of [18F]fluoride 
4.5.9.1. [18F]Fluoride Filtering Testing  
We explored whether passing the [18F]fluoride/[18O]H2O solution through an SCX cartridge 
helped to improve the trapping efficiency of the downstream concentrator module. We 
hypothesized that SCX cartridges may filter out some competing contaminants and/or particles 
that may be interfering with the [18F]fluoride trapping efficiency.  
Two different SCX cartridges were explored: Oasis MCX Plus short cartridges (225mg, 
186003516, Waters, Milford, MA, USA) and Maxi-Clean cartridges (600mg, 21902, Alltech 
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Associates Inc. Deerfield, IL, USA). Before use, SCX cartridges were first preconditioned via 
manufacturer recommendations. Alltech Maxi-clean cartridges were preconditioned with 10mL of 
DI water while Oasis MCX cartridges were conditioned with 5mL of MeOH followed by 5mL of DI 
water. 
1.0 mL of decayed bombarded [18O]H2O (1mL; original activity of ~37 GBq [~1 Ci]), was 
manually passed through a SCX cartridge via syringe, and then spiked with 50 μL of [18F]fluoride 
(15 - 37MBq [0.4 - 1mCi]). The spiked solution was then used as the source solution for the 
radioisotope concentrator and the trapping efficiency was measured. For this experiment, we 
used preconditioned 3 mg or 5 mg micro-cartridges packed with Sep-Pak QMA resin. The results 
are listed in Table 4-9. For the 3mg Sep-Pak QMA cartridges, SCX filtration (will Alltech Maxi-
Clean cartridge) resulted in a dramatic increase in trapping efficiency from 42% (n = 1) to 78 ± 
4% (n = 2). The trapping efficiency was even higher (92 ± 1%, n=2) when the Oasis MCX cartridge 
was used for the SCX filtration step. For the 5mg cartridges, this effect was less significant. 
Trapping efficiency increased from 81 ± 4% (n = 3) to 96 ± 2% (n = 4) after SCX filtration using 
the Alltech Maxi-Clean cartridge. Oasis MCX cartridges in conjunction with the 5mg Sep-Pak 
QMA cartridges were not tested. Interestingly, after SCX filtration, higher trapping efficiency could 
be obtained with 3 mg cartridges, compared to trapping efficiency of 5 mg cartridges if SCX 
filtration was not performed.  We elected to use the 3 mg Sep-Pak QMA cartridges in conjunction 
with SCX filtration (Oasis MCX cartridge) for the majority of experiments in the paper. 
Future studies are needed to determine if higher resin masses, in conjunction with the SCX 
module, could consistently achieve high trapping efficiencies, as well as high elution efficiency 
with low eluent volume. 
 
Table 4-9: Trapping performance of [18F]fluoride using the microcartridges. 
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The [18F]fluoride solution spiked into a solution of decayed [18O]H2O that was filtered through an 
SCX cartridge or not filtered (indicated as “None” for SCX cartridge type).  The micro-SAX 
cartridges were all packed with Sep-Pak QMA resin. 
SCX cartridge type None Alltech Maxi-Clean Oasis MCX None Alltech Maxi-Clean 
Micro-SAX cartridge 
resin mass (mg) 3 3 3 5 5 
Trapping Efficiency (%) 42 
(n = 1) 
78 ± 4 
(n=2) 92 ± 1 (n=2) 81 ± 4 (n=3) 96 ± 2 (n=4) 
 
 
4.5.9.2. Setup and Operation of SCX Filtration Module  
The core of SCX filtration module (Figure 4-10) is a 7-port, 6-position rotary stream selection 
valve (“filtration selection valve”, Titan HT 715-005, IDEX Health and Science). Connected to 
three inputs of this valve are three septum-capped glass v-vials (3mL, W986277NG, Wheaton, 
Millville, NJ, USA) for supplying [18F]fluoride and two rinses of DI water (each 0.5 mL). The 
remaining three inputs of the stream selection valve are not used. The vials are each connected 
to the valve via an ETFE dip tube (0.02′’ ID, 1/16″ OD ETFE tubing; 1516L; IDEX), and are also 
connected to a regulated inert gas source or vented to atmosphere via 3-way valves (V1-V3) 
(S070B-5DG, SMC). Inert gas pressure was provided from an electronic pressure regulator 
(ITV0010-2BL, SMC Corporation, Japan) connected to a nitrogen source. The output of the 
stream selection valve is connected to an SCX cartridge and then to a collection vial (3mL v-vial; 
Wheaton) via 0.02′’ ID, 1/16″ OD ETFE tubing (1516L, IDEX). Two strong cation exchange 
cartridges were explored; Oasis MCX plus short cartridges (225mg, 186003516, Waters), and 
Maxi-Clean cartridges (600mg, 21902, Alltech). The collection vial is also connected via a 3-way 
valve (LVM105R, SMC Corporation, Japan) to atmosphere or the regulated inert gas supply. 
Finally a dip tube from the collection vial is connected to the fluoride input port of the [18F]fluoride 
concentrator via 0.02′’ ID, 1/16″ OD ETFE tubing (1516L, IDEX).  
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The use of the SCX filtration module required a slight modification of the [18F]fluoride trapping 
procedure. Initially the reagent selection valve of the SCX filtration module is set to the [18F]fluoride 
vial, and V4 is set to vent the collection vial of the module. V1 is connected to pressure (20 psi) 
pushing [18F]fluoride through the SCX cartridge into the SCX module collection vial. Immediately 
after, the reagent select valve is switched to connect to the first water rinse vial and V2 is 
connected to pressure (20 psi) to deliver 0.5 mL of DI water through the SCX cartridge to recover 
residual [18F]fluoride. The radioisotope concentrator is then configured in “trapping” mode, the 
reagent selection valve of the SCX filtration module is changed to an unused (plugged) position 
(to prevent pressure leakage from the SCX module collection vial), and V4 is switched to connect 
to pressure (20 psi) to drive the mixture of filtered [18F]fluoride and DI water rinse to the 
concentrator. When complete, V4 of the SCX filtration module is switched to vent the collection 
vial, the reagent select valve is connected to the second water rinse vial, and V2 is connected to 
pressure (20 psi) to flush the 0.5 mL of DI water through the SCX cartridge and into the collection 
vial. Finally, the reagent selection vial of the SCX filtration module is switched to an unused 
(plugged) position, and V4 is connected to pressure (20 psi) to drive the water to the radionuclide 
concentrator. Operation of the concentrator module then proceeds as described earlier. 
 
 
 
123 
 
 
 
Figure 4-10: Schematic of the SCX filtration module.  
 
 
4.5.10. Optimization of Transfer Method  
To optimize the transfer method, the components were disassembled after transfer, and 
activity left in the dispenser, activity loaded on the chip, activity left in the intermediate vial and 
activity left in the tubing and frit were measured to figure out the activity loss. 
 
Table 4-10: Activity loss in various locations within the integrated system. 
 
 Distribution of radioactivity after elution 
 Without the 2nd DI water rinse With the 2nd DI water rinse 
Activity left in the dispenser (%) 25.6 3.1 
Activity loaded on the chip (%) 48.2 95.9 
Activity left in the intermediate vial (%) 20.1 0.5 
Activity left in the tubing and frit (%) 1.5 0.5 
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4.5.11. HPLC purification chromatograms 
 
 
 
Figure 4-11: Examples of HPLC purification (crude) chromatograms of syntheses starting 
with different activities. 
(A) 0.19 GBq, (B) 8.5 GBq, (C) 21 GBq, and (D) 41 GBq. 
  
 
 
 
125 
 
 
5. Chapter 5: Compact microdroplet radiosynthesizer using a 
rotation stage 
5.1. Introduction 
Positron emission tomography (PET) is a non-invasive medical imaging method that can be 
used as a research tool for studying the biological processes involved in the course of diseases 
and making critical measurements during the development of new drugs [3,69,70]. It is also widely 
used in the clinic to diagnose and stage disease, predict treatment response, and evaluate 
efficacy of treatment [71–73]; furthermore, PET can also be used to help guide treatment and 
serves a critical role in the emerging field of personalized medicine [74]. Shortly before undergoing 
a PET imaging procedure, the patient (or subject) must be injected with a short-lived radiolabeled 
compound, which is designed to highlight a particular biological target or pathway. 
The current processes and technologies for producing these PET “tracers” are complex and 
expensive, which greatly hinders research efforts into the development and validation of novel 
tracers, or the translation of new tracers into the clinic. For more than a decade, investigators 
have been exploring the use of microfluidics to improve the production of PET tracers[8,75,76] 
and have advanced this technology to the point of demonstrating production of tracers suitable 
for clinical use [25,65,66]. 
These studies, especially the use of micro-volume reactors [19,21,25,77] or droplet-based 
reactors [11,36,78] , have revealed several important advantages of microfluidics in 
radiochemistry that can reduce the cost and complexity of PET tracer production [10]. Though all 
uses of PET tracers can benefit, the improvements will be especially impactful for the small 
batches needed in research applications or in the initial studies to develop novel tracers and 
translate them to the clinic. Particularly important advantages of small-volume radiosynthesizers 
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compared to conventional synthesizers are the significant reduction in footprint of the 
radiochemistry setup, enabling self-shielding rather than requiring operation within specialized 
“hot cells”, and the 2-3 orders of magnitude reduction in consumption of expensive reagents (e.g. 
precursors, peptides, etc.). Microvolume synthesis has also been shown to boost the molar 
activity of tracers produced via isotope exchange [67] and can achieve high molar activities even 
when producing small batches of tracers [13], both of which are not possible in conventional 
systems unless very high amounts of radioactivity are used. 
As a testament to the versatility of these approaches, a wide range of PET tracers have been 
synthesized using these methods[27], including [18F]fallypride [21,28,36,79], [18F]FDG 
[19,26,27,36,57], [18F]FLT [29], [18F]SFB [23,27], [18F]FDOPA [80], sulfonyl [18F]fluoride [78] , 
[18F]FMISO [77], [18F]FES [77], [18F]AMBF3-TATE [67], etc. In addition, these microscale reactors 
are scalable, with the possibility to produce clinically-relevant doses by increasing the 
concentration of radioisotope supplied into the system [25,37,81]. 
Our group has focused particularly on droplet-radiochemistry platforms, including 
electrowetting-on-dielectric (EWOD) devices [11] and a more recent system using patterned 
wettability for passive droplet transport [36], due to the extremely small reaction volumes and 
straightforward fluidic system. In the passive transport approach, the chip consists of a Teflon 
coated silicon wafer with patterned circular hydrophilic reaction zone in the center and several 
radial tapered channels to transport droplets from reagent loading sites at the periphery into the 
reaction zone. Though this approach significantly decreased the chip cost and complexity, and 
we could successfully synthesize [18F]fallypride and [18F]FDG, we have found the behavior of the 
droplets to be sensitive to the solvent type, temperature, and volume, sometimes leading to 
unwanted spreading out of the solution along the tapered reagent pathways of the chip. Such 
spreading can adversely affect synthesis performance and lead to inconsistent results, requiring 
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expenditure of time and effort to optimize reagents and solvents, loading protocols (timing) and 
other aspects to achieve high synthesis performance. 
To avoid those issues, and further streamline the adoption of new protocols to the microdroplet 
format, we present here an even simpler microfluidic chip with just a circular hydrophilic reaction 
zone. Instead of reagents moving from multiple fixed loading sites (located under reagent 
dispensers) to the reaction zone spontaneously, a simple system is designed to rotate the chip 
under a carousel of reagent dispensers for on-demand loading of desired reagents when needed. 
We also spent considerable effort in designing the system to be as compact as possible (similar 
to the size of a coffee cup) to show that sophisticated multi-step radiochemistry can be 
accomplished with a small apparatus. In this chapter, we present the design and operation of this 
next-generation microdroplet radiosynthesizer and show that it can quickly and efficiently 
synthesize the PET tracer [18F]fallypride. The platform is able to leverage our other efforts to 
develop high-throughput radiochemistry methods (i.e. using arrays of hydrophilic reaction zones 
on a single chip) [82], enabling the rapid translation of the optimum protocol to the new automated 
platform with zero changes. As a result of the simplified approach, we expect to help enable the 
low-cost production of diverse tracers for research as well as clinical applications. 
5.2. Materials and Methods 
5.2.1. Materials 
Anhydrous acetonitrile (MeCN, 99.8%), methanol (MeOH), 2,3-dimethyl-2-butanol (thexyl 
alcohol, 98%), trimethylamine (TEA), ammonium formate (NH4HCO2; 97%) were purchased from 
Sigma-Aldrich. Tetrabutylammounium bicarbonate (TBAHCO3, 75mM), tosyl fallypride (fallypride 
precursor, >90%) and fallypride (reference standard for [18F]fallypride, >95%) were purchased 
from ABX Advanced Biochemical Compounds (Radeberg, Germany). Food dye was purchased 
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from Kroger (Cincinnati, OH, USA) and diluted with solvents in the ratio of 1:100 (v/v) to perform 
a mock synthesis. DI water was obtained from a Milli-Q water purification system (EMD Millipore 
Corporation, Berlin, Germany). No-carrier-added [18F]fluoride in [18O]H2O was obtained from the 
UCLA Ahmanson Biomedical Cyclotron Facility.   
 
5.2.2. Apparatus 
Reactions were performed on microfluidic chips (Figure 5-1), each comprising a hydrophilic 
circular reaction site (4 mm diameter) patterned in the hydrophobic Teflon AF surface of a silicon 
chip (25 mm x 27.5 mm). The patterned chips were prepared by coating silicon wafers with Teflon 
AF, and then etching away the coating to leave the desired hydrophilic pattern as described 
previously[36]. For this work, we omitted the final Piranha cleaning step. Chips were used once 
each and then discarded after use. 
 
 
Figure 5-1. Photo of the microfluidic chip and the fabrication method.  
(A) Diameter of the hydrophilic reaction site is 4 mm. (B) Photolithography process for fabrication 
of the microfluidic chip. 
 
Operations on the microfluidic chip were automated by a custom-built compact framework 
(Figure 5-2), consisting of a rotating, temperature-controlled platform, a set of reagent 
dispensers, and a collection system to remove the reaction droplet at the end of the synthesis. 
The control system is shown in Figure 5-3. 
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Figure 5-2. The microdroplet radiosynthesizer.  
(A) A CAD rendering of the system alongside a 12 oz. coffee cup. (B) A photograph of the 
synthesizer, including the reagent dispensing, product collection, temperature control, and 
rotation subsystems. 
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Figure 5-3. Control system of the microdroplet radiosynthesizer. 
 
Heating was provided by placing the chip in direct contact with a 25 mm x 25 mm ceramic 
heater (Ultramic CER-1-01-00093, Watlow, St. Louis, MO, USA). A thin layer of thermal 
conducting paste (OT-201-2, OMEGA, Norwalk, CT, USA) was applied between the chip and 
heater to improve heat transfer. The heater was glued atop a 40 mm x 40 mm thermoelectric 
device (Peltier, VT-199-1.4-0.8, TE Technology, Traverse City, MI, USA) mounted to a 52 mm x 
52 mm integrated heatsink and fan (4-202004UA76153, Cool Innovations, Concord, Canada). 
The integrated cooling part was mounted via a custom aluminum plate to a motorized rotation 
stage (OSMS-40YAW, OptoSigma, Santa Ana, CA, USA). The signal from a K-type thermocouple 
embedded in the heater was amplified through a K-type thermocouple amplifier (AD595CQ, 
Analog Devices, Norwood, MA, USA) and connected to an analog input of the data acquisition 
device (DAQ; NI USB-6003, National Instruments, Austin, TX, USA). The power supply (120 V 
 
 
 
131 
 
 
AC) for the heater was controlled by a solid-state relay (SSR, Model 120D25, Opto 22, Temecula, 
CA, USA) driven by a digital output of the DAQ. An on-off temperature controller was programmed 
in LabView (National Instruments) to maintain a desired setpoint. A power step down module 
(2596 SDC, Model 180057, DROK, Guangzhou, China) was connected to a 24V power supply to 
provide 12V for the cooling fan, which was switched on during cooling via an electromechanical 
relay (EMR, SRD-05VDC-SL-C, Songle Relay, Yuyao city, Zhejiang, China) controlled by the 
LabView program. The motorized stage was driven by a stage controller (GSC-01, OptoSigma) 
controlled by the LabView through serial communication.  
Droplets were loaded at the reaction site of the microfluidic chip through miniature, solenoid-
based, non-contact dispensers. Chemically-inert dispensers with FFKM seal (INKX0514100A, 
Lee Company, Westbrook, CT, USA) were used for reagents containing organic solvents, while 
a dispenser with EPDM seal (INKX0514300A, Lee Company) was utilized to dispense 
[18F]fluoride solution. Each dispenser was connected to a pressurized vial of a reagent and the 
internal solenoid valve was opened momentarily to dispense liquid. More details of the fluidic 
connections were reported previously[36]. Each dispenser was connected to a dedicated 
controller (IECX0501350A, Lee Company), driven by a digital output from the DAQ and controlled 
via the LabView program. Since the volume of dispensed liquid is related to the driving pressure, 
the opening duration of the valve, and physical properties (e.g. viscosity) of the solvent, calibration 
curves were generated for each reagent as described previously[36]. 
A fixture was built to hold up to 7 dispensers with nozzles located ~3 mm above the chip. Each 
dispenser was secured within a hole by an O-ring (ORBN005, Buna-N size 005, Sur-Seal 
Corporation, Cincinnati, OH, USA). The fixture was mounted to a vertically-oriented movable 
slide, and a single-acting air cylinder (6604K13, McMaster-Carr) was configured to allow the 
fixture to be raised 16 mm above the surface to facilitate installation and removal of microfluidic 
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chips and cleaning of the dispensers. The air cylinder was connected to a 3-way valve (LVM105R-
2, SMC Corporation) to apply either pressure (~210 kPa [~30 psi]) or vent to atmosphere, the 
valve controlled by the LabView program.  
The heater and chip were mounted off-center of the rotation axis. During multi-step reactions, 
the chip was rotated to position the reaction site underneath a dispenser to add the desired 
reagent, and was then rotated to a position in between dispensers while performing evaporations 
or reactions at elevated temperatures. 
To transfer the final crude product from the reaction site on the chip to the collection vial, a 
metal tubing (0.25 mm inner diameter) was mounted in the dispenser fixture such that the end 
was ~0.5 mm above the chip surface. At the end of synthesis, the platform was rotated such that 
the reaction droplet was aligned under the collection tube and vacuum was applied to the 
headspace of the collection vial using a compact vacuum pump (0-16" Hg vacuum range, D2028, 
Airpon, Ningbo, China) connected via a vacuum regulator (ITV0090-3UBL, SMC Corporation) 
controlled via LabView program. Vacuum pressure was ramped from 0 to 14 kPa (~2 psi, 0.01 
psi increment every 50 ms) over 10 s to transfer the droplet into the vial. 
After the synthesis, dispensers were each cleaned by flushing with DI water (1 mL) and MeOH 
(1 mL) in sequence, driven at 69 kPa [~10 psi], and then drying with nitrogen for 2 min.  
 
5.2.3. Automated droplet synthesis of [18F]fallypride 
As a model reaction to demonstrate the ability to perform multi-step reactions automatically 
with the microdroplet radiosynthesizer, we performed syntheses of the PET tracer [18F]fallypride. 
The synthesis protocol was adapted from a manual synthesis protocol developed via manual 
optimization efforts using microfluidic chips having a similar circular hydrophilic reaction zone[82]. 
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A [18F]fluoride stock solution was prepared by mixing [18F]fluoride/[18O]H2O (60 μL, ~110 MBq 
[~3 mCi]) with 75 mM TBAHCO3 solution (40 μL). The final TBAHCO3 concentration was 30 mM. 
Precursor stock solution was prepared by dissolving tosyl-fallypride precursor (2 mg) in a mixture 
of MeCN and thexyl alcohol (1:1 v/v, 100 μL) to result in a final concentration of 39 mM. A stock 
solution for dilution of the crude product prior to collection was prepared from a mixture of MeOH 
and DI water (9:1, v/v, 500 µL). These solutions were loaded into individual reagent vials 
connected to dispensers.  
To carry out the synthesis on the chip, the chip was first rotated to position the reaction site 
below the [18F]fluoride/TBAHCO3 dispenser and eight 1 μL droplets of [18F]fluoride/TBAHCO3 
solution (~8.9 MBq; ~0.24 mCi) were sequentially loaded onto the chip (total time < 10s). The chip 
was rotated 45° counterclockwise (CCW) and heated to 105°C for 1 min to evaporate the solvent 
and leave a dried residue of the [18F]TBAF complex at the reaction site. Then, the chip was rotated 
45° CCW to position the reaction site under the precursor dispenser and twelve 0.5 μL droplets 
of precursor solution were loaded to dissolve the dried residue. Next, the chip was rotated 45° 
CCW and heated to 110°C for 7 min to perform the radiofluorination reaction. Afterwards, the chip 
was rotated 45° CCW to position the reaction site under the collection solution dispenser, and 
twenty 1 μL droplets of collection solution were deposited to dilute the crude product. After rotating 
the chip 90° CCW to position the reaction site under the collection tube, the diluted solution was 
transferred into the collection vial by applying vacuum. The collection process was repeated a 
total of four times to minimize the residue on the chip (i.e. by rotating the chip 90° CW back to the 
collection solution dispenser, loading more collection solution, etc.). A schematic of the whole 
synthesis process is shown in Figure 5-4.  
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Figure 5-4. A schematic of the synthesis process.  
(A) Top view schematic of the (moveable) microfluidic chip and (fixed) locations of reagent 
dispensers and the collection tube. The angle marker shows the center of rotation. (B) Synthesis 
scheme. (C) Schematic (showing chip orientation) and photograph of the chip (using mock 
reagents) for each step of the [18F]fallypride synthesis process. First the chip was rotated under 
the [18F]fluoride/TBAHCO3 dispenser and 10 droplets (1μL each; DI water, dyed yellow) were 
loaded at the reaction site. Then, the chip was rotated 45° and heated to 105°C to remove the 
solvent. Next, the chip was rotated 45° under the precursor dispenser, 10 droplets (1μL each; 1:1 
v/v MeCN/ thexyl alcohol, dyed red) were loaded, and then the chip was rotated 45° and heated 
to 110°C to simulate the fluorination reaction. Next, the chip was rotated 45° under the collection 
solution dispenser and 20 droplets (1μL each; 9:1 v/v MeOH/water, dyed blue) were loaded to 
dilute the reaction mixture. Finally the chip was rotated 90° under the collection tube, and the 
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droplet was collected into the product vial using vacuum. The collection solution loading and 
collecting were repeated a total of 4 times to minimize the residue left behind at the reaction site. 
 
5.2.4. Analytical methods           
Performance of the [18F]fallypride synthesis on the chip was assessed through measurements 
of radioactivity and fluorination efficiency. 
Radioactivity was measured with a calibrated dose calibrator (CRC-25R) at various times 
throughout the synthesis process, including starting radioactivity on the chip after loading of 
[18F]fluoride/TBAHCO3 stock solution, radioactivity of crude product transferred into the collection 
vial and radioactivity of residue on the chip after collection step. Radioactivity recovery was 
calculated as the ratio of radioactivity of collected crude product to starting radioactivity on the 
chip. Residual activity on the chip was the ratio of radioactivity on the chip after collection to the 
starting radioactivity on the chip. All measurements were corrected for decay. 
Fluorination efficiency of the crude product collected from the chip was determined via radio 
thin layer chromatography (radio-TLC).   A 1 μL droplet was spotted on a silica gel 60 F254 sheets 
(aluminum backing) with a micropipette. The TLC plate was dried in air and developed in the 
mobile phase of 60% MeCN in 25 mM NH4HCO2 with 1% TEA (v/v), and then analyzed with a 
scanner (MiniGITA star, Raytest, Straubenhardt, Germany). The resulting chromatograms 
showed peaks corresponding to unreacted [18F]fluoride (Rf=0.0) and [18F]fallypride (Rf=0.9). 
Fluorination efficiency was calculated as the peak area of the [18F]fallypride peak divided by the 
area of both peaks. Crude radiochemical yield (crude RCY, decay-corrected) was defined as the 
radioactivity recovery times the fluorination efficiency. 
In some cases, radio-HPLC purification of the collected crude product was carried out via 
analytical HPLC as previously described [36]. Separation was performed using an analytical C18 
column (Kinetex, 250 x 4.6 mm, 5 µm, Phenomenex) with mobile phase (60% MeCN in 25 mM 
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NH4HCO2 with 1% TEA (v/v)) at 1.5 mL/min flow rate. The purity and identity of the purified 
[18F]fallypride was verified using the same system and procedure. The retention time of 
[18F]fallypride was ~4.5 min. 
For the experiments that included the purification step, the radioactivity of purified product 
recovered from HPLC was also measured. The purification efficiency was calculated by dividing 
the radioactivity of the purified product by the radioactivity of the collected crude product. Isolated 
RCY was defined as the ratio of radioactivity of the purified product to the starting radioactivity on 
the chip. 
To visualize the distribution of radioactivity on the chips, a custom Cerenkov Luminescence 
Imaging (CLI) setup [57] was used. In particular, we focused on imaging after the collection step. 
To acquire an image, the chip was placed in a light-tight box, covered with a plastic scintillator (1 
mm thick) to increase the luminescence signal, and imaged for 300s. After acquisition, the raw 
image was processed via image correction and background correction steps as described 
previously [36]. To analyze the ratio of residual activity within the area of the reaction site to the 
total residual activity on the chip (i.e., reaction site and surrounding region), regions of interests 
(ROIs) were drawn to encircle both the reaction site and the whole chip. The desired ratio was 
calculated as the sum of pixel values within the reaction site ROI divided by sum of pixel values 
within the whole chip ROI. 
5.3. Results and discussion 
5.3.1. Mock radiosynthesis 
To test the feasibility of multi-step reactions on the microdroplet radiosynthesizer, we first 
performed a mock synthesis of [18F]fallypride, in which [18F]fluoride/TBAHCO3 solution was 
replaced with DI water, and precursor solution was replaced with the solvent mixture only. Diluted 
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food dyes of different colors were added in each solution: yellow dye was mixed with DI water, 
red dye was mixed with a mixture of MeCN and thexyl clcohol (1:1, v/v), and blue dye was mixed 
with a mixture of MeOH and DI water (9:1, v/v).  To dispense these solutions, reagent reservoirs 
were pressurized to ~35 kPa [~5 psi] and an opening duration of 1.0 ms was used. The synthesis 
scheme and a series of photographs of the overall process is shown in Figure 5-4. During the 
mock synthesis, we observed the rotation stage move the chip quickly and accurately to each 
desired position, the reagents were accurately delivered to the reaction sites without any visible 
splashing, and the solutions on the chip remained confined to the reaction site during all steps of 
the synthesis process.  
 
5.3.2.  [18F]fallypride synthesis 
To evaluate the performance and consistency of the [18F]fallypride syntheses, we performed 
multiple radiosynthesis per day on two separate days (Table 5-1). Overall, the crude RCY was 
very high and was consistent across the two days (95 ± 3% (n=5) for day 1 and 97 ± 2% (n=4) for 
day 2).  The fluorination efficiency was very consistent (94.8 ± 0.1% (n=5) for day 1 and 94.3 ± 
0.5% (n=4) for day 2), as was the radioactivity recovery (101 ± 3% (n=5) for day 1 and 102 ± 2% 
(n=4) for day 2). Values greater than 100% are likely a result of slight geometry-related biases 
that occur in the dose calibrator, e.g. when measuring the activity of a vial versus a chip. Only ~1 
% of radioactivity remained stuck to the chip (as unrecoverable activity) on both days.  
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Table 5-1. Comparison of [18F]fallypride syntheses performed on different days.  
Synthesis time for all experiments was ~17 min. All measurements are decay corrected. All values 
are average ± standard deviation, computed from the indicated number of measurements on each 
day. 
  Day 1 (N=5)  Day 2 (N=4)  
Radioactivity recovery (%) 101 ± 3 102 ± 2 
Fluorination efficiency (%) 94.8 ± 0.1 94.3 ± 0.5 
Crude RCY (%) 95 ± 3 97 ± 2 
Residual activity on chip (%) 0.7 ± 0.4 0.8 ± 0.2 
 
Notably, the synthesis conditions were taken directly from previous manual efforts to optimize 
the synthesis of [18F]fallypride[82], with no need for re-optimization. The synthesis performance 
on the new automated system was very similar to manually-performed syntheses during the 
optimization studies (Table 5-2). The similarity is not surprising considering that the high-
throughput studies used similar microfluidic chips, but containing a 2x2 array of circular 
hydrophilic reaction sites (each 4 mm diameter). The fluorination efficiency of the two methods 
was the same (94.6 ± 0.4% (n=9) for the automated chip, compared to 95 ± 1% (n=6) for the 
manually-performed high-throughput experiments). However, the radioactivity recovery was 
higher for the automated setup (101 ± 3% (n=9) versus 91 ± 1% (n=6)). This was due to the 
improved automated collection process, which eliminated losses due to manual pipetting. 
Consequently, the crude RCY obtained with the microdroplet reactor was 96 ± 3% (n=9), about 
~10% higher than that obtained previously with the high throughput reactor (87 ± 1% (n=6)) [82]. 
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Table 5-2. Comparison of [18F]fallypride syntheses performed using the reported platform 
and the high-throughput chip. 
Comparison of [18F]fallypride syntheses performed using the automated droplet synthesis 
platform with previous manually-performed reactions on high-throughput chips (containing 2x2 
array of reaction sites) using the same synthesis protocol. All measurements are decay corrected. 
All values are average ± standard deviation, computed from the indicated number of 
measurements in each case. 
  
Automated operation 
on single-reaction chip 
(N=9)  
Manual operation 
on high-throughput chip 
(N=6)  
Radioactivity recovery (%) 101 ± 3 91 ± 1 
Fluorination efficiency (%) 94.6 ± 0.4 95 ± 1 
Crude RCY (%) 96 ± 3 87 ± 1 
Residual activity on chip (%) 0.7 ± 0.3 0.12 ± 0.05 
 
 
In fact, the crude RCY on the new platform improved about ~50% relative to our previous 
generation of automated radiosynthesizer (64 ± 6% (n=4)), which used a different microfluidic 
chip where reagents were passively transported from reagent loading sites to the reaction site via 
tapered hydrophilic “channels”[36]. Improvements were seen both in the fluorination efficiency as 
well as recovery efficiency.  We suspect the increase in fluorination efficiency (95 ± 0% (n=9) 
versus 76 ± 4% (n=4)) is in part due to the optimized reagent concentrations, in particular the 
amount of TBAHCO3 in the reaction (240 nmol in this chapter, 7.1 nmol in the previous paper 
[36]). The increase in radioactivity recovery (101 ± 3% (n=9) versus 84 ± 4% (n=4)) is likely due 
to the use of a circular reaction site. On our previous passive transport chip, we often saw 
reagents slightly spread out along the passive “channels” (i.e. away from the reaction site), 
leading to mixing inefficiencies and difficulty in recovering all the radioactivity from the chip. In 
fact, this phenomenon resulted in the need for a certain degree of re-optimization when translating 
the best conditions, determined using manually-loaded high-throughput chips (2x2 arrays of 
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reaction sites), onto the passive transport chip. Interestingly, with our new setup, the overall 
synthesis time was also slightly improved (~17 min here compared to ~20 min in previous work 
[36]). The fast speed of the rotary actuator limited the amount of time needed to properly position 
the chip between steps, and the optimized collection procedure (with faster vacuum ramping 
speed) shaved a few minutes from the process time. Further synthesis time reduction may be 
possible by optimizing the position of dispensers and collection tube within a smaller angular 
range. 
Though the main focus of this work was on improving and streamlining the synthesis steps, 
we also performed purification of the crude product via analytical radio-HPLC. The purification 
efficiency was 81% (n=1) and overall isolated RCY was 78% (n=1). Chromatograms of the crude 
product, purified product and purified product co-injected with fallypride reference standard are 
shown in Figure 5-5. Due to the small amount of reagents (i.e. TBAHCO3, precursor) used in 
microdroplet reactions, the crude product can be purified via analytical-scale HPLC compared to 
the semi-preparative HPLC used in conventional radiosynthesis. This results in short retention 
times (and short purification times) and lower mobile phase volume of the collected pure fraction 
(simplifying and shortening the formulation process). Furthermore, both the UV and radioactivity 
chromatograms of the crude [18F]fallypride product were in general  much cleaner compared to 
the synthesis carried out in the macroscale [32] (where overlap of product with impurities has 
been observed). In the radioactivity chromatogram, the product peak was sharp (~0.5 min wide) 
and well separated from the [18F]fluoride peak and a couple of very small radioactive side-product 
peaks. In the UV chromatogram, the impurity peaks are well-defined and are well-separated from 
the product peak, making separation very straightforward. The needed purification time was only 
~5 min (retention time ~4.5 min), and the purified product was 100% radiochemically pure.  
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Figure 5-5. Examples of HPLC chromatogram. 
(A) crude [18F]fallypride, (B) purified [18F]fallypride, and (C) purified [18F]fallypride co-injected with 
fallypride reference standard for identity verification. Radiochemical purity was 100%. 
 
For some experiments, we performed Cerenkov imaging to view the distribution of activity on 
the chip after collection (Figure 5-6). Though the residual activity on the chip after collection of 
the product was very small (0.5 ± 0.3 % (n=4)), we observed that 90.6 ± 5.6 % (n=4) of this activity 
was confined at the reaction site, confirming that this loss is due to strong adsorption to the chip, 
and not due to another effect such as splashing of radioactivity outside the reaction zone (see 
Appendix, Figure 5-7). 
 
Figure 5-6. Activity distribution on the chip after collection step, visualized with Cerenkov 
luminescence imaging.  
The reaction site is outlined with a red dashed circle and the ratio of residual activity at the reaction 
site to total residual activity on the chip is indicated. 
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5.4. Conclusions 
A very compact (coffee cup-sized) microdroplet radiosynthesizer was developed for performing 
automated radiochemical reactions. The apparatus (10 x 6 x 12 cm, W x D x H) is over an order 
of magnitude smaller than commercial synthesizers that are currently considered to be very 
compact (e.g. IBA RadioPharma Solutions Synthera® has dimensions 17 x 29 x 28.5 cm, W x D 
x H). This could potentially allow much smaller shielding than a typical hot cell, or could allow a 
large number of synthesizers to be operated within a single hot cell. 
Multi-step chemical reactions (including evaporative drying and radiofluorination) were 
performed to synthesize the PET tracer [18F]fallypride. The synthesis yield was very high and was 
consistent within a given day and from day to day. A significant advantage of this next-generation 
(rotary) platform compared to our previous passive transport approach [36] is that the reaction 
site (hydrophilic circle) is identical to the shape of the reaction site on chips we use for high-
throughput reaction optimization (arrays of circular sites), eliminating the need for any 
reoptimization. 
The small amount of reagents used in the microdroplet reactor resulted in a very clean 
chromatogram and short retention time (~5 min) despite the purification being performed with only 
an analytical-scale HPLC column. The small volume of the mobile phase in the collected fraction 
(~1.5 mL) could be rapidly removed via evaporation for reformulation in saline within ~5-10 min. 
This time could potentially be further decreased using a microfluidic-based based PET tracer 
reformulation device [83]. 
Recently, we have reported the capability of producing [18F]fallypride at the GBq level by 
integrating the passive transport based reactor[36] and a micro-cartridge based radionuclide 
concentrator[81]. In that work, extensive studies were carried out to figure out how to optimally 
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load ~25 µL concentrated [18F]fluoride solution to the small reaction site without having the liquid 
spread out along the passive transport “channels” which can lead to poor mixing, low reaction 
efficiencies, and poor recovery of crude product. By integrating the concentrator with the 
presented next-generation microdroplet radiosynthesizer in the future, it will be much easier and 
faster to scale up the synthesis to clinically-relevant levels.  
In addition to [18F]fallypride, this compact microdroplet reactor can also be used for the 
synthesis of other PET tracers, such as [18F]FDOPA[80], [18F]FET, and [18F]Florbetaben 
([18F]FBB), which we have recently shown can be synthesized in high efficiency in droplet format, 
and could also be applied to labeling with other isotopes such as radiometals for both imaging 
and radiotherapeutic applications. Other than production of radiopharmaceuticals for imaging or 
therapy, our automated platform also has the potential to be applied for small scale chemical 
reactions or assays, in applications where compact apparatus and/or small reagent volumes are 
critical. 
5.5. Appendix 
5.5.1. Cerenkov imaging study 
During the preliminary study of using the microdroplet reactor to synthesize another tracer, 
[18F]FDOPA, we noticed signs of significant splashing of radioactivity outside of the reaction site 
(Figure 5-7A) after observing the distribution of residual radioactivity (after the collection step) on 
a series of microfluidic chips via Cerenkov imaging.  Suspecting that the addition of collection 
solution with the piezoelectric dispenser (driven at 69 kPa [10. psi]) may be causing some of the 
contents of the chip (crude product after fluorination reaction) to splash, we repeated experiments 
using a lower driving pressure (35 kPa [5.0 psi]) and observed that the signs of splashing 
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disappeared (Figure 5-7B).  The initially high residual activity on the chip after collection (17%) 
was lowered to 5% with this change in the driving pressure. 
Since all other reagents are driven at 69 kPa [10. psi] without signs of splashing, this study 
indicated that delivery of each reagent (or solvent) involved in the synthesis may require a little 
bit of optimization, to determine the best dispensing pressure, as new tracers are explored.  
 
 
Figure 5-7. Activity distribution on droplet reaction chips after the collection step, 
visualized with Cerenkov luminescence imaging.  
Collection solution (80% MeOH / 20% DI water, v/v) was dispensed on the reaction site at (A) 10 
psi or (B) 5 psi. The red dashed circle outlines the reaction site.  Ratio of residual activity at the 
reaction site to total residual activity on the chip is indicated in the images. 
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6. Chapter 6: High-throughput radio-TLC analysis 
6.1. Introduction 
Thin layer chromatography (TLC) is a technique used to separate the chemical components 
of a mixture to identify its composition. This method was first used for the separation of alkaloids 
present in extracts from medicinal herbs [84]. Now TLC has multiple uses ranging from analysis 
of purity and yield in chemical synthesis [85,86], separation of phospholipids in biological assays 
[87], and, in conjunction with a radiation detector, analysis of radiopharmaceuticals used for 
positron emission tomography (PET) [36,88,89], single-photo emission computed tomography 
(SPECT) [90,91], or targeted radiotherapy [92,93].  In particular, radio-TLC is useful as a means 
to measure the conversion of radionuclide incorporation into the target radioactive product during 
synthesis development and optimization: its use is further extend as a  quality control (QC) testing 
of the final formulated radiopharmaceutical to ensure radiochemical purity and radiochemical 
identity [94] before administering to patients. Radio-high-performance liquid chromatography 
(radio-HPLC) is another chromatography technique for QC testing, and is particularly useful when 
distinct separation of multiple compounds is needed. However, in many radiopharmaceutical 
analysis applications, radio-TLC is sufficient and is preferred over radio-HPLC due to its simplicity, 
quantitative accuracy (e.g. retention of fluoride-18 on the HPLC column affects the quantitative 
accuracy of radio-HPLC) [95], relatively short measurement time [96], and low need for 
maintenance.  
Generally, a small amount of the sample is spotted near one end of the TLC plate, and then 
the edge of the plate is immersed in a solvent to “develop” the TLC plate. As the solvent flows up 
the TLC plate due to capillary action, the sample is separated into multiple spots each 
corresponding to a chemical component of the sample. After developing, the plate is dried and 
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analyzed. Typically, a developed silica TLC plate will be analyzed using a radio-TLC scanner, in 
which a radiation detector is moved along the plate to obtain measurements of emitted radiation 
as a function of distance along the plate, which can then be expressed as a chromatogram. Most 
radio-TLC scanners (e.g. AR-2000, Eckert & Ziegler) use gas-based radiation detectors that are 
sensitive to gamma radiation as well as beta particles. Downsides of such systems are high cost, 
and the requirement for continuous supply of gas as well as periodic calibrations. Other radio-
TLC scanners (e.g. miniGITA, Raytest) are based on crystal scintillators and photodiodes that do 
not require a gas supply but are also expensive. Sometimes, different detectors can be installed 
depending on the radionuclides of interest, and collimators can be added to improve spatial 
resolution of gamma detection (at the expense of sensitivity). Typically, the TLC plates used are 
60 - 100 mm long and typically take 10 - 30 min to develop.  The length of the TLC plate is needed 
both to achieve adequate chemical separation and provide enough readout resolution. The 
scanning time depends on activity level, but typically 1-3 min is sufficient to analyze the TLC plate 
[97,98]. 
Our laboratory is developing high-throughput radiolabeling methods for optimization of 
synthesis conditions or preparation of compound libraries, resulting in the need to perform 
significant numbers of TLC separations and analyze the resulting TLC plates, requiring significant 
time for development and scanning. 
Though some scanners, e.g. AR-2000, have space to install multiple TLC plates which can be 
scanned automatically in sequence, the overall analysis time still remains long[99]. To reduce the 
readout time, we have looked into alternative approaches for readout of TLC plates. Other than 
scanning detectors, several techniques have been used to more efficiently read radio-TLC plates. 
One such technique is electronic autoradiography. Such systems, e.g. Instant Imager (Canberra 
Packard) have a large-area multiwire proportional counter detector, on which multiple radio-TLC 
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plates can be imaged simultaneously. While shown to be convenient, accurate, and able to image 
a wide range of isotopes (Tc-99m, I-124, F-18, Cu-64, C-11) [64,100], the readout system is far 
more expensive than other approaches [97,101]. Radio-TLC plates have also been imaged in a 
more cumbersome two-step process by first exposing a phosphor screen that is subsequently 
scanned with a phosphor imaging system [102] (e.g. Perkin Elmer Cyclone Plus). Additional types 
of detectors have been used for simultaneous readout at multiple positions along a TLC plate 
thus avoiding the need for scanning. For example, using a 64x1 array of scintillator crystals above 
a photodiode array, Jeon et al. quantified samples spotted at multiple locations with different 
radioisotopes (Tc-99m, F-18) and found excellent agreement with an AR-2000 scanner [98].  In 
another example, Maneuski et al. used a pixelated solid-state Timepix silicon detector to obtain a 
2D image of a partial radio-TLC plate spotted with an unspecified 18F-containing compound [103]; 
however the detector size is small and multiple detectors would be needed to image a full radio-
TLC plate or multiple plates, resulting in a high instrument cost. 
A more scalable approach is Cerenkov luminescence imaging (CLI) in which radiation is 
detected indirectly via Cerenkov light emission, and the overall detection area can be scaled with 
a suitable optical system rather than larger detector. CLI-based detection of compounds 
containing a wide variety of radionuclides has been demonstrated, including H-3, C-11, C-14, F-
18, P-32, Cu-64, Ga-68, I-124,and  I-131. Originally reported as a method to observe radioactivity 
in microfluidic chips [56,104], CLI is also used for in vivo optical imaging [105,106], intraoperative 
imaging [107,108], and has been reported for readout of radio-TLC plates [109]. One of the 
attractive features is that this technique can be used for imaging of β-  particles (mostly involved 
in therapeutic applications in cancer), which do not emit gamma rays (as occurs after positron 
emission) and thus are not easily imaged by systems based on gamma detection [105].  
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Park et al. reported a proof-of-concept demonstration in 2011, showing the possibility to use a 
commercial small-animal luminescence imaging system (IVIS 200, Caliper Life Sciences) to 
perform CLI of a developed radio-TLC plate spotted with an unspecific mixture of 131I-containing 
compounds [109]. The quantified percentage of luminescence in each of four ROIs compared 
favorably to the analysis using a conventional radio-TLC scanner (AR-2000). Furthermore, the 
CLI approach augmented the resolution between separated species and the imaging could be 
performed rapidly (1 min). Using a custom-built optical imaging system, Spinelli et al. later showed 
that the imaging time of radio-TLC plates with spotted samples of [68Ga]Ga-DOTANOC (7 kBq) 
could be reduced (compared to CLI) by placing the plates in contact with a phosphor-containing 
intensifying screen [110].  Recently, Ha et al.  investigated the effect of different types of TLC 
plates (differing backing materials, stationary phase type and thickness, and addition of 
fluorescent indicator) by placing multiple spots of various radioisotope solutions (e.g. H-3, P-32, 
I-124, and I-131 ) on TLC plates, imaging these plates directly and quantifying relative intensity 
between spotting locations [111], showing the possibility to significantly increase the CLI signal 
and sensitivity. An interesting feature of this work was a demonstration that multiple radio-TLC 
plates (16) could be positioned within the large field of view of the small animal scanner (IVIS 
Spectrum or IVIS Lumina II, Caliper) for simultaneous imaging, and thus speeding the readout 
when multiple plates are analyzed. However, the high cost (an order of magnitude higher than a 
conventional radio-TLC scanner) and large size of the small animal scanners may not be practical 
for many radiochemistry laboratories.  
Though demonstrating the potential for high-throughput readout of radio-TLC plates, Ha et al. 
did not perform developing of the TLC plates (i.e. did not perform sample separations). It can be 
assumed that this step would be very time-consuming and cumbersome for a large number of 
TLC plates, and that this time and effort would dominate the overall radio-TLC analysis process. 
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In this chapter, we tackle this missing step and we show a practical approach for the complete 
analysis of radio-TLC plates (both separation and readout) in a high-throughput, time- and labor-
efficient manner. This was accomplished by leveraging the high resolution of CLI and optimizing 
the sample volume to enable multiple samples to be spotted close together on the same TLC 
plate. All samples could then be rapidly developed in parallel (leveraging the high imaging 
resolution to enable very short separation distances) and then read out simultaneously using a 
compact, low-cost Cerenkov imaging system. We demonstrate high-throughput radio-TLC 
analysis of complex mixtures of 18F-labeled and 177Lu-labeled radiopharmaceuticals including (S)-
N-((1-Allyl-2-pyrrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide 
([18F]fallypride), [18F]fluoroethyl-tyrosine ([18F]FET) and [177Lu]Lu-PSMA-617 for assessment of 
radiochemical purity or reaction conversion. Interestingly, the Cerenkov imaging readout clearly 
showed small peaks that were not discernable with a conventional radio-TLC scanner (miniGITA), 
was able to identify anomalies in the spotting/separation process that also would not be apparent 
when using a conventional scanner and resulted in superior accuracy and precision compared 
with conventional radio-TLC scanning. 
6.2. Methods 
6.2.1. Preparation and developing of radio-TLC plates 
Samples of crude radiopharmaceuticals were deposited with a micropipettor 15 mm from the 
edge of the TLC plate. Deposited volume was 1.0 μL unless otherwise specified. Typically, 4 
samples were spotted on each 50 mm x 60 mm TLC plate along the 50 mm edge at 1 cm spacing 
so that 4 “lanes” would be formed during development. We also performed spotting of 8 samples 
at 0.5 cm spacing on 50 mm x 35 mm TLC plates. For mock TLC plates, we spotted with 
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[18F]fluoride/[18O]H2O at multiple points on the TLC plate and then immediately dried the plate (i.e. 
no developing was performed).   
[18F]fallypride samples (synthesized according to Figure 6-7) were deposited onto silica gel 60 
F254 sheets (aluminum backing) and developed with 60% MeCN in 25 mM NH4HCO2 with 1% TEA 
(v/v). The solvent front took ~8 min to travel 55 mm (i.e. 35 mm separation distance), or ~2.5 min 
to travel 30 mm (i.e. 15 mm separation distance). 
Samples of [18F]FET and the fluorinated intermediate (see Figure 6-7) were spotted onto silica 
gel 60 F254 sheets (aluminum backing) and developed with a 80:20 (v/v) mixture of MeCN and DI 
water. The solvent front took ~9 min to travel 55 mm (i.e. 35 mm separation distance). In some 
cases, single samples were spotted onto longer TLC plates (Baker-flex silica gel IB-F sheets, 25 
mm x 75 mm, plastic backing) to allow increased separation distance. In these cases, the solvent 
front took ~20 min to travel 70 mm (i.e. 55 mm separation distance).  
Samples of [177Lu]Lu-PSMA-617 were spotted onto RP-18 silica gel 60 F254 sheets (aluminum 
backing) and developed with a 75:25 (v:v) mixture of MeOH and DI water with 0.1% TFA. After 
developing, the plates were dried at room temperature. 
To estimate radioactivity of deposited samples, measurements of radioactivity to estimate 
radioactivity concentration of samples were performed with a calibrated dose calibrator (CRC-
25PET, Capintec, Florham Park, NJ, USA). 
 
6.2.2. Analysis of TLC plates by Cerenkov luminescence imaging 
After drying, the plates were imaged for 5 min with a previously-described home-built 
setup[112], with minor modifications to support radio-TLC plates instead of microfluidic chips. 
Briefly, the radio-TLC plate was placed in a light-tight chamber, covered with a transparent 
substrate, and Cerenkov light was detected by a scientific cooled camera (QSI 540, Quantum 
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Scientific Imaging, Poplarville, MS) equipped with a 50 mm lens (Nikkor, Nikon, Tokyo, Japan). 
The temperature of the camera was maintained at -10°C for dark current reduction. The field of 
view was 50 x 50 mm2. 
The raw image comprised an array of values (analog-to-digital units; ADUs) corresponding to 
detected light at each pixel location.  Using custom-written MATLAB software, images were first 
processed with three corrections as previously described [57], including CCD dark current and 
bias level correction, lens vignetting and CCD pixel nonuniformity correction, and 3 x 3 median 
filtering. In addition, we performed background subtraction by selecting an area of the image not 
containing radioactive sample, computing the average pixel value, and subtracting this average 
from the pixel values across the whole image. Regions of interest (ROIs) were drawn on this final 
corrected image to enclose the radioactive regions/spots. Each ROI was integrated, and then the 
fraction of the integrated signal in that ROI (divided by the sum of integrated signal in all ROIs) 
was computed. 
 
6.2.3. Analysis of TLC plates via radio-TLC scanner  
TLC plates were scanned with a miniGITA TLC scanner (Elysia-Raytest; Straubenhardt, 
Germany) for 3 min, and the resulting chromatograms were analyzed by GINA-STAR software 
(Elysia-Raytest). Specifically, the software allowed identification of peaks and integrating the area 
under the curve (AUC) for each peak. The fraction of total AUC contained within each peak was 
then computed.  
Prior to radio-TLC scanner analysis, TLC plates containing multiple samples of 
radiopharmaceuticals were first cut into individual “lanes”, each lane corresponding to a single 
separated sample. 
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6.3. Results and Discussion 
6.3.1. High-throughput radio-TLC analysis 
Recently we have developed droplet-based platforms to perform multiple radiochemical 
reactions simultaneously that can be used for exploration of reaction parameters and/or to 
increase the number of replicates of each reaction. Such studies require a means for high-
throughput sample analysis. A previously-described home-built Cerenkov imaging setup [57] with 
minor modifications to support radio-TLC plates instead of microfluidic chips (Figure 6-1) was 
used to image the radio-TLC plates. The field of view was 50 mm x 50 mm. When using 5 min 
acquisitions, the corresponding limit of detection (LOD) and limit of quantification (LOQ) were 
determined to be 0.8 kBq/µL and 2.4 kBq/µL, respectively, for 1 µL spots of fluoride-18 (Figure 
6-8, Figure 6-9), and the linear range extended up to 21.3 MBq (Figure 6-11). The LOD could be 
further reduced by replacing the glass cover with a scintillator (Figure 6-10). 
 
 
Figure 6-1. Cerenkov luminescence imaging setup within the light-tight enclosure.  
(A) Schematic. (B) Photograph. 
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As an initial demonstration of high-throughput analysis, replicates of both [18F]fallypride 
(Appendix) and [18F]FET samples were  studied. Two replicates of a sample of the crude 
intermediate product (collected after fluorination of the FET precursor) were spotted on the left 
half of the plate and two replicates of a sample of the crude [18F]FET product (collected after the 
subsequent hydrolysis step) were spotted on the right side. The CL image of the developed TLC 
plate (35 mm separation distance; silica gel 60 F254) is shown in Figure 6-2A.  At the same time, 
each sample was also spotted on an additional, longer TLC plate (55 mm separation distance; 
silica gel IB-F), developed, and scanned with the radio-TLC scanner (sample chromatograms in 
Figure 6-2B and Figure 6-2C). The greater separation resolution of CLI was readily apparent: a 
low-abundance side product (6 ± 0% of activity, n=2) was easily visible in the CL images (showing 
3 distinct regions for both samples), but was not clearly discernable or quantifiable using the radio-
TLC scanner software (showing only 2 peaks for each sample). For the pair of samples of the 
fluorinated intermediate, percentages of [18F]fluoride, impurity and intermediate determined from 
the CL image were 27 ± 0 % (n=2), 4 ± 0 % (n=2) and 68 ± 0 % (n=2), respectively. Using the 
miniGITA scanner after cutting the TLC plate into individual “lanes”, the percentages of 
[18F]fluoride and intermediate for one “lane” were 32% and 68%, respectively. For the pair of 
samples of the crude [18F]FET product, percentages of [18F]fluoride, [18F]FET and impurity from 
the CL image were 15 ± 0 % (n=2), 79 ± 0 % (n=2) and 6 ± 0 % (n=2), respectively. In the analysis 
from the miniGITA scanner, the percentages of [18F]fluoride and [18F]FET were 19% and 81%, 
respectively. Aside from the cleaner separation and better resolution, the CLI-based method also 
had the benefit of faster analysis. The total imaging time for the whole plate (5 min) is independent 
of the number of samples, while additional scanning time is needed for each strip cut from the 
radio-TLC plate (4 x 3 min = 12 min). 
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Figure 6-2. High-throughput analysis of [18F]FET samples.  
(A) Cerenkov image of developed TLC plate spotted with two replicates of crude fluorination 
product (1 µL each) and two replicates of crude hydrolysis product (1 µL each). The dashed circles 
indicate the ROIs used for analysis. The dashed arrow indicates the direction of solvent 
movement during developing. (B) Example chromatogram obtained with the radio-TLC scanner 
spotted with crude fluorination product. (C) Example chromatogram from radio-TLC scan of crude 
hydrolysis product. Note that for B and C, the samples were spotted onto a different TLC plate 
and separation performed over 55 mm instead of 35 mm (in the Cerenkov image) to try to enhance 
separation between the species, but the low-abundance impurity could not be discerned. 
 
6.3.2. Increasing sample throughput 
To further increase the number of samples that can be analyzed simultaneously, one option 
would be to redesign the optical system (including lens) to achieve a larger field of view. Then, a 
TLC plate (wider than 50 mm) with more spots (“lanes”) could be developed and imaged without 
increasing the overall analysis time (i.e. without increasing the developing time or readout time). 
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Such an approach would result in a reduction in the number of pixels per imaged spot, however, 
potentially increasing the noise level slightly and decreasing sensitivity. 
Alternatively, the size of the radio-TLC plates could be further reduced to allow multiple plates 
to fit within the field of view. Due to the excellent separation in the Cerenkov images, we 
hypothesized that the separation length could be even further reduced. Figure 6-3A shows the 
separation of 4 crude samples of [18F]fallypride, with a separation distance of only 15 mm. The 
radio-TLC plate (silica gel 60 F254) cut to 50 mm x 35 mm size was spotted with two 1 μL droplets 
and two 0.5 μL droplets at 1 cm spacing along the long edge of the plate, 15 mm from this edge. 
After developing, the resulting CLI images showed clear separation of the spots, allowing accurate 
quantification. The fluorination efficiency obtained with the CLI-based analysis for 1 μL spot size 
was 76 ± 0 % (n=2), and for 0.5 μL spot size was 74 ± 1 % (n=2). To compare with the radio-TLC 
scanner, each TLC plate was cut into four lanes. The resulting chromatograms showed 78% 
conversion for 1 µL spot size and 74% for 0.5 µL spot size, but, notably, the peaks exhibited very 
significant overlap (Figure 6-3B), which we show, below, can introduce significant errors and 
uncertainties into the analysis. To further increase the throughput, 8 samples from a batch of 
crude [18F]Fallypride were spotted (0.5 μL droplet size)  on the TLC plate at 5 mm spacing and 
separated for 15 mm as well (Figure 6-3C). The fluorination efficiency obtained with the CLI-
based analysis appears to be consistent (73 ± 1 %, n=8). In another experiment, 2 different 
batches (n=4 replicates each batch) of crude [18F]fallypride were analyzed, enabling fluorination 
efficiency to be easily determined for each (Figure 6-3D). In addition to being able to fit a larger 
number of samples in the CLI system field of view, the plate could be developed more quickly (i.e. 
2.5 min for the 15 mm separation distance vs. 8 min for 35 mm separation). Though not 
demonstrated here, readout throughput could be further increased by placing 2 of these TLC 
plates within the field of view of the CLI system. 
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Figure 6-3. High-throughput analysis of crude [18F]fallypride samples.  
(A) Cerenkov image of developed TLC plate spotted with 4 replicates (two 1.0 µL and two 0.5 µL) 
of the same crude reaction mixture using only 15 mm separation distance. (B) One example 
chromatogram obtained from the 0.5 µL sample in (A) using the radio-TLC scanner. The TLC 
plate was first imaged with the CLI based scanner and then was cut into 4 “lanes” each of which 
was scanned separately with miniGITA scanner. (C) Cerenkov image of developed TLC plate 
spotted with 8 replicates (0.5 µL) of another batch of crude [18F]fallypride. The dashed circles 
represent the ROIs for analysis. The dashed arrow represents the direction of solvent flow during 
developing. (D) Cerenkov image of developed TLC plate spotted with 8 droplets (0.5 µL) sampled 
from 8 different batches of crude [18F]fallypride reacted under different sets of conditions (n=4 
replicates each of two different sets of conditions, spotted in alternating pattern).The dashed 
circles highlight the ROIs for the 8 samples. The dashed arrow represents the direction of solvent 
flow during developing.  
 
6.3.3. Comparison of readout via CLI versus a radio-TLC scanner  
In a systematic analysis, we found the accuracy and precision of CLI-based analysis to be 
higher than analysis using commercial radio-TLC scanner software (miniGITA), especially for 
closely spaced peaks and unequal activity distribution (Appendix). The results of gamma 
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counting (taken as ground truth; calibration curve in Figure 6-13) and analysis via CLI and radio-
TLC scanner are summarized in Table 6-1 and Figure 6-4. 
 
 
 
 
 
 
 
 
 
 
Figure 6-4. Radio-TLC readout performance comparison of radio-TLC scanner and 
Cerenkov luminescence of the plates.  
The data points show the average activity fraction in each spot (averaged over the analysis 
performed by n=8 participants) normalized by the activity fraction determined by gamma counting. 
The error bars show the relative standard deviations. The black dashed vertical lines separate 
the data from each of the five radio-TLC plates. Cartoons of the activity distribution are shown at 
the top of the graph (darker green spots represent higher activity level). Raw data was presented 
in Figure 6-14.  
 
6.3.4. Assessing quality of the TLC spotting and development process 
One notable advantage of the Cerenkov imaging readout technique versus radio-TLC scanner 
readout is the ability to see a high-resolution 2D image of the final separation. This can be used 
to monitor the quality of the spotting and developing process. For example, compared to a normal 
separation (Figure 6-5A), we have been able to observe problems such as the splitting of single 
spots into multiple regions due to incomplete drying of the sample before developing (Figure 
6-5B), poor separation as a result of large spot size (Figure 6-5C), and non-linear separation path 
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due to accidentally introducing an additional source (droplet) of liquid at the side of the radio-TLC 
plate during developing (Figure 6-5D).  It should also be possible to detect problems such as 
double-spotting, or inadvertent contamination of the plate during spotting or subsequent handling.  
This feedback provides increased information to ensure accurate readout of a given radio-TLC 
plate or to determine when a TLC (sample spotting and separation) should be re-run. 
While not implemented in this study, the CLI readout can be improved by using the same 
camera to take a bright-field image of the radio-TLC plate (including markings on the TLC plate 
of sample origin and solvent front) and superimposing the CL image. For example, in the work of 
Ha et al. [111], such superposition allowed confirmation of the multiple positions where samples 
were spotted on each TLC plate. An example using our setup, showing both the sample origin 
and solvent front from the brightfield image (e.g. to compute Rf values), is shown in the Appendix. 
 
 
Figure 6-5. Assessing quality of the TLC spotting and developing process.  
(A) Cerenkov image of developed plate after spotting of two replicates (1 µL) each of crude 
[18F]FET product. This image indicates a normal spotting and developing process. (B) Separation 
artifacts visible in most distant spots when the plate was not completely dried prior to developing. 
(C) Separation artifacts due to a combination of incomplete drying as well as abnormally large 
sample volume (right spot 2.0 µL). (D) Separation artifacts arising from liquid contamination at the 
right edge of the TLC plate during developing, causing the main solvent flow to be deflected to 
the left. The TLC plate in this case was spotted, at the positions marked with dash circles, with 
two replicates (1 µL each) of crude [18F]fallypride product. 
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6.3.5. Radiochemical purity measurement of [177Lu]-PSMA-617 via CLI 
To explore the application of CLI-based radio-TLC analysis to additional isotopes, labeling 
yield of [177Lu]Lu-PSMA-617 was measured as a function of reaction time by sampling 2 µL crude 
product (925 kBq/µL) at different time points and spotting on a TLC plate (silica gel 60 RP-18 F254, 
aluminum backing). The results of CLI analysis in Figure 6-6 suggest that high labeling efficiency 
(99%) can be achieved in just 10 min, rather than the typical 30 min timeframe used [112]. 
 
 
Figure 6-6. CLI-based analysis of crude [177Lu]Lu-PSMA-617 samples (β--emitter).  
(A) Cerenkov image of developed TLC plates spotted with droplets (2 µL) of the crude reaction 
mixture sampled at different reaction times. In this demonstration, each TLC plate was developed 
individually, resulting in variable separation distances, but multiple plates were imaged together. 
The dashed circles represent the ROIs for analysis. The dashed arrow represents the direction of 
solvent flow during developing. (B) Graph of radiolabeling yields as a function of reaction time.  
 
6.4. Conclusion 
Cerenkov imaging in combination with parallel developing of multiple samples on a single TLC 
plate proved to be a practical method for rapid, high-throughput radio-TLC analysis. Compared 
with the miniGITA radio-TLC scanner, the CLI-based imaging method provided significantly higher 
resolution, the ability to image multiple samples in parallel (rather than requiring sequential 
scanning), and the ability to detect and quantify low-abundance impurities that were not 
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discernable with radio-TLC scanning. The bulk of time and effort savings were realized by spotting 
multiple samples onto a single TLC plate and developing the multiple samples in parallel prior to 
imaging, rather than spotting the developing separate TLC plates individually. Furthermore, by 
leveraging the high resolution of CLI, a much smaller separation distance could be used while still 
resolving each region of radioactivity, further reducing the time needed for developing the 
samples. The shorter separation distance in turn can facilitate increased throughput by enabling 
more TLC plates to be imaged within the field of view; alternatively, the optical system could be 
redesigned to increase the field of view, thus allowing more spots to be imaged without increasing 
the system cost or imaging time.  
Quantitative accuracy of the CLI-based readout was found to be higher compared to analysis 
via the radio-TLC scanner software, and relative uncertainty was lower. This was especially true 
when chromatograms contained overlapping peaks and/or small peaks. Furthermore, CLI-based 
analysis enabled detection of quality issues in the spotting or development processes.  
CLI imaging of TLC plates has broad application for the analysis of radiotracers labeled with 
radionuclides that are positron emitters (F-18, Cu-64, Zr-89, I-124) used for PET imaging [36,113] 
and radiopharmaceuticals labeled with beta emitters (e.g., I-131, Lu-177) [114–116]. Though we 
demonstrated the analysis of 18F-labeled compounds and 177Lu-labeled peptide, this approach 
could also be used for the analysis of radiopharmaceuticals labeled with alpha emitters (e.g. Ac-
225, Bi-213), with applications in targeted radiotherapeutics [117,118]. Previous reports have 
shown detectable Cerenkov emission from such radionuclides [118,119], likely due to emissions 
from daughter isotopes [117]. In addition to high-throughput analysis applications, the rapid 
separation and readout of radio-TLC plates by the method described here could be especially 
useful in conjunction with very short-lived isotopes such as C-11 (half-life 20.4 min).  
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6.5. Appendix 
6.5.1. Materials 
Methanol (MeOH), 2,3-dimethyl-2-butanol (thexyl alcohol; 98%), trifluoroacetic acid (TFA, 
99%), ethanol (EtOH, 99.5%), anhydrous acetonitrile (MeCN, 99.8%), and 1 N hydrochloric acid 
(HCl) were purchased from Sigma-Aldrich. Sodium acetate was purchased from Alfa Aesar. 
Tetrabutylammounium bicarbonate (TBAHCO3, 75 mM), (S)-2,3-dimethoxy-5-[3-[[(4-
methylphenyl)-sulfonyl]oxy]-propyl]-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-benzamide 
(Fallypride precursor), O-(2-[18F]Fluoroethyl)-L-tyrosine (FET precursor) and PSMA-617 were 
purchased from ABX Advanced Biochemical Compounds (Radeberg, Germany). Unmodified and 
RP-18 modified silica gel 60 F254 sheets (aluminum backing; 50 mm x 200 mm) were purchased 
from Merck KGaA (Darmstadt, Germany) and were cut into 50 mm x 60 mm pieces for use.  Baker-
flex silica gel IB-F sheets (plastic backing; 25 mm x 75 mm) were obtained from Fisher Scientific 
(Hampton, NH, USA). Sheets of organic scintillator BC-400 (1 mm and 3 mm thicknesses) were 
purchased from Saint-Gobain (Karnataka, India). Glass microscope slides (76.2 mm x 50.8 mm, 
1 mm thick) were obtained from C&A Scientific (Manassas, VA, USA). DI water was obtained 
from a Milli-Q water purification system (EMD Millipore Corporation, Berlin, Germany). No-carrier-
added [18F]fluoride in [18O]H2O was obtained from the UCLA Ahmanson Biomedical Cyclotron. 
No-carrier-added [177Lu]LuCl3 was obtained from Isotope Technologies Munich and Spectron 
MRC LLC.  
 
6.5.2. Samples of [18F]fallypride 
Crude [18F]fallypride was obtained from a microdroplet synthesis (Figure 6-7) previously 
reported [36]. Briefly, from a 50 µL [18F]fluoride  stock solution (1 mCi; 3.75 mM TBAHCO3), an 8 
μL droplet was deposited on the chip and dried for 1 min at 105 oC. Next, a 4 μL solution of 
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fallypride precursor (77 mM in 1:1 v/v mixture of thexyl alcohol and MeCN) was added, mixed with 
the dried residue, and allowed to react for 7 min at 110 oC. Crude [18F]fallypride product was 
collected from the chip with 60 μL of 90% MeOH and 10% DI water.   
 
6.5.3. Samples of [18F]FET 
The microdroplet synthesis of [18F]FET (Figure 6-7) was adapted from the method of 
Hamacher and Coenen[120] and Bourdier et al. [121].  A 1.5 μL droplet of 9.8 mM TBAHCO3 
solution and 10 μL of [18F]fluoride/[18O]H2O (1-7 mCi) were loaded on a chip and dried for 1 min 
at 105 °C. Next, 10 µL of FET precursor (5 mM in 1:1 v/v mixture of thexyl alcohol and MeCN) 
was added and reacted with the dried [18F]TBAF residue for 5 min at 80 °C. Finally, 10 µL of 1 N 
HCl was added to hydrolyze the intermediate at 90 °C for 3 min, and the crude product was 
collected using 40 µL of a 1:1 (v/v) mixture of EtOH and DI water.  When needed, samples of the 
fluorinated intermediated were collected using 90:10 (v/v) mixture of MeOH and DI water. 
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Figure 6-7. Radiosyntheses of [18F]fallypride and [18F]FET.  
For both compounds, [18F]fluoride in [18O]H2O is first dried and activated. To synthesize 
[18F]fallypride, the dried residue is reacted with tosyl-fallypride, and to synthesize [18F]FET, the 
dried residue is first reacted with O-(2-[18F]Fluoroethyl)-L-tyrosine (precursor TET) and then the 
resulting intermediate undergoes a deprotection reaction. 
 
6.5.4. Samples of [177Lu]Lu-PSMA-617 
PSMA-617 was added to a solution of [177Lu]LuCl3 (84 MBq/nmol precursor) in 0.4M sodium 
acetate buffer, pH 4.8, containing dihydroxybenzoic acid (10 mg/mL). The mixture was heated to 
95°C in a dry heating block. 
Multiple samples for Cerenkov analysis were obtained by opening the reaction vial and 
sampling the reaction mixture at different timepoints. 
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6.5.5. Detection range 
6.5.5.1. Methods 
To determine the limit of detection (LOD) of the CLI setup for 5 min acquisitions, samples 
containing different amounts of radioactivity were spotted and analyzed. Based on the recent 
report by Ha et al. [111], we used TLC plates containing a fluorescent dopant to maximize the 
Cerenkov brightness and thus the sensitivity. Radioactivity of the original mixture of 
[18F]fluoride/[18O]H2O and DI water,  measured with a dose calibrator, was 88.8 kBq/µL. A series 
of 1:1 (v/v) dilutions was created and spotted across two TLC plates. Each plate had five of the 
dilutions, each spotted with n=4 replicates at 1 cm intervals for a total of 20 spots per TLC plate. 
1 μL was deposited for each spot. The plates were dried and a glass slide was placed over top 
during imaging. For each spot on the same TLC plate, the deposited activity was estimated and 
decay-corrected to the start-time of plate imaging. For each TLC plate, decay-correction was 
performed to the start-time of imaging of that TLC plate. 
A circular ROI (consisting of 4250 pixels) was drawn around each deposited droplet and the 
total integrated signal calculated for each from the corrected image. To determine the background 
noise level, 8 ROIs of the same size were drawn in the blank region of the image and the 
integrated signal (i.e. total ADUs) computed for each. Since background subtraction has been 
performed, the integrated signal for each ROI was expected to be close to zero. The noise level 
was determined by calculating the standard deviation of the integrated signal for the 8 ROIs. The 
LOD was then taken as the point where a plot of the integrated ADU as a function of activity 
crossed 3x the noise level. 
The maximum detectable activity was determined by a similar procedure using a dilution series 
of higher activity spots (radioactivity of the original mixture was 20.7 MBq/µL). After processing 
Cerenkov images, the integrated signal versus radioactivity was fit to a straight line and the 
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maximum detectable activity was defined where the data points deviated from the line. We 
expected this would occur when spots contain a significant number of saturated pixels. 
6.5.5.2. Results 
Sample images from the dilution series are shown in Figure 6-8. (The full set of data is shown 
in the Figure 6-9.) From the background ROIs (-1300 ± 1300, n=8), we determined the noise level 
to be 1300 ADU. After linear fitting of the integrated ADU as a function of activity (Figure 6-8), 
the corresponding LOD was determined to be 0.8 kBq (intersection with 3x noise level).  
 
 
Figure 6-8. Evaluation of limit of detection (LOD) of the Cerenkov luminescence approach.  
(A-B) A dilution series of [18F]fluoride solution was deposited (1 μL each spot) on two TLC plates 
and imaged.  Each spot was replicated n=4 times but only one representative of each dilution is 
shown. (C) Integrated signal was plotted as a function of deposited activity. A weighted linear 
least squares fit was performed to determine the minimum detectable activity (R2=0.99998). Note 
that the linear fit appears non-linear on the log-log plot due to the non-zero intercept. The non-
zero intercept arises as the background subtraction procedure is not perfect. Note that, if needed, 
the LOD can be easily modified as described in the text. 
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Figure 6-9. Full set of Cerenkov images used for determination of limit of detection. 
 
The limit of quantification (LOQ) was 2.4 kBq. To reliably quantify the proportion of activity in 
different spots resulting from a real TLC separation process, the initially deposited sample activity 
must be sufficient that the amount of activity in each spot after the separation process is above 
the LOQ. In general, the greater the activity in the initial sample, the more accurate quantification 
of low-activity spots (i.e. low-abundance species) after developing. For example, spotting a 37 
kBq sample would allow species with abundance as low as ~10% to be quantified.  Spotting a 
370 or 3700 kBq sample would allow species with abundance as low as ~1% or ~0.1% to be 
quantified, respectively. 
It should be mentioned that increasing the sample volume is typically not a desirable way to 
increase the activity level. Instead one can use a different cover plate. For example, by replacing 
the cover glass (1 mm thick) with an organic BC-400 scintillator (1 mm thick), light output was 
increased significantly, and the LOD could be improved (Figure 6-10). Light output of the plate 
with the 1 mm thick and 3 mm thick scintillators are comparable since the positrons travel less 
than ~ 1 mm in plastic. Note that the spots on TLC plates covered with the scintillators appear to 
be blurrier than the glass cover; we believe this is due to a slight shift in focal plane. If needed, 
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the sensitivity could be further boosted by imaging for a longer period of time (detection limit 
improves as the square root of acquisition time), or potentially by choosing a thicker TLC plate or 
adding a liquid scintillator spray as demonstrated by Ha et al. [111].  
 
 
Figure 6-10. Improvement of detection limit by varying the cover over the TLC plate (glass 
or BC-400 scintillator).  
For each case, two TLC plates were prepared, each spotted with n=2 replicates of 4 different 
concentrations of [18F]fluoride solution (1 µL each). The left side of the image represents the 
higher activity samples (shown with two different ranges of the color scale), and the right side of 
the image represents the lower activity samples.  
 
For higher activity levels, pixels in the image can become saturated and the integrated ROI 
underestimates the actual activity level. The maximum detectable activity of the CLI setup was 
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determined to be 21300 kBq, the interception of the linear fit and theoretical limit (Figure 6-11). If 
higher activity samples need to be analyzed, saturation can be avoided by reducing the imaging 
time (i.e. signal will be reduced in proportion to the reduction in acquisition time), or reducing the 
lens aperture. Alternatively, the signal can be reduced by using a thinner or lower refractive index 
material as a cover during imaging. 
 
 
Figure 6-11. Analysis of maximum detectable activity.  
A dilution series of [18F]fluoride solutions was prepared and spotted (1 µL each) onto radio-TLC 
plates. An initial stock solution with concentration 20700 kBq/µL was prepared. (A) The first plate 
contained samples of 20700 kBq, 10400 kBq, and 5180 kBq (top to bottom). (B) The second plate 
contained samples of 2210 kBq, 1110 kBq, and 553 kBq. (C) The third plate contained samples 
of 256 kBq, 129 kBq, and 64 kBq. All values were decay-corrected to the start time of imaging. 
(D) The data are plotted (n=2 each point) and weighted linear least squares fit was performed 
(R2= 0.99996) to determine the linear range. Theoretical limit is determined by multiplying the 
number of pixels in the ROI (2604) by the maximum possible pixel value from CCD camera (216 
= 65536). Note that the limit, if needed, can be easily modified as described in the text. 
 
6.5.6. Repeatability Test 
As an initial demonstration of high-throughput analysis to study replicate samples, we 
deposited four droplets of the same crude [18F]fallypride product on a single TLC plate (silica gel 
60 F254), developed the plate to separate all samples simultaneously (separation distance 35 mm), 
and then performed CLI imaging of the whole plate. Figure 6-12 shows the resulting CLI image, 
as well as a representative chromatogram from a conventional radio-TLC scanner (obtained after 
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cutting the TLC plate into individual lanes, each corresponding to one separated sample). The 
fluorination efficiency obtained with the CLI-based analysis (88 ± 1 %, n=4) compared favorably 
with the analysis using the radio-TLC scanner software (90 ± 0 %, n=4). 
 
Figure 6-12. High-throughput analysis of crude [18F]fallypride samples.  
(A) Cerenkov image of developed TLC plate spotted with 4 replicates (1 µL each) of the same 
crude reaction mixture using a separation distance of 35 mm. The dashed circles represent the 
ROIs for analysis. The dashed arrow represents the direction of solvent flow during developing. 
(B) One example chromatogram obtained using the radio-TLC scanner. To scan the TLC plate, it 
was cut into 4 strips after Cerenkov imaging was performed.  
 
6.5.7. Comparison of radio-TLC analysis methods  
6.5.7.1. Methods 
Three methods of reading and analyzing the TLC plates were compared. 
Solutions comprising [18F]fluoride/[18O]H2O and DI water were prepared in different activity 
concentrations ranging from ~17 kBq/µL to ~148 kBq/µL. Droplets of the same or different 
concentrations were spotted on the TLC plate to test the detection performance at different peak 
ratios. Five different TLC plates were prepared by depositing 1 µL droplets with activities in the 
following ratios: (1) 50:50 (two droplets of 37 kBq/μL each), (2) 10:90 (droplets of ~17 kBq/µL and 
~148 kBq/µL, respectively), (3) 80:10:10 (droplets of ~148, ~17, and ~17 kBq/µL, respectively), 
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(4) 10:80:10 (droiplets of ~17, ~148, and ~17 kBq/µL, respectively), and (5) 33:33:33 (three 
droplets of 37 kBq/μL each). For cases with two radioactive spots, the distance between spot 
centers was 35 mm, and for cases with three spots, the distance was 17.5 mm. Plates were dried 
after spotting but not developed. 
Cerenkov images and radio-TLC scans were obtained as described above. As a reference 
point, and to account for possible errors in preparing stock solutions and pipetting, the activity in 
the spots was also measured with an automatic well-type gamma counter (WIZARD 3” 1480, 
Perkin Elmer, Waltham, MA, USA). The TLC plates were cut with scissors at the midpoint between 
expected spot locations (2 halves for plates with 2 samples and 3 thirds for plates with 3 samples). 
Individual pieces of TLC plates were placed in 20 mL HDPE scintillation vials from Thermo Fisher 
Scientific (Pittsburg, Pennsylvania, USA) and the activity was counted for 1 min. For each original 
TLC plate, the radioactivity distribution of a single spot was expressed as a fraction of the total 
radioactivity (sum of radioactivity of all spots on the plate). 
A calibration curve was separately generated to ensure all measurements were within the 
linear range of the gamma counter. The calibration curve was generated by preparing a dilution 
series of [18F]fluoride/[18O]H2O solution in Eppendorf tubes. A stock solution was prepared with 
concentration 2590 kBq/mL, and then a 2x dilution series was created by preparing mixtures of 
500 µL of DI water with 500 µL of the previous dilution. Samples were measured in a gamma 
counter for 1 min counting time and decay-corrected to the measurement time of the first sample. 
The relationship was found to be linear up to ~300 kBq (Figure 6-13). For higher activity samples, 
the counter reached saturation.  
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Figure 6-13. Calibration of gamma counter to determine linear range.  
A linear least square fit of the linear part of the curve was performed (R2=0.9987). 
 
To compare readout methods (CLI and miniGITA scanner), a survey was made that requested 
participants (experienced operators of radio-TLC scanners; n=8) to analyze the chromatograms 
obtained with the miniGITA scanner and the CLI images without knowing the deposited 
percentages on each of the 5 sample plates. The average percentage was computed for each 
spot/method (across all participants) and the relative error was determined by using the gamma 
counter as a reference. This was done by subtracting the percentage as measured by the gamma 
counter and dividing the result by the gamma counter percentage. The relative uncertainty for a 
particular spot/method was calculated as the standard deviation of percentages (across all 
participants) divided by the average of percentages computed above. 
6.5.7.2. Results 
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To systematically compare the performance of CLI readout to a conventional radio-TLC 
scanner and to determine the influence of overlapping peaks, five mock radio-TLC plates were 
prepared by spotting with different patterns of activity (Figure 6-14), and n=8 participants (with 
experience in radio-TLC scanner operation and analysis of chromatograms) were asked to 
analyze the resulting data. The results of gamma counting (taken as ground truth; calibration 
curve is Figure 6-13) and analysis via CLI and radio-TLC scanner are summarized in Table 6-1 
and Figure 6-4 of the chapter. 
For all plates, the CLI images showed well-separated spots and participants could readily draw 
ROIs that accurately contained the activity of each spot. In contrast, the radio-TLC scanner, not 
equipped with a collimator, showed wide peaks that overlapped in many of the plates. In all cases, 
the CLI-based results were in better agreement with gamma counter values (lower relative error) 
compared to the radio-TLC scanner based results.  
For analysis of the chromatograms from the radio-TLC scanner, we observed that participants 
used two different methods for integrating the area under the curve (AUC). In “Method 1”, the 
area under each peak is integrated down to zero signal level. In “Method 2”, a baseline is first 
drawn joining the left and right sides of each peak, and the AUC is computed for the area between 
the curve and the baseline. The varied analysis method introduced variation (higher relative 
uncertainty) into the radio-TLC scanner results, and the Method 2 analysis led to especially large 
errors in certain cases (i.e. for small peaks).  For samples containing only 2 spots separated by 
35 mm (plates A and B), the peaks showed minimal overlap and the AUC could be accurately 
computed by the radio-TLC scanner software. Results were in reasonable agreement with the 
gamma counter values, though error and uncertainty was higher than for CLI-based analysis, 
likely due to variation in where participants defined the edges of each peak and the mixture of 
integration methods. When the spots had very different activity levels (plate B), the relative 
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uncertainty was significantly higher for the lower activity spot. This trend was observed both for 
the CLI and radio-TLC scanner methods (6% relative uncertainty in the lower activity spot vs 1% 
in the higher activity spot for CLI; 10% vs 1% for radio-TLC scanner). In addition, the activity in 
the smaller peak tended to be underestimated (-5% relative error for CLI; -15% for radio-TLC 
scanner) while the large peak tended to be slightly overestimated. 
These phenomena were exaggerated for the TLC plates with three radioactive spots, where 
the corresponding peaks in the chromatogram were overlapping (plates C and D). Using CLI, the 
smallest spots were underestimated up to -8%, while using the radio-TLC scanner, the smallest 
peaks were underestimated up to -26%. In these cases, relative uncertainties were lower for CLI 
(<5%) but were quite high (20-39%) for radio-TLC-based analysis. The higher activity spots in 
samples C and D were quantified more accurately and precisely by both methods, though the 
relative accuracy and precision were significantly higher for the CLI-based method. For plate E, 
with more equal activity distribution among spots, the results were similar to plate A, despite the 
overlap observed in the radio-TLC chromatograms.  
Overall, the relative uncertainty was much lower for CLI-based analysis compared to radio-
TLC scanner software analysis. When analyzing radio-TLC plates containing regions of unequal 
radioactivity, CLI-based analysis showed improved quantitative accuracy. Because overlapping 
peaks are often observed in radio-TLC samples in our laboratory and in the literature, it is likely 
that many studies contain non trivial quantitation errors. Such errors could be minimized by 
switching to a CLI-based readout method, or alternatively by modifying the radio-TLC scanner to 
reduce the overlap (e.g. using a collimator on the detector head to decrease peak widths at the 
expense of reduced sensitivity, or increasing the length of the radio-TLC plates to increase 
separation between peaks at the expense of longer development times). 
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Figure 6-14. Comparison of analysis via radio-TLC scanner software and Cerenkov 
luminescence imaging approach for five specially-prepared radio-TLC plates.  
The first column depicts a cartoon of the arrangement of [18F]fluoride solution samples (1 µL each 
but different concentrations) on the radio-TLC plate. The darkness of each spot represents the 
amount of radioactivity. Note that the radio-TLC scanning direction is from bottom to top. The 
intended radioactivity distributions (bottom to top) were: 50:50 (Plate A), 10:90 (Plate B), 80:10:10 
(Plate C), 10:80:10 (Plate D), and 33:33:33 (Plate E). The second and third columns show radio-
chromatograms obtained from a radio-TLC scanner. The columns depict the same radio-
chromatograms, but use two different methods of integrating the peaks. Finally, the fourth column 
shows a Cerenkov luminescence image of the same plate. 
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Table 6-1.  Comparison of analyses using radio-TLC scanner software and CLI-based 
approach for the five TLC plates of Figure 6-14.  
For each plate, the spots are listed in the order they would be encountered by the scanner (i.e. 
bottom to top in Figure 6-14). Values for radio-TLC scanner and CLI-based analysis are derived 
from n=8 analyses of the same plate and are normalized to the measurements from the gamma 
counter.  n=1 for the gamma counter measurements. 
 
Gamma 
counter Conventional radio-TLC scanner Cerenkov luminescence imaging (CLI) 
Plate 
Fraction of 
activity in 
each spot 
(%) 
Fraction of 
activity in each 
spot (average ± 
std. dev. %) 
Relative 
error 
(%) 
Relative 
uncertainty 
(%) 
Fraction of 
activity in each 
spot (average ± 
std. dev. %) 
Relative 
error 
(%) 
Relative 
uncertainty 
(%) 
A 
55.1 49.4 ± 0.7 -10 1 52.1 ± 0.9 -5 2 
44.9 50.6 ± 0.7 13 1 47.5 ± 0.5 6 1 
B 
11.7 9.9 ± 1.0 -15 10 11.1 ± 0.7 -5 6 
88.3 90.1 ± 1.0 2 1 88.9 ± 0.7 1 1 
C 
80.0 85.0 ± 4.3 6 5 81.2 ± 0.5 2 1 
11.1 8.2 ± 3.2 -26 39 10.6 ± 0.4 -4 4 
8.8 6.9 ± 1.4 -22 20 8.1 ± 0.2 -8 3 
D 
9.8 7.4 ± 2.3 -25 32 9.7 ± 0.5 -1 5 
82.2 84.8 ± 4.9 3 6 82.5 ± 0.7 0 1 
7.9 7.8 ± 2.6 -1 34 7.8 ± 0.2 -2 3 
E 
31.4 34.0 ± 1.3 8 4 32.3 ± 0.3 3 1 
34.1 32.5 ± 1.3 -5 4 35.2 ± 0.2 3 0 
34.5 33.5 ± 0.6 -3 2 32.4 ± 0.3 -6 1 
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6.5.8. Superposition of bright-field and CLI images 
In some cases, it may be useful to superimpose the CLI image onto a brightfield image of the 
radio-TLC plate. For example, the brightfield image could shows markings on the TLC plate of 
spotting locations and solvent front to help quantify Rf values and identify radioactive species. An 
example of a superimposed image of a developed TLC plate is shown in Figure 6-15.  
 
Figure 6-15. An example image obtained by superimposing the Cerenkov luminescence 
signal (false color) over a brightfield image (greyscale).  
Eight replicate samples (0.5 µL each) of crude [18F]FET were spotted on a single TLC plate with 
5 mm pitch and then separated in parallel. The separation distance was 15 mm. 
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7. Chapter 7: High-throughput radiochemistry optimization in 
microdroplets 
7.1. Introduction 
Most of positron emission tomography (PET) tracers available for preclinical and clinical 
research are produced using commercial macroscale radiosynthesizers [7,122,123]. These 
automated devices enable the consistent production of tracers while protecting the operator from 
radiation. Most systems are designed for production of relatively large batches, which can be 
divided up among many end users to share the production cost. While this approach is suitable 
for commonly used tracers, like [18F]FDG, the systems can be wasteful for production of smaller 
batches of tracers (e.g. less common tracers, or novel tracers in development). Reaction volumes 
are typically in the ~1 mL range with needed amounts of expensive precursors in the range of 1s 
– 10s of mg, and the systems must be operated in specialized facilities (hotcells) to provide 
radiation protection.   
To develop a new tracer or synthesize the existing tracers on different systems, optimization 
of synthesis protocols is needed to achieve sufficient and consistent yield. Using macroscale 
radiosynthesizers for new tracer development, is a cumbersome and tedious process as the 
apparatus generally becomes contaminated after use and one must wait for radioactive decay 
(e.g. overnight) before beginning the next experiment, limiting the experimental throughput. 
Performing optimization studies over weeks or months has significant costs, including labor, 
facilities, multiple batches of radionuclide, as well as the high amount of precursor needed per 
reaction. These challenges can hinder the development of new tracers and limits the progress of 
research relying on those tracers.  
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Recently, Zhang et al. reported a high-throughput technique for optimization of 18F-
radiosyntheses [124] that avoids the use of radioactivity, thus allowing multiple syntheses to be 
carried out back to back on the radiosynthesizer without worry of radioactive contamination of the 
apparatus. Syntheses are performed starting with levels of [19F]fluoride (in the form of KF) that 
are comparable to what would be expected in an actual radiosynthesis (using [18F]fluoride), and 
reaction yield is determined by detecting species of interest in the crude reaction mixture with very 
high sensitivity using liquid chromatography/tandem mass spectrometry (LC-MS/MS). 
Reasonable correlation of yields between the non-radioactive approach and conventional 
radiosynthesis were reported for two PET tracers, [18F]fallypride and [18F]MDL100907 [124].  
While enabling optimization to be carried out in a shorter time and reducing radionuclide costs, 
this technique relies on a very expensive instrument that is not commonly found in radiochemistry 
laboratories. Furthermore, the optimization remains somewhat labor intensive as reactions are 
carried out serially. 
In recent years, microfluidic radiochemistry has drawn increasing attention due to several 
advantages over radiochemistry performed in conventional radiosynthesizers [75,125]. Several 
microfluidic platforms have demonstrated reactions in very small volumes with short synthesis 
times [11,19,25,36,77,125], yet can produce tracers in comparable radiochemical yield to 
conventional approaches. As a result of the small volume, consumption of expensive reagents 
(e.g. precursors, peptides, proteins…) can be up to two orders of magnitude less [11], purification 
can be simplified and accelerated, and high molar activity of the tracer can be achieved, even 
when using only a small amount of radioactivity [13]. All these factors contribute to significant 
reductions in the cost of radiosynthesis, which will have particular impact when only small batches 
are needed.   
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Leveraging the benefits of microfluidic radiochemistry, Pascali et al. reported an optimization 
protocol for 18F-radiosyntheses using a flow-based microfluidic device (Nanotek, Advion , Ithaca, 
NY, USA). Operating in a back-to-back experiment mode, optimization of the radiofluorination 
step (reaction temperature, residence time and reagent ratio) could be completed in only 5–10 
experimental days, which is significantly shorter than the time typically required for optimization 
on conventional systems. 
Inspired by these advances, we developed a high throughput radiochemistry optimization 
platform, adapted from droplet-based microdroplet reactors developed by our group [36], where 
multiple reactions can be performed in parallel instead of sequentially.  This approach uses a 
microfluidic chip that contains an array of reaction sites (either 2x2 or 4x4) for performing 
simultaneous droplet-based radiosyntheses. This approach has considerable advantages: (i) 
reactions are performed in parallel, with up to 16 reactions (different conditions and/or replicates) 
completed in the time taken to perform 1 reaction; (ii) each reaction uses only a tiny amount of 
reagents (typically 10s of µg), reducing the cost of optimization and enables optimization even in 
early stage development when precursor is scarce; (iii) the droplet-based microdroplet reactor 
uses low-cost analytical radiochemistry techniques and does not require significant new 
instrumentation. Furthermore, the platform significantly relieves the radiochemist from tedious 
and repetitive work typically required if using traditional synthesis means. As a proof of concept, 
we optimize the synthesis of [18F]fallypride, a PET tracer used to study diseases associated with 
the dopaminergic system such as Parkinson’s, Huntington’s, and Alzheimer’s diseases [126–
128]. To assess the suitability of this approach, we performed experiments to measure cross-
contamination from one site to another and to measure the consistency of radiochemical 
processes among different reaction sites. Finally, extensive sets of varied reaction conditions (e.g. 
base amount, volume of precursor, and precursor concentration) were performed with each to 
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map out the parameter space and ultimately maximize the yield. By having 16 reaction sites, we 
could perform analysis of 8 different reaction conditions while using 2 replicates per condition to 
assess repeatability, all within a single day. 
7.2. Materials and Methods 
7.2.1. Materials 
Teflon AF 2400 (1% solids) solution was purchased from Chemours (Wilmington, DE, USA).  
Positive photoresist (MEGAPOSIT SPR 220-7.0) and developer (MEGAPOSIT MF-26A) were 
purchased from MicroChem (Westborough, MA, USA). Additional solvents and chemicals used 
for microfluidic chip fabrication, including methanol (MeOH, Cleanroom LP grade), acetone 
(Cleanroom LP grade) and isopropanol (IPA, Cleanroom LP grade) were purchased from KMG 
Chemicals (Fort Worth, TX, USA). 
Anhydrous methanol (MeOH, 99.8%), anhydrous acetonitrile (MeCN, 99.8%), 2,3-dimethyl-2-
butanol (thexyl alcohol, 98%), ammonium formate (NH4HCO2, 97%) and trimethylamine (TEA, 
99%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tetrabutylammounium 
bicarbonate (TBAHCO3, 75mM), tosyl fallypride (fallypride precursor, >90%) and fallypride 
(reference standard for [18F]fallypride, >95%) were purchased from ABX Advanced Biochemical 
Compounds (Radeberg, Germany). DI water was obtained from a Milli-Q water purification system 
(EMD Millipore Corporation, Berlin, Germany). No-carrier-added [18F]fluoride in [18O]H2O was 
obtained from the UCLA Ahmanson Biomedical Cyclotron Facility.   
 
7.2.2. Multi-reaction microfluidic chips 
The multi-reaction microfluidic chips were fabricated utilizing the standard lithographic 
processes reported previously [36]. The 4-spot chip (25.0 x 27.5 mm2) comprises a hydrophobic 
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Teflon surface with four circular hydrophilic reaction sites (4 mm diameter) positioned in 2 x 2 
array with 5 mm space between adjacent reaction sites (9 mm center to center). The 16-spot 
chips (25.0 x 27.5 mm2) have sixteen circular hydrophilic reaction sites (3 mm diameter) 
positioned in a 4 x 4 array with 2 mm space in between (5 mm center to center). The reagents 
were manually loaded on the hydrophilic reaction site and retained within it during reaction 
processes due to the preferred wettability compared to the surrounding hydrophobic (Teflon AF) 
surface. Each reaction site was designed for performing an individual synthesis. 
The chip was affixed to a temperature control platform, which was previously described [36]. 
The chips and overall setup are shown in Figure 7-1. 
 
 
Figure 7-1: The microfluidic chips and overall setup. 
 (A) Photograph of the 4-spot microfluidic chip. Diameter of each reaction site is 4 mm and the 
pitch is 9 mm. (B) Photograph of the 16-spot microfluidic chip. Diameter of each reaction site is 3 
mm and the pitch is 5 mm. (C) Schematic of the side view of the experimental setup for performing 
parallel radiosyntheses on the multi-spot microfluidic chip. 
 
7.2.3. Synthesis and optimization of [18F]fallypride on the chip 
[18F]fallypride was synthesized using a modified version of a previously described droplet 
synthesis protocol [36].  Briefly, a [18F]fluoride stock solution (30 mM TBAHCO3 ;  4 mCi; 148 MBq) 
was prepared by mixing with TBAHCO3 with [18F]fluoride/[18O]H2O and diluting with DI water up 
to 150 μL. An 8 μL droplet of this stock solution was loaded to each of the desired spot(s) on a 2 
x 2 or a 4 x 4 multi-reaction chip and dried for 1 min at 105 °C. Next, a 6 μL solution of fallypride 
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precursor (39 mM in 1:1 v/v mixture of thexyl alcohol and MeCN) was added, mixed with the dried 
residue at the desired spot(s), and allowed to react for 7 min at 110 °C. Crude [18F]fallypride 
product was collected from the desired spot(s) on the chip, with 60 μL of 90% MeOH and 10% DI 
water. 
Variation of individual parameters (TBAHCO3 concentration, volume of precursor solution, and 
precursor concentration) was carried out with at least n=2 replicates each to determine their 
influence on fluorination efficiency and crude radiochemical yield (RCY). Volume of precursor was 
varied from 2 to 8 µL, TBAHCO3 concentration was varied from 0.95 to 60 mM, and precursor 
concentration ranged from 0.6 to 77 mM.  
 
7.2.4. Analytical methods 
The activity distribution on the chips at three different stages of [18F]fallypride synthesis (after 
drying of fluoride, after fluorination, and after collection) were analyzed using Cerenkov imaging 
as previously described [36,57]. Briefly, chips were placed in a home-built light-tight box [57], 
covered with a transparent substrate, and Cerenkov light was detected by a scientific cooled 
camera (QSI 540, Quantum Scientific Imaging, Poplarville, MS, USA) equipped with a 50 mm 
lens (Nikkor, Nikon, Tokyo, Japan). The temperature of the camera was maintained at -10°C for 
dark current reduction and the field of view of the system was 50 x 50 mm2. Exposure time was 5 
min and raw images were corrected as previously described [57], followed by background 
subtraction and decay correction to the starting time of the first image. The images were then 
analyzed by drawing regions of interest (ROIs) using custom-written MATLAB software. (One of 
the ROIs, drawn in an area that did not contain radioactive sample, was used for background 
subtraction.)  
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Moreover, performance of synthesis was evaluated by analyzing the collection efficiency and 
fluorination efficiency to obtain the crude radiochemical yield (crude RCY). Radioactivity 
measurements were made using a calibrated dose calibrator (CRC-25R, Capintec, Florham Park, 
NJ, USA). Activity on chip was measured when adding an 8 μL droplet mixture of TBAHCO3 with 
[18F]fluoride/[18O]H2O to the first reaction site and subsequent measurements were performed 
after adding activity to each reaction site on the chip. Subtraction and decay correction to the first 
measurement on the chip was performed to calculate the starting activity on each reaction site. 
Collection efficiency was determined by dividing the activity of the collected crude sample (decay 
corrected) by the starting activity in the reaction site Fluorination efficiency was analyzed using 
radio-TLC. The crude sample was spotted (1 μL) onto a silica gel 60 F254 plate (Merck KGaA, 
Darmstadt, Germany), and developed with 60% MeCN in 25 mM NH4HCO2 with 1% TEA (v/v). 
To accelerate analysis, radio-TLC plates were spotted with multiple samples (up to 8 at 0.5 mm 
pitch) before developing. After separation, a glass microscope slide (76.2 mm x 50.8 mm, 1 mm 
thick) was placed over the multi-sample plates and were read out using Cerenkov imaging (5 min 
exposure)[129] using the same method as for imaging the microfluidic chips. To determine the 
fluoride conversion, ROIs were drawn on the final corrected image to enclose the radioactive 
regions/spots. Each ROI was integrated, and then the fraction of the integrated signal in that ROI 
(divided by the sum of integrated signal in all ROIs corresponding to the particular sample) was 
computed. Finally, crude RCY was determined by multiplying the collection efficiency by the 
fluorination efficiency.  
Analytical radio-HPLC was performed using a Smartline HPLC system (Knauer, Berlin, 
Germany) equipped with a degasser (Model 5050), pump (Model 1000), a UV (254nm) detector 
(Eckert & Ziegler, Berlin, Germany) and a gamma-radiation detector and counter (B-FC- 4100 
and BFC-1000; Bioscan, Inc., Poway, CA, USA). Separation was performed using a C18 column 
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(Kinetex, 250 x 4.6 mm, 5 µm, Phenomenex, Torrance, CA, USA). The mobile phase was 60% 
MeCN in 25 mM NH4HCO2 with 1% TEA (v/v) and flow rate was 1.5 mL/min. The retention time 
of fallypride was 4.5 min. The crude [18F]fallypride mixture collected from the chip was mixed with 
fallypride (reference standard) and manually injected into the HPLC system for confirmation of 
radiochemical identity. Examples of chromatograms of crude [18F]fallypride were shown in Figure 
7-7. 
7.3. Results and discussion 
The chips were installed on top of a heater such that the temperature was the same at all 
reaction sites (confirmed with thermal imaging, data not shown). Syntheses were carried out in 
parallel, with the whole chip (i.e. whole array of sites) heated or cooled simultaneously after adding 
the relevant reagent to all reaction sites (Figure 7-2). After completion of reactions, crude reaction 
products were collected independently from each reaction site for analysis.  
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Figure 7-2: Parallel synthesis of [18F]Fallypride using the multi-reaction platform.  
Up to 4 reactions can be performed in parallel on 2 x 2 array chips and up to 16 reactions can be 
performed in parallel on 4 x 4 array chips. (A) Schematic of the multi-step radiochemical synthesis 
of [18F]fallypride in micro-droplets. First, at each site, an 8 µL droplet of [18F]fluoride (~3.7 MBq) 
mixed with TBAHCO3 (240 nmol) was added and then dried at 105 °C for 1 min. Then, a 6 µL 
droplet of tosyl-fallypride precursor (39 mM) was added and reacted for 7 min at 110 °C. Finally, 
20 µL collection solution (90:10 v/v MeOH:water) was loaded on the reaction site to dissolve 
resulting compounds and the mixed droplet was collected from the chip. Each site was collected 
for independent analysis via 3 repeats of the collection process. (B) Cerenkov image showing the 
distribution of radioactivity on a 2x2 chip of the parallel synthesis after the evaporation of 8 µL 
droplets of [18F]fluoride mixed with TBAHCO3 . (C) Cerenkov image showing the distribution of 
radioactivity on a 2x2 chip of crude [18F]fallypride after the fluorination of tosyl-fallypride with 
[18F]fluoride.  (D) Cerenkov image showing the distribution of the residual radioactivity on a 2x2 
chip after the collection of crude [18F]fallypride. The Cerenkov brightness is decay-corrected to a 
common timepoint for all images. 
 
Evaluation of synthesis performance was achieved by analyzing the collection efficiency and 
fluorination efficiency to calculate the crude radiochemical yield (crude RCY). Collection efficiency 
was determined by dividing the activity of the collected crude sample (decay corrected) from the 
starting activity in the reaction site. Fluorination efficiency was analyzed via radio-TLC or radio-
HPLC.  
 
7.3.1. Cross-contamination tests 
We first assessed the independence of each reaction site by performing droplet radiochemical 
syntheses of [18F]fallypride at some sites on the chip while other sites were left “blank” (no 
[18F]fluoride added, but otherwise synthesis steps still carried out). Cerenkov luminescence 
imaging of the chip surface[36,57] was used to quantify any cross-contamination of radioactive 
species to the blank sites at different stages of the synthesis process. In one experiment on a 2x2 
chip, 1 of 4 sites was used to perform the first step of [18F]fallypride synthesis (i.e., drying of 
solution containing [18F]fluoride and TBAHCO3 to form the [18F]TBAF complex), and Cerenkov 
images taken afterwards (see Appendix, Figure 7-4A) revealed negligible signal in the blank 
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sites, i.e. activity level was <0.3-0.6% of the activity at the non-blank site suggesting no cross-
contamination of radioactivity. In another experiment on a 2x2 chip, 3 of 4 sites were used to 
perform the complete synthesis of [18F]fallypride while a mock synthesis (no [18F]fluoride) was 
performed at the remaining site. In this case, Cerenkov images taken afterwards (see Appendix, 
Figure 7-4B) also showed negligible radioactive contamination of the blank site, i.e. activity level 
was<0.4 % of the activity at the non-blank sites. Similarly, no significant cross-contamination was 
observed on 4x4 chips either, despite the closer spacing of these reaction sites. Quantitation of 
Cerenkov images (see Appendix, Figure 7-5A and Figure 7-5B) showed the amount of 
contamination in blank spots to be <1.4% of the average activity in non-blank spots. Overall, these 
results suggest that the parallel reactions can be considered independent. 
 
7.3.2. Reproducibility tests 
Next, we assessed the reproducibility at different reaction sites by performing replicates of 
syntheses using multiple reaction sites on a single chip. In a set of experiments on 2x2 chips, we 
performed drying of the [18F]TBAF complex and subsequent fluorination of tosyl-fallypride on all 
sites (see Appendix, Table 7-1) and found the crude radiochemical yield (crude RCY) to be 88 
± 1 %  (n=4), indicating excellent reproducibility from site to site. Similar reproducibility was found 
for an experiment on a 4x4 chip, in which syntheses on half of the sites were carried out with a 
TBAHCO3 amount of 240 nmol, and the other half were carried out with 7 nmol (see Appendix, 
Table 7-2). The crude RCYs were measured to be 85 ± 2% (n=8) and 38 ± 4% (n=8) for the two 
conditions, respectively, the low standard deviation across each condition indicates excellent site-
to-site reproducibility. In later experiments (described below), we discovered that the yield is 
highly sensitive to the amount of base at the low-base condition and thus the higher variability in 
crude RCY of those reactions is expected. 
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7.3.3. Optimization studies 
To demonstrate the utility of the platform, we then leveraged the parallel reactions to perform 
an extensive, fine-grained optimization of several [18F]fallypride synthesis parameters, each data 
point with multiple replicates. The initial syntheses were performed using the reaction conditions 
adapted from Wang et al. [36] to gather baseline performance.  In short, a [18F]fluoride stock 
solution was prepared by combining [18F]fluoride/[18O]H2O (150 μL, ~200 MBq; 5.5 mCi) with 30 
nmol of TBAHCO3. An 8 μL droplet of the mixture was added to each reaction site and dried at 
105°C for 1 min, then a 4 μL droplet of tosyl-fallypride precursor (77 mM) in a mixture of MeCN 
and thexyl alcohol (1:1, v/v) was added in each reaction site,  and the chip was heated to 110°C 
for 7 min to carry out the fluorination step. Collection of the crude reaction product at each site 
was carried out by repeating the following steps 3 times: adding 20 µL of a mixture of MeOH and 
DI water (9:1, v/v) and collecting the resulting mixture from the chip (total of 60 µL). In repeated 
experiments under identical conditions, we observed high variability of crude RCY from 8-84%, 
suggesting the reactions were either highly sensitive to certain conditions (e.g. reagent amount) 
or to a variable we had not accounted for. 
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Figure 7-3: Influence of reaction parameters on the performance of the microdroplet 
synthesis of [18F]fallypride, explored using the high-throughput platform.  
(A) Effect of concentration of base solution. Reaction volume: 4 µL. Precursor solution 
concentration: 77 mM. The optimal value was taken as 240 nmol of TBAHCO3, giving a crude 
RCY of 92±1% (n=2). (B) Effect of volume of precursor solution. Base amount: 240 nmol. 
Precursor solution concentration: 77 mM. The optimal value was taken as 6 µL, giving a crude 
RCY of 90±1% (n=4). (C) Effect of concentration of the precursor solution. Base amount: 240 
nmol. Precursor solution volume: 6 µL. The optimal value was taken as 39 mM, giving a crude 
RCY of 87±3% (n=2).  
 
We first explored the impact of the amount of TBAHCO3 in the reaction (Figure 7-3A, and 
Appendix, Table 7-3). Standard deviations of data points were small, and the yield showed a 
clear dependence on the amount of base. From nearly zero yield at low base amount, the yield 
sharply rises to ~86% at 80 nmol base, where it remains relatively stable, and then falls off again 
with higher base amounts. The highest yield (92 ± 1%, n=2) was obtained at 240 nmol. The very 
high sensitivity to base at 30 nmol may suggest why high variability was observed under the 
original synthesis conditions: a small variation in the amount of base (e.g. due to pipetting error 
when adding the [18F]fluoride/TBAHCO3 solution) could result in large variation in yield. The 
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relatively low slope in the 80-240 nmol range suggests the yield would be fairly immune to 
pipetting errors. 
We next examined the effect of fluorination reaction volume on yield, using 240 nmol of 
TBAHCO3 in the initial [18F]fluoride/TBAHCO3 droplet and 77 mM concentration of precursor 
solution (Figure 7-3B, and Appendix, Table 7-4). The crude RCY yield showed a strong 
dependence on reaction volume, rising from a moderate value (43 ± 3%, n= 4) for a 2 µL reaction 
to nearly 100% for volumes of 4, 6, and 8 µL. Based on visual observations, we suspect that the 
smaller volumes are not sufficient to fully wet the reaction site and thus some of the dried 
[18F]TBAF residue remaining after the drying step does not get dissolved into the reaction droplet. 
We chose a reaction volume of 6 µL for subsequent experiments as in that region the flat slope 
of the graph indicates an insensitivity to errors in precursor droplet volume. 
Finally, we explored the influence of precursor concentration, when using 240 nmol of 
TBAHCO3 and a 6 µL fluorination reaction volume (Figure 7-3C, and Appendix, Table 7-5). 
Crude RCY was near zero for low precursor concentrations, increasing rapidly with precursor 
concentration, and reaching a plateau with near 100% yield above ~40 mM. At the optimal 
conditions (240 nmol TBAHCO3, 6 µL reaction volume, and 39 mM precursor concentration), the 
fluorination efficiency was 96.0 ± 0.5 % (n=2) and the crude RCY was very high, namely 87 ± 3 
% (n=2). 
The optimized reaction conditions found using our multi-reaction microfluidic chip provided 
higher and more consistent crude RCY compared to previous reports using microscale 
platforms[21,27,28,59]. For example, 84 ± 7 % (n=6) was reported for droplet-based reactions on 
an EWOD chip[27] and 64 ± 6 % (n=4) was reported for droplet-based reactions on a chip using 
a passive droplet transport mechanism[36]. Furthermore, we were able to perform 16 syntheses 
within only 90 min (starting from the loading of [18F]fluoride/TBAHCO3 mixture, up to the end of 
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collection process. On other microscale platforms, the time for a single synthesis run was, e.g.,  
31 min [27] or 25 min [36], which would require ~500 min [8.3 h] or ~400 min [6.7 h] to perform 
16 experiments. The time savings using the multi-reaction chip are a direct result of performing 
many of the steps (e.g. drying step and fluorination step) at all reaction sites in parallel.  
Interestingly, we observed the formation of a side-product on the TLC chromatogram when the 
molar ratio of base to precursor exceeded 1.0. (This observation seems to be consistent withMoon 
et al. who reported that the usage of high base concentration (either K222/K2CO3 or TBAHCO3) led 
to low radiochemical yield and unidentified radio-impurities [32].) We found no detectable side 
product as long as the molar ratio of base to precursor remained < 1.0 (as shown in the Appendix, 
Figure 7-6). This finding might be applicable to synthesis of [18F]fallypride, or other base-sensitive 
tracers in other setups to help choose an appropriate precursor amount depending on the amount 
of base needed to elute [18F]fluoride from the QMA cartridge. 
7.4. Conclusion 
Using the reaction array chips, the synthesis conditions could be rapidly optimized, and the 
optimization could be performed with fine granularity while including replicates of each data point. 
Using the 2x2 reaction chips, it was possible to run 16 experiments per day at low activity levels, 
allowing the full optimization study reported here (20 conditions, n=2 each) to be completed in 3 
days. By using 4x4 reaction chips that we started developing near the end of this study, it would 
be practical to complete this study in even shorter time. Further increase in throughput could be 
accomplished by operating multiple heaters (and multiple chips) in parallel. 
Though in this study we examined the effect of reaction volume and reagent concentrations, 
one could also study variables such as reaction temperature or time, by using multiple heaters, 
or by running multiple chips sequentially on the same heater. 
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An important aspect of high-throughput reaction optimization is the ability to rapidly analyze all 
of the collected reaction mixtures. To accomplish this, we developed an optimized TLC separation 
method with short separation length (35mm), and spotted multiple samples (1.0 µL each, 1.0 mm 
pitch) that could be separated and read out in parallel using CLI [57]. 
Due to limitations of conventional radiochemistry systems that allow only one or a small 
number of reactions per day, one typically explores only a small range of the potential parameter 
space and results are often reported with no repeats (n=1). Compared to such approaches, our 
high-throughput droplet radiosynthesis platform makes it practical to perform more 
comprehensive and robust studies of radiosynthesis conditions, potentially enabling new insights 
on parameters that influence product yield and side-product formation, or on what choice of 
parameter values leads to a robust synthesis (i.e. insensitivity to small variations in variables). 
Furthermore, since the amount of precursor consumed per reaction is extremely small (e.g. ~84 
µg per data point compared to 4 mg per data point in conventional reactions), and many reactions 
can be carried out using the same batch of radioisotope, the cost of the optimization process can 
be significantly lower than for conventional setups. The low precursor consumption may be 
especially useful in the early development of novel tracers when only a small amount of precursor 
may be available.  
Due to success in synthesizing other tracers on this and similar microfluidic platforms 
[27,36,67], we expect this platform to be applicable to the development and optimization of a wide 
range of PET tracers and other radiopharmaceuticals. In other work, we have shown the ability to 
increase the scale of droplet-based reactions by pre-concentrating the radioisotope [37], providing 
a route to immediately transition from low-activity optimization runs to high-activity production runs 
using the exact same microfluidic reaction geometry and synthesis process. Thus, microdroplet 
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reactions are not only a useful tool during the optimization phase, but also can produce sufficient 
quantity of tracers for preclinical or even clinical studies. 
In summary, we have developed a general platform and strategy for the rapid optimization of 
PET tracer syntheses and demonstrates efficient translation of macroscale synthesis procedures 
to microscale syntheses by using a novel multi-reaction microfluidic chip that allows analysis of 
performance of up to 16 parallel reactions. Contamination tests confirmed the independence of 
reaction sites and reproducibility of reactions was demonstrated by performing replicate 
syntheses.  
7.5. Appendix 
7.5.1. Cross-contamination and repeatability studies 
To investigate the cross contamination between adjacent reaction sites, Cerenkov 
luminescence imaging (CLI) was employed to image the activity distribution on the chip after 
performing drying of [18F]fluoride/TBAHCO3 or fluorination in different patterns of reaction sites. 
In an initial test of 2x2 chips, an 8 µL droplet of [18F]fluoride/TBAHCO3 solution (~1.8MBq; 3.8 
mM) was loaded on 1 of 4 reaction sites, 8 µL droplets of TBAHCO3 solution (3.8 mM) were loaded 
on the remaining reaction sites, and all spots were dried simultaneously at 105 °C for 30 s, 
followed by CLI imaging (Figure 7-4A). Suspecting that steps with more volatile organic solvent 
could increase cross-contamination, we also performed investigations during the fluorination 
reaction. On a 2x2 chip, 3 of 4 sites were loaded with 8 μL of [18F]fluoride/TBAHCO3 (~1.8 MBq; 
3.8 mM), while one was loaded with just TBAHCO3 solution (no [18F]fluoride). After the drying 
step, 6 μL of 39 mM precursor solution was added to all reaction sites, and fluorination was carried 
out in parallel, followed by CLI imaging (Figure 7-4B).  
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Figure 7-4: Cross-contamination tests using 2x2 chips.  
(A) (Left) Schematic of an experiment to test cross-contamination during drying of [18F]TBAF 
complex. (Right) Cerenkov image of the chip after the drying step. (B) (Left) Schematic of 
experiment to test cross-contamination during synthesis of [18F]fallypride. (Right) Cerenkov image 
of the chip after the fluorination step. 
 
To assess the reproducibility at different reaction sites, syntheses of [18F]fallypride were 
performed in parallel at multiple sites of the same chip. In a set of experiments on 2x2 chips, we 
performed drying of the [18F]TBAF complex and subsequent fluorination of tosyl-fallypride on all 
sites. The crude product was collected from each site and analyzed (Table 7-1).  
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Table 7-1: Performance of [18F]fallypride synthesis on 4 sites on a 2x2 reaction chip.  
Reactions were carried out with 240 nmol of TBAHCO3, 39 mM of precursor, and 6 μL of 
precursor solution loaded on each reaction site. High reproducibility is evident.  
Performance measure Reaction site 1 
Reaction 
site 2 
Reaction 
site 3 
Reaction 
site 4 
Average ± std 
dev (n=4) 
Collection efficiency 
(%) 91 92 93 91 92 ± 1 
Fluorination efficiency 
(%) 97 93 94 95 95 ± 2 
Crude RCY (%) 89 86 88 87 88 ± 1 
 
 
We also tested the 4x4 chips to determine if the closer spacing had an impact on cross-
contamination. Two experiments were performed with different solution loading patterns.  One 
pattern was made by loading an 8 µL droplet of [18F]fluoride solution (~ 3.6 MBq) on the reaction 
sites at the four corners of the 4 x 4 array, and another pattern was made by loading an 8 µL 
droplet of [18F]fluoride solution on alternating reaction sites. The remaining reaction sites were 
each filled with an 8 µL droplet of DI water.  Then, the chips were dried at 100 °C for 1 min, 
followed by CLI imaging (Figure 7-5A and Figure 7-5B, respectively). 
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Figure 7-5: Cross-contamination and repeatability tests using 4x4 chips.  
(A) (Top) Schematic of an experiment with a pattern of loaded and blank reaction sites. (Bottom) 
Cerenkov image of the chip after drying. (B) (Top) Schematic of an experiment with a different 
pattern of loaded and blank reaction sites. (Bottom) Cerenkov image of the chip after drying. (C) 
(Top) Schematic of experiment to test repeatability during synthesis of [18F]Fallypride (240 nmol 
TBAHCO3 amount for top two rows and 7 nmol TBAHCO3 amount for bottom two rows). (Bottom) 
Cerenkov image of the chip after the collection step. 
 
To assess repeatability on the 4x4 chip, we loaded 8 μL of two different concentrations of 
[18F]fluoride/TBAHCO3 solution: ~3.6 MBq [18F]fluoride and 30 mM [240 nmol] TBAHCO3 in the 
first 2 rows and ~3.6 MBq [18F]fluoride and 0.9 mM [7 nmol] TBAHCO3  in the second two rows. 
After the drying step was performed, 6 μL of 39 mM precursor was added to all reaction sites and 
the fluorination reaction was performed by heating the whole chip. The crude products were 
collected and analyzed (Table 7-2) and a CLI image of the chip after sample collection was 
obtained (Figure 7-5C). 
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Table 7-2. Synthesis performance from 16 sites on a 4x4 reaction chip using two different 
base concentrations (n=8 each) corresponding to Figure 7-5C.  
For all reactions, precursor concentration was 39 mM, and volume of precursor solution was 6 
µL. TBAHCO3 amount was 240 nmol in the reactions of rows 1 and 2 on the chip, and 7 nmol in 
rows 3 and 4. High reproducibility is evident. The higher variability in rows 3 and 4 may be caused 
by the higher sensitivity to salt concentration under this condition.  
 Performance measure Column 1 Column 2 Column 3 Column 4 Average ± std dev (n=4) 
Row 1 
Collection efficiency (%) 93 92 94 94 93±1 
Fluorination efficiency 
(%) 93 92 93 90 92±1 
Crude RCY (%) 87 84 87 84 86±2 
Row 2 
Collection efficiency (%) 92 95 92 93 93±2 
Fluorination efficiency 
(%) 89 91 91 89 90±1 
Crude RCY (%) 81 86 84 83 84±2 
Row 3 
Collection efficiency (%) 92 84 89 88 89±3 
Fluorination efficiency 
(%) 50 41 41 40 43±5 
Crude RCY (%) 46 35 36 35 38±5 
Row 4 
Collection efficiency (%) 91 86 88 95 90±4 
Fluorination efficiency 
(%) 41 45 39 44 42±3 
Crude RCY (%) 37 39 34 42 38±3 
 
7.5.2. Optimization results 
This section contains all the raw data that was used to generate the plots in Figure 7-3. 
Experiments to compare the effects of amount of base, precursor solution volume, and precursor 
solution concentration are summarized in Table 7-3, Table 7-4 and Table 7-5, respectively. 
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Table 7-3. Details of syntheses to evaluate influence of base amount on the synthesis of 
[18F]fallypride.  
Reactions were carried out with 77 mM of precursor, 4 μL of precursor solution, and base amount 
in an 8 μL droplet as indicated. Each condition was replicated n=2 times. 
Base amount 
(nmol) 
Collection efficiency % Fluorination efficiency 
% 
Crude RCY 
% 
480 94 ± 1 63 ± 11 59 ± 9 
240 94 ± 1 98.9 ± 0.2 92 ± 1 
120 93 ± 1 96 ± 1 88.3 ± 0.3 
80 92 ± 1 94 ± 1 86.0 ± 0.2 
60 91 ± 3 92 ± 2 83.1 ± 0.5 
30 90.4 ± 0.1 65 ± 2 59 ± 2 
15 91 ± 2 13 ± 1 12 ± 1 
7 88 ± 1 9 ± 1 8 ± 1 
 
 
 
Table 7-4. Details of syntheses to evaluate the influence of precursor solution volume on 
the synthesis of [18F]fallypride.  
Reactions were carried out with 240 nmol of TBAHCO3 in an 8 μL droplet with [18F]fluoride, 77 
mM of precursor, and volume of precursor solution as indicated. Each condition was replicated 
n=2 times. 
Precursor solution 
volume (μL) 
Collection 
efficiency % 
Fluorination 
efficiency % 
Crude RCY % 
2 87 ± 4 51 ± 7 43 ± 3 
4 92 ± 1 96 ± 1 88 ± 2 
6 92 ± 1 98 ± 1 90 ± 1 
8 92 ± 1 96 ± 1 88 ± 1 
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Table 7-5. Details of syntheses to evaluate influence of precursor concentration on the 
synthesis of [18F]fallypride.  
Reactions were carried out with 240 nmol TBAHCO3 in an 8 μL droplet with [18F]fluoride, 6μL of 
precursor solution, and precursor concentration as indicated. Each condition was replicated n=2 
times. 
Precursor 
concentration (mM) 
Collection efficiency 
% 
Fluorination efficiency 
% 
Crude RCY % 
77 92 ± 2 97 ± 2 89 ± 4 
38.5 91 ± 2 96.0 ± 0.5 87 ± 3 
19.3 91.1 ± 0.5 81.1 ± 0.3 74 ± 1 
9.6 91 ± 1 63 ± 1 57.0 ± 0.5 
4.8 89 ± 1 37 ± 1 33 ± 1 
2.4 88 ± 2 22 ± 2 19 ± 2 
1.2 82 ± 1 13 ± 1 10.4 ± 0.1 
0.6 82 ± 4 7 ± 1 5.1 ± 0.5 
 
 
The data in Figure 7-6 shows the correlation between base: precursor ratio and the 
appearance of radioactive side-products in the crude product. 
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Figure 7-6. Correlation of amount of side-product with the base:precursor ratio in 
microdroplet synthesis of [18F]fallypride.  
 (A) Cerenkov luminescence image of developed TLC plate spotted with 1 µL each of  2 crude 
[18F]fallypride samples, performed with 240 nmol TBAHCO3  and 110 nmol of precursor (6 µL 
droplet of 19 mM solution). (B) Developed TLC plate spotted with 1 µL each of 2 crude 
[18F]fallypride samples, performed with 480 nmol TBAHCO3 and 310 nmol of precursor (4 µL 
droplet of 77 mM solution) (C) Developed TLC plate spotted with 1 µL each of  2 crude 
[18F]fallypride samples, performed with 240 nmol TBAHCO3  and 154 nmol of precursor (2 µL 
droplet of 77 mM solution). (D) Developed TLC plate spotted with 1 µL each of 2 crude 
[18F]fallypride samples, performed with 240 nmol TBAHCO3  and 230 nmol of precursor (6 µL 
droplet of 39 mM solution). (E) Developed TLC plate spotted with 1 µL each of 2 crude 
[18F]fallypride samples, performed with 240 nmol TBAHCO3 and 310 nmol of precursor (4 µL 
droplet of 77 mM solution). (F) Developed TLC plate spotted with 1 µL each of 2 crude 
[18F]fallypride samples, performed with 240 nmol TBAHCO3  and 460 nmol of precursor (6 µL 
droplet of 77 mM solution). The dashed circles represent the ROIs for analysis. The dashed arrow 
represents the direction of solvent flow during developing. 
 
7.5.3. HPLC chromatogram of crude [18F]fallypride  
Radiochemical purity of the crude sample was determined using analytical-scale radio HPLC 
(Figure 7-7).  Due to the low reagent mass, the chromatogram is very clean. The absence of 
impurities near the [18F]fallypride peak suggests that purification via analytical-scale radio-HPLC 
should be straightforward. 
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Figure 7-7. Example of analytical radio-HPLC chromatogram showing the crude 
[18F]fallypride product synthesized on the microfluidic chip.  
Non-radioactive fallypride reference standard was injected together with the crude product to 
confirm the identity of [18F]fallypride.  
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8. Chapter 8: Microscale synthesis of [18F]FDOPA 
8.1. Introduction 
The amino acid positron-emission tomography (PET) tracer 3,4-dihydroxy-6-[18F]fluoro-L-
phenylalanine ([18F]FDOPA) is mainly applied to the clinical imaging of Parkinson’s disease [130], 
brain tumors [131,132] and diseases related to dopaminergic system. Recently, there has also 
been increasing interest in the use of [18F]FDOPA to image various neuroendocrine tumors 
(NETs) [133], in which the uptake of [18F]FDOPA through the transmembrane amino acid 
transporter systems is upregulated significantly. It has been demonstrated that [18F]FDOPA has 
high sensitivity and precision for imaging of carcinoid tumors, medullary thyroid cancer and et al. 
[134–136]. 
Even though [18F]FDOPA has wide application in molecular imaging, its usage is limited due 
to its complicated synthesis. The earliest methods relied on a straightforward synthesis pathway 
involving electrophilic fluorination (which requires the production of [18F]F2 [137]) and deprotection. 
However, the low availability of [18F]F2 contributes to poor accessibility. Thus, many groups have 
been exploring alternative production pathways based on nucleophilic fluorinations using 
[18F]fluoride [138]. High radiochemical yield (RCY ~40%) has been reported using two-step 
copper-mediated approaches[139], but these methods require a high amount (~40 mg) of the 
expensive precursor, which can complicate purification. Furthermore, the toxicity of copper also 
complicates purification and testing for clinical use. Libert et al. described a five-step 
radiosynthesis employing a chiral phase-transfer catalyst and successfully produced more than 
45 GBq [1.2 Ci] [18F]FDOPA after 65 min synthesis time with 36 ± 3% (n=8) (decay corrected) 
RCY [140]. However, the preparation of the catalyst is difficult and expensive, and the synthesis 
can be difficult to implement on some synthesizers because two reaction steps are performed on 
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solid supports. Kuik et al. reported a simple 2-step diaryliodonium salt synthesis method to 
produce [18F]FDOPA with RCY of 14 ± 4% [38]. The overall synthesis time was still relatively long 
(~117 min as reported by Kuik et al., and ~71 min as reported by us [141]) due to the need for an 
intermediate purification step.  
To overcome the limitations of current synthesis methods for [18F]FDOPA, we explored the 
feasibility of synthesizing [18F]FDOPA using microfluidics. Our group has previously demonstrated 
the successful production of multiple tracers (e.g. [18F]fallypride, [18F]FDG, [18F]FET, [18F]SFB, 
etc.) using microdroplet reactors, including devices based on electrowetting-on-dielectric (EWOD) 
[11,27] and passive droplet transport by patterned wettability [36]. By performing syntheses in the 
microscale, 10s to 100s times less reagents are needed, which can significantly reduce the 
production cost and increase the molar activity (by reduction of [19F]fluoride contamination) [13]. 
Moreover, rapid purification is possible via analytical-scale HPLC instead of semi-preparative 
HPLC due to the reduced quantity of unreacted reagents and side products. By integrating a 
radionuclide concentrator [37], microdroplet-based syntheses can be scaled to clinically-relevant 
levels [81].  
Here, we implement the diaryliodonium salt based method [38] of synthesizing [18F]FDOPA to 
microdroplet format. We focused on this method due to the simple synthesis process and the 
commercial availability of the precursor. We optimized the synthesis protocol by testing various 
parameters, including concentrations of base and precursor, and reaction temperature. In 
addition, we investigated the use of the radical scavenger 2,2,6,6-tetramethyl-1-piperidinyloxy 
(TEMPO) to increase yield through prevention of precursor decomposition during the reaction 
[142]. Furthermore, we automated the synthesis on a newly developed ultra-compact microdroplet 
reactor (similar in size to a small (12 oz) coffee cup).  
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8.2. Materials and Methods 
8.2.1. Materials 
Anhydrous acetonitrile (MeCN, 99.8%), methanol (MeOH, 99.9%), ethanol (EtOH, 99.5%), 
diethylene glycol dimethyl ether (diglyme, 99.8%), TEMPO (98%), potassium carbonate (K2CO3, 
99%), 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (K222, 98%), hydrocholoric 
acid (HCl, 37%), sulfuric acid (H2SO4, 99.99%), ethylenediaminetetraacetic acid (EDTA, 99%), 
acetic acid (99%), L-ascorbic acid and perchloric acid (HClO4) were purchased from Sigma-
Aldrich. Both 6-Fluoro-L-DOPA hydrochloride (reference standard for L type [18F]FDOPA) and 6-
Fluoro-D,L-DOPA hydrochloride (reference standard for mixture of D and L type [18F]FDOPA) 
were purchased from ABX Advanced Biochemical Compounds (Radeberg, Germany). ALPDOPA 
precursor was obtained from Ground Fluor Pharmaceuticals (Lincoln, NB, USA). DI water was 
obtained from a Milli-Q water purification system (EMD Millipore Corporation, Berlin, Germany). 
No-carrier-added [18F]fluoride in [18O]H2O was obtained from the UCLA Ahmanson Biomedical 
Cyclotron Facility. 
Prior to synthesis of [18F]FDOPA, several stock solutions were prepared. Base stock solution 
was prepared by dissolving K222 (22.8 mg) and K2CO3 (4.08 mg) in a 9:1 (v/v) mixture of DI water 
and MeCN (600 μL). [18F]fluoride stock solution (containing 8.4mM K222 and 4.1mM K2CO3) was 
prepared by mixing [18F]fluoride/[18O]H2O (10 μL, ~220 MBq [~6.0 mCi]), base solution (10 μL) 
and DI water (100 μL). Precursor stock solution (containing 9mM ALDOPA) was prepared by 
dissolving ALDOPA (0.96 mg) in  in diglyme (120 μL, 75 mol% TEMPO). Finally, a collection 
solution to dilute the crude product prior to collection from the chip was prepared from a 4:1 (v/v) 
mixture of MeOH and DI water (500 µL). 
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8.2.2. Microscale synthesis of [18F]FDOPA  
The initial microscale [18F]FDOPA synthesis protocol was adapted from the macroscale 
synthesis method reported by Kuik et al. [38]. Experiments were first performed on multi-reaction 
microfluidic chips to optimize the protocol in a more high-throughput fashion, and then the 
synthesis with optimal conditions was automated. Optimization experiments were performed on 
microfluidic chips comprising a 2x2 arrays of circular hydrophilic reaction sites (4 mm diameter, 9 
mm pitch) patterned in a hydrophobic substrate (25 mm x 27.5 mm) (Figure 8-1A). The patterned 
chips were prepared as described previously [36] (except that no final acid treatment step was 
used) by coating silicon wafers with Teflon AF, and then etching away the coating to leave 
exposed silicon regions. The microfluidic chip was affixed atop of a heater platform to control 
temperature, and reagent addition and crude product collection were performed with a micro-
pipette.  Each chip was used once and then discarded after use. 
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Figure 8-1. Microfluidic chips and experiment setup. 
(A) Photograph of the microfluidic chip with four hydrophilic liquid traps serving as the reaction 
sites. Diameter of the site is 4 mm and pitch is 9 mm. (B) Photograph of the microfluidic chip 
comprising a Teflon-coated silicon wafer with one hydrophilic liquid trap serving as the reaction 
site. Diameter of the site is 4 mm. (C) Schematic of the side view of the experimental setup for 
the microdroplet reactor. 
 
The details of the microscale synthesis are shown in Figure 8-2B. Briefly, a 10µL droplet of 
[18F]fluoride stock solution (~11MBq, 84 nmol K222 / 41 nmol K2CO3) was first loaded on each 
reaction site, and the chip was heated to 105°C for 1min to form the dried [18F]KF/K222 complex 
at each site. Then, a 10µL droplet of precursor solution was added to reach reaction site and the 
chip was heated to 100°C to perform the fluorination step. During the 5 min reaction, the solvent 
was replenished at all sites by adding droplets (~7 µL) of diglyme every 30 s. Following 
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fluorination, a 10 µL droplet of H2SO4 (6M) was added to each reaction site and the mixtures were 
heated to 125°C for 5 min to perform the deprotection step. Finally, for each individual reaction 
site, a 20 µL droplet of collection solution was loaded at each site to dilute the resulting crude 
product, which was then recovered via pipette. The dilution and collection process was repeated 
4x in total to maximize the radioactivity recovery.  
 
 
Figure 8-2. Multi-step radiochemical synthesis of [18F]FDOPA.  
(A) Synthesis scheme. (B) Schematic of manual [18F]FDOPA synthesis process using the multi-
reaction chip. 
 
8.2.3. Automated synthesis using the microdroplet reactor 
To increase safety and to facilitate routine production, we next automated the synthesis. 
Automated syntheses were conducted on chips with a single reaction site (Figure 8-1B) operated 
using a custom-built compact framework (Figure 8-1C), consisting of a rotating, temperature-
controlled platform, a set of reagent dispensers, and a collection system to remove the reaction 
droplet at the end of the synthesis. The rotating stage positions the reaction site as desired under 
a carousel in which reagent dispensers and product collection tube are mounted. More details 
about the ultra-compact microdroplet reactor were previously described.  
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Prior to synthesis, reagent vials connected to the reagent dispensers were loaded with the 
[18F]fluoride stock solution, precursor stock solution, replenishing solution (diglyme), deprotection 
solution (6M H2SO4) and collection solution. An illustration of the automated microdroplet 
radiosynthesis is shown in Figure 8-3. The chip was first rotated to position the reaction site below 
the dispenser 1 for [18F]fluoride stock solution and ten 1 μL droplets of [18F]fluoride stock solution 
(~18.5 MBq; ~0.5 mCi) were sequentially loaded onto the chip (total time < 10s). The chip was 
rotated 45° counterclockwise (CCW) and heated to 105°C for 1 min to evaporate the solvent and 
leave a dried residue of the [18F]KF/K222 complex at the reaction site. Then, the chip was rotated 
45° CCW to position the reaction site under the precursor dispenser and ten 1 μL droplets of 
precursor solution were loaded to dissolve the dried residue. Next, the chip was rotated 45° CCW 
to position the reaction site under the replenishing dispenser (diglyme) and heated to 100°C for 5 
min to perform the fluorination reaction. Solvent was replenished by adding a 1 μL droplet of 
diglyme every 10 s. Afterwards, the chip was rotated 45° CCW to position the reaction site under 
the deprotection solution dispenser, twenty 0.5 μL droplets of deprotection solution were loaded 
on the reaction site and the chip was heated to 125°C for 5 min to perform deprotection step. 
Finally, the chip was rotated 45° CCW to position the reaction site under the collection solution 
dispenser, and twenty 1 μL droplets of collection solution were deposited to dilute the crude 
product. After rotating the chip 45° CCW to position the reaction site under the collection tube, 
the diluted solution was transferred into the collection vial by applying vacuum. The collection 
process was repeated a total of four times to minimize the residue on the chip (i.e. by rotating the 
chip 45° CW back to the collection solution dispenser, loading more collection solution, etc.).  
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Figure 8-3. Schematic of the automated microdroplet radiosynthesis. 
 (A) Top view schematic of the microfluidic chip mounted on the rotating heating platform and the 
fixed locations of reagent dispensers and the collection tube above the chip. (B) Schematic of 
automated [18F]FDOPA synthesis process with the microdroplet reactor setup. 
 
8.2.4. Analytical methods 
Performance of the fluorination step was assessed through measurements of radioactivity 
using a calibrated dose calibrator (CRC-25R, Capintec, Florham Park, NJ, USA) at various stages 
of the synthesis process, and measurements of fluorination efficiency using radio thin-layer 
chromatography (radio-TLC). All radioactivity measurements were corrected for decay. 
Radioactivity recovery was calculated as the ratio of radioactivity of the collected crude product 
to the starting radioactivity on the chip after loading the [18F]fluoride stock solution. Residual 
activity on the chip was the ratio of radioactivity on the chip after collection to the starting 
radioactivity on the chip. Fluorination efficiency of the crude product collected from the chip was 
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determined via radio-TLC. Fluorination yield (decay-corrected) was defined as the radioactivity 
recovery times the fluorination efficiency. 
To accelerate the analysis, radio-TLC was performed using recently-developed parallel 
analysis methods. Groups of 4 samples were spotted via pipette (1 µL each, 1 mm pitch) onto 
each TLC plate (silica gel 60 F254 TLC plate, aluminum backing (Merck KGaA, Darmstadt, 
Germany)). TLC plates were dried in air and developed in the mobile phase (95:5 v/v MeCN : DI 
water). After separation, the multi-sample TLC plate was read out by imaging (5 min exposure) 
with a custom-made Cerenkov luminescence imaging (CLI) system [57]. To determine the 
fluorination efficiency, regions of interest (ROIs) were drawn on the final image (after image 
corrections and background subtraction) to enclose the radioactive regions/spots. Each ROI was 
integrated, and then the fraction of the integrated signal in that ROI (divided by the sum of 
integrated signal in all ROIs) was computed. Two radioactive species were separated in the 
samples: [18F]fluoride (Rf = 0.0) and the fluorinated intermediate (Rf = 1.0). 
Analysis of samples (crude reaction mixture or purified product) was performed on a Smartline 
HPLC system (Knauer, Berlin, Germany) equipped with a degasser (Model 5050), pump (Model 
1000), a UV detector (Eckert & Ziegler, Berlin, Germany) and a gamma-radiation detector and 
counter (B-FC- 4100 and BFC-1000; Bioscan, Inc., Poway, CA, USA). Injected samples were 
separated with a C18 column (Luna, 5 µm pore size, 250 x 4.6 mm, Phenomenex, Torrance, CA, 
USA).  The mobile phase consisted of 1 mM EDTA, 50 mM acetic acid, 0.57 mM L-ascorbic acid 
and 1% v/v EtOH in DI water. The flow rate was 1.5 mL/min and UV absorbance detection was 
performed at 280 nm. The retention times of [18F]fluoride, [18F]FDOPA and the fluorinated 
intermediate were 2.4, 6.2, and 25.8 min, respectively. [18F]FDOPA conversion was determined 
via dividing the area under the [18F]FDOPA peak by the sum of areas under all three peaks.  
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For purification, the collected crude product (~ 80 µL) was first diluted with 80 µL of the mobile 
phase, and then separated under the same conditions as above. 
8.3. Results and discussion 
8.3.1. Optimization of manual synthesis 
Before developing our multi-reaction microfluidic chips, we performed some initial studies of 
the fluorination step with varied reaction conditions to establish a baseline set of conditions upon 
which further fine-grained optimizations could be made. The initial studies examined reaction 
temperature (85 – 125 °C), reaction time (5 – 15 min), reaction solvent (DMF, MeCN, DMSO, 
diglyme), precursor concentration (9 – 71 mM), base amount (21 – 168 nmol of K222 and 10 - 82 
nmol of K2CO3). The highest fluorination yield (~7%) was observed using 84 nmol K222 / 41 nmol 
K2CO3, 9 mM precursor, diglyme as reaction solvent, 105°C temperature, and 5 min reaction time, 
but the yield exhibited poor day to day consistency.  
Previously, Carroll et al. reported that the yield and reproducibility of the fluorination of 
diaryliodonium salts could be improved by adding TEMPO as a radical scavenger to improve the 
stability of the diaryliodonium salt precursor [142]; we investigated whether this approach could 
be potentially used to improve the yield and consistency of [18F]FDOPA synthesis using the multi-
reaction chips.  
Initially we added 20 mol% TEMPO into the precursor solution, and performed a detailed study 
of the effect of precursor concentration on the fluorination yield (Figure 8-4A) with 5 min reaction 
time and 105°C reaction temperature. The highest yields were obtained with moderate precursor 
concentrations. At 9 mM and 18 mM, the fluorination yields were 12.0 ± 1.7 % (n=3) and 11.6 ± 
0.3 % (n=3), respectively. We chose 12 mM for subsequent experiments to study of the effect of 
TEMPO concentration on the fluorination step (Figure 8-4B). The fluorination yield was only 6.5 
 
 
 
211 
 
 
± 0.1 % (n=2) without any TEMPO but nearly tripled (18.8 ± 0.2 % (n=2)) when 80 mol% TEMPO 
was added. The improvement was mainly due to an increase in fluorination efficiency from 23 ± 
1 % (n=2) to 53 ± 2 % (n=2), respectively, though a small increase in radioactivity recovery (from 
28 ± 2 % (n=2) to 35 ± 2 % (n=2), respectively) was also observed. Next, we studied the effect of 
the amount of base, keeping the ratio of K222 at K2CO3 fixed at 2.05. (Figure 8-4C). As the amount 
of base was increased, starting from 21 nmol K222 / 10 nmol K2CO3, the fluorination yield rose 
sharply and reached the maximum, 21.89 ± 0.02 % (n=2) at 84 nmol K222 / 41 nmol K2CO3). The 
fluorination yield remained relatively constant up to ~252 nmol K222 / 123 nmol K2CO3 (18.8 ± 1.7 
% (n=2)), and then began to drop significantly as base amount was further increased. Thus, for 
the later deprotection study, we picked 75 mol% TEMPO, 9 mM precursor solution, 84 nmol K222 
/ 41 nmol K2CO3 as base amount.  
 
 
Figure 8-4. Optimization of microdroplet synthesis of [18F]FDOPA using the manual setup.  
(A) Effect of precursor concentration. (B) Effect of TEMPO concentration. (C) Effect of base 
amount, represented by K222 amount, which is 2.05 times of K2CO3 amount. Data points represent 
average values and error bars represent standard deviations. For 70 and 90 mol % datapoints in 
(B), n=1, and the rest of datapoints have n=2. For datapoints in (C), n = 2.  
 
Deprotection was performed immediately after fluorination, with no intermediate purification 
step. To assess the performance of this step, the [18F]FDOPA conversion after deprotection was 
assessed via radio high-performance liquid chromatography (HPLC). Crude radiochemical yield 
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(RCY, decay-corrected) was defined as the radioactivity recovery times the [18F]FDOPA 
conversion. Isolated RCY was defined as the ratio of radioactivity of the purified product 
(recovered from the same analytical-scale radio-HPLC) to the starting radioactivity on the chip. 
Preliminary optimization of the deprotection step (deprotection reagent, concentration, reaction 
temperature and reaction time) is summarized in the Appendix, Table 8-2. Even though the 
overall crude RCY and isolated RCY were below 10% due to performing these experiments 
starting with non-optimal fluorination conditions (i.e. 20 mol% TEMPO, 36 mM precursor, 84 nmol 
K222 / 41 nmol K2CO3), comparative conclusions could still be drawn.  Performing deprotection 
with 6 M H2SO4 at 115°C enabled the highest RCY. Combining these conditions with the optimal 
fluorination conditions, [18F]FDOPA could be produced on the chip with crude RCY of 11% (n=1) 
and isolated RCY of 7.2 % (n=1). By adding a cover plate over the droplet during deprotection 
(see Appendix, Figure 8-6 and Table 8-3), the crude RCY and isolated RCY could be further 
increased to 14.3 ± 0.5 % (n=2) and 10.0 ± 0.7 % (n=2), respectively. Noting that the [18F]FDOPA 
conversion was only 84 ± 5 % (n=2) at 115°C, indicating the deprotection reaction was not 
complete, we increased the deprotection temperature to 125°C and the conversion improved to 
95% (n=1). 
Finally, we performed full (manual) syntheses including analytical-scale HPLC purification and 
formulation. The fluorination conditions were 75 mol% TEMPO, 9 mM precursor solution, 84 nmol 
K222/41 nmol K2CO3 at 105°C for 5 min, and the deprotection conditions were 6M H2SO4 at 125°C 
for 5 min (with cover plate). The resulting crude RCY and isolated RCY were 20.5 ± 3.5 % (n=3) 
and 15.1 ± 1.6 % (n=3), respectively (Table 8-1). An example of a radio-HPLC chromatogram of 
the crude product is shown in the Appendix, Figure 8-7A, and a co-injection with L-DOPA and 
D-DOPA reference standards to determine enantiomeric purity (98.0 ± 0.2 (n=3)) is shown in the 
Appendix, Figure 8-7B. The retention time of [18F]FDOPA was ~6 min, and the chromatogram 
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was relatively clean with no nearby side-product peaks, despite omission of the intermediate 
cartridge purification between fluorination and deprotection steps [38]. The overall synthesis time 
was only ~40 min, including ~25 min for initial drying of [18F]fluoride and the two reactions, ~7 min 
for purification and ~8 min for formulation. 
 
8.3.2. Optimization of automated synthesis 
Considering the accuracy of droplet volume dispensed by the dispensers (~10%) studied 
previously, we adjusted some concentrations so the overall synthesis would be more robust and 
repeatable, and tolerant of volume errors. The optimal condition was selected where the slope of 
the optimization curves (in Figure 8-4) was close to zero.  Automated syntheses were performed 
with 80 mol% TEMPO, 12 mM precursor solution and 101 nmol K222 / 49 nmol K2CO3.  
Benefiting from the automated dispensing system, the frequency of replenishing solvent during 
heated reactions could be increased (up to several droplets per second, compared to one droplet 
per ~7s via manual dispensing), and we therefore briefly explored higher fluorination 
temperatures. As shown in Figure 8-5, with the increase of reaction temperature from 100°C to 
140°C, even though the fluorination efficiency increases from 58 ± 3 % (n=3) to 95 ± 1 % (n=2), 
the radioactivity recovery fell from 36 ± 4 % (n=3) to 27.3 ± 0.3 % (n=2). Due to these opposite 
effects, the overall fluorination yield was relatively constant (~26%) for temperatures above 
105°C. Overall, 120°C reaction temperature resulted in the highest fluorination yield of 26.9 ± 1.3 
% (n=2) and was chosen as the optimal reaction temperature for the automated synthesis. As 
shown in Table 8-1, with full automated synthesis, the crude RCY and isolated RCY were 15.2 ± 
2.1 % (n=3) and 10.3 ± 1.4 % (n=3), respectively. Both are slightly lower than the manual 
synthesis, which is commonly occurs when transferring from manual to automated synthesis 
protocol. We note that the [18F]FDOPA conversion was lower for the automated synthesis (i.e., 
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78 ± 4 % (n=3) vs 95.6 ± 0.4 % (n=3), respectively), likely due to the absence of the cover plate, 
which was omitted to avoid the need for manual intervention during operation, while the 
radioactivity recoveries of both methods were comparable (20 ± 2 % (n=3) vs 21 ± 4 % (n=3), 
respectively). To further increase the [18F]FDOPA conversion, we attempted performing the 
deprotection step at even higher temperature (130°C), but significant side products appeared..  
The synthesis time was ~22 min, which was slightly faster than the manual synthesis (~25 min) 
due to the automation steps. 
 
 
Figure 8-5. Optimization of reaction temperature.  
(A) Effect on the fluorination yield. (B) Effect on the radioactivity recovery. (C) Effect on the 
fluorination efficiency. Datapoints represent average values and error bars represent standard 
deviations. For 100, 105, 110, 120, 130, and 140°C datapoints, the number of replicates is n = 3, 
2, 3, 3, 2, 2, respectively. 
 
Compared to macroscale methods for [18F]FDOPA synthesis using the same precursor and 
route, the microscale method, with 10 μL reaction volume, used significantly less precursor, i.e. 
0.12 μmol versus 16.8 μmol [141] or 13.4 μmol [38]. The small mass of reagents and small volume 
collected from the chip (~80 µL) furthermore facilitated the use of analytical-scale HPLC to 
perform purification. This enabled rapid purification (~7 min) and also needed only a short time 
for formulation (~8 min). Overall the synthesis time with the microdroplet reactor was ~37 min, 
compared to ~71 min [141], or ~117 min [38] in conventional radiosynthesizers. In fact the isolated 
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non-decay-corrected yield of the microscale method 8.2 ± 1.1 % (n=3) (was higher than both 
macroscale approaches, i.e.  2.9 ± 0.8 % (n=3) [141] and 6.7 % ± 1.9 % (n =?) [38]. 
 
Table 8-1. Comparison of microscale [18F]FDOPA synthesis performance using manual and 
automated approaches.  
All values are averages ± standard deviations for the indicated number of replicates. All 
percentages are decay-corrected. N.M. indicates the quantity was not measured. 
 Manual synthesis (n=3) 
Automated synthesis 
(n=3) 
Starting activity (MBq) 4.4 ~ 12.2 12.6 ~ 22.9 
Synthesis time including purification (min) ~40 ~37 
[18F]FDOPA conversion (%) 95.6 ± 0.4 78 ± 4 
Crude RCY (%) 20.5 ± 3.5 15.2 ± 2.1 
Isolated RCY (%) 15.1 ± 1.6 10.3 ± 1.4 
Enantiomeric purity (%) 98.0 ± 0.2 N.M. 
Total activity loss during overall synthesis (%) 50 ± 5 78 ± 2 
Unrecoverable activity on cover chip (%) 24.7 ± 0.3 NA 
Unrecoverable activity on bottom chip (%) 2.1 ± 0.4 2.9 ± 0.2 
Radioactivity recovery (%) 21 ± 4 20 ± 2 
 
8.4. Conclusion 
A straightforward synthesis for [18F]FDOPA using the diaryiodonium salt-based route was 
implemented in microscale for the first time. Through optimizing various parameters (base 
amount, precursor concentration, reaction temperature, etc.…) and adding a radical scavenger 
(i.e. TEMPO), a moderate yield could be achieved reliably.  With manual operation, the isolated 
RCY (decay corrected) was ~15%, which slightly exceeded the highest reported macroscale 
synthesis (~14%) [38]. Furthermore, the non-decay corrected isolated RCY of manual synthesis 
was 11.9%, significantly higher than 6.7% [38] and 2.9% [141] of the diaryliodonium precursor-
based macroscale synthesis The synthesis was automated using a novel, ultra-compact 
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microdroplet reactor. By performing synthesis in the microdroplet, the tedious and time-
consuming solid-phase extraction process and evaporative solvent exchange (for intermediate 
purification between fluorination and deprotection) could be eliminated while still achieving 
comparable yields and a crude product that could be easily purified with analytical-scale HPLC. 
Due to this change and the rapid heating, cooling, and evaporation of small volumes, the overall 
synthesis time was shortened significantly (~37 min vs ~71 min or ~117 min). Another prominent 
benefit brought by this microscale synthesis was substantial reduction (> 100x) reduction in 
precursor consumption, which could significantly lower the cost per batch of [18F]FDOPA. At the 
time of writing, the retail price of the precursor is ~$600 per batch using the macroscale approach. 
While the volume of the droplet reactor is very small, integration with a radionuclide 
concentrator[81] can be used to safely increase the production scale to clinically-relevant levels, 
while also providing advantages of a very compact system (enabling easy shielding) and the 
possibility of performing multiple syntheses in a single day. 
8.5. Appendix 
8.5.1. Optimization of deprotection step 
Using single-reaction microfluidic chips, the influence of several deprotection reaction 
parameters was investigated, including type of acid (HCl and H2SO4), acid concentration, reaction 
time, and reaction temperature. These experiments were performed prior to complete optimization 
of the fluorination step, and used 84 nmol K222, 41 nmol K2CO3, 36 mM precursor, and 20 mol% 
TEMPO. Results are tabulated in Table 8-2. 
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Table 8-2. Effect of various deprotection conditions (without cover plate).  
Radioactivity loss indicates the combined activity losses (due to formation of volatile species) 
during evaporation, fluorination and deprotection steps. Percentages are corrected for decay. For 
most conditions, only n=1 experiment was performed. * indicates n=2 replicates were performed, 
and values indicate average ± standard deviation. 
Deprotection reagent HCl H2SO4 
Concentration (M) 6 3 6 
Deprotection time (min) 5 10 15 15 5 5 
Deprotection temperature (°C) 90 90 90 100 100 120* 130 140 
Radioactivity loss (%) 86 88 86 88 78 84 ± 3 90 87 
Residual activity on chip (%) 3 1 2 1 3 3 ± 1 2 2 
Radioactivity recovery (%) 8 8 10 8 15 9 ± 1 6 7 
[18F]FDOPA conversion (%) 24 37 53 72 42 87 ± 1 83 92 
Crude RCY (%) 2.0 3.1 5.2 5.5 6.3 7.2 ± 0.5 4.9 6.8 
Isolated RCY (%) 1.4 2.7 4.0 4.5 4.5 4.8 ± 0.6 3.2 3.7 
 
 
For some experiments, a cover chip consisting of a Teflon-coated glass slide (25 mm x 25 mm) 
was positioned 150 μm above (resting on spacers along the chip edges) above the reaction 
mixture to reduce evaporation (Figure 8-6). In this experiments, extra dilution and collection 
processes were performed to recover the crude product from the cover chip as well as the 
(bottom) chip.   
 
Figure 8-6. Schematic of [18F]FDOPA synthesis process when a cover plate is used during 
the deprotection step.  
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A detailed comparison of the reaction performance with and without the cover plate is 
summarized in Table 8-3. 
 
Table 8-3. Effect of cover plate on the synthesis performance.  
Radioactivity loss indicates the combined activity losses (due to formation of volatile species) 
during evaporation, fluorination and deprotection steps. Percentages are corrected for decay. 
Values of the group with cover plate indicate average ± standard deviation computed from the 
indicated number of replicates. 
 No cover plate (n=1) 
With cover plate 
(n=2) 
Radioactivity loss (%) 84 53.7 ± 0.4 
Residual activity on cover chip (%) NA 26 ± 2 
Residual activity on bottom chip (%) 3 1.5 ± 0.2 
Radioactivity recovery (%) 12 17 ± 2 
[18F]FDOPA conversion (%) 91 84 ± 5 
Crude RCY (%) 11.0 14.3 ± 0.5 
Isolated RCY (%) 7.2 10.0 ± 0.7 
 
 
8.5.2. Example radio-HPLC chromatograms 
 
Figure 8-7. Examples of analytical radio-HPLC chromatograms. 
(A) Crude [18F]FDOPA product, (B) purified [18F]FDOPA product coinjected with a mixture of 
reference standards of both D-FDOPA and L-FDOPA. 
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9. Chapter 9: Outlook 
9.1. Overview 
In Chapter 1 of this dissertation, I illustrated the advantages of applying microfluidic 
technologies for radiosynthesis of PET tracers and summarized the batch-mode microfluidic 
devices that have been developed for radiosynthesis, i.e. the “coin-shaped” reactor, EWOD 
droplet reactor, etc… Despite our group having reported successful production of tracers using 
the EWOD radiosynthesizer, routine use was limited by the complex fabrication (requiring many 
processing steps) and high chip cost as well as the suboptimal reliability of the chips (due to the 
difficulty in producing dielectric layers that were free of defects across the entirely of the (large) 
chip surface area, and the tendency of the Teflon layer to delaminate from the dielectric layer 
during certain reaction steps.) 
Thus, in Chapter 2, I described efforts to optimize the fabrication of EWOD chips (i.e. 
improving Teflon adhesion to the dielectric layer, and improving the deposition of the dielectric 
layer) to improve their reliability. With the resulting changes, reliability was significantly improved 
with very few failures during radiochemical processes and I demonstrated the successful 
production of several tracers with the improved EWOD chips. However, even after optimization, 
the fabrication cost remained high and costs could not be reduced to a level compatible with the 
idea of disposable-use chips.  
To further lower the production cost of PET tracers, in Chapter 3, I developed a significantly 
simpler microfluidic chip for droplet radiosynthesis by leveraging an alternative passive method 
of droplet manipulation method for tracer production. The chip was integrated with a fully-
automated standalone [18F]fluoride concentrator in Chapter 4 to produce clinical-grade tracer 
(several doses) that passes all quality control (QC) tests. In Chapter 5, I showed that the chip 
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could be even further simplified and the overall system could be implemented in a very compact 
platform for automated microdroplet-based radiosynthesis. A further advantage of the chip was 
that the reaction site matched exactly the “model chips” used for reaction optimization, eliminating 
the need for additional re-optimization that was needed to implement syntheses on the passive 
chip platform. 
To further reduce the time needed for reaction optimization, I worked on developing some 
technologies (high-throughput radio-TLC analysis in Chapter 6, high-throughput multi-reaction 
microfluidic chip in the Chapter 7) to enable radiochemistry to be performed in a high-throughput 
fashion to relieve operators from tedious and repetitive work. These technologies facilitate 
extensive synthesis optimization studies for new tracers in a short time-frame. 
Finally, in Chapter 8, I described the application of these technologies to optimize and 
automate the synthesis of [18F]FDOPA in microdroplet format.  
9.2. Outlook for droplet-based radiosynthesizers 
While my work focused mainly on the central reaction steps of the radiosynthesis process, the 
droplet-based radiosynthesizers that I developed, i.e. the passive transport-based reactor and the 
microdroplet reactor, can be integrated with other miniaturized components in order to automate 
the full radiosynthesis process (including radionuclide concentration, tracer synthesis, purification 
and formulation). 
For example, integration with an upstream radionuclide concentrator [37] was demonstrated 
in Chapter 4, and I have developed a prototype system for automated injection of the collected 
crude product into an analytical-scale radio-HPLC system for purification. The purified fraction 
could then be connected to a downstream microfluidic-based formulator, as developed in our lab 
[83]. To automate the purification process, an electronically-controlled injection valve (8 ports, 2 
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position) in conjunction with tubing liquid sensors can be used to load the crude product (collected 
automatically into a vial as the last stage of the microdroplet radiosynthesis) into an injection loop 
for analytical-scale HPLC purification. Real-time analysis of the chromatogram (or semi-manual 
operation) could be used to collect the desired fraction, and this fraction could be automatically 
transferred to the microfluidic tracer formulator to resuspend the tracer into an injectable solution. 
With the fully automated synthesis using all components, the need of manual intervention is 
eliminated, simplifying operation and protecting personnel from radiation exposure.  
In addition to the synthesis of [18F]fallypride, [18F]FDG, [18F]FDOPA demonstrated here, the 
droplet-based radiosynthesizer can also be used for the synthesis of other PET tracers, such as 
[18F]FET, [18F]Florbetaben, [18F]FLT and so on, which we have recently shown can be synthesized 
with high efficiency in the microdroplet format. The setup could also be applied to labeling with 
other isotopes such as radiometals (68Ga, 177Lu, etc.) for both imaging and targeted radionuclide 
therapy applications. Other than production of such radiopharmaceuticals, the microdroplet 
reaction system could also be applied to small scale chemical reactions or assays, where compact 
apparatus and/or small reagent volumes are critical. 
However, due to the special reaction mode (open chip), there are some limitations on the types 
of reactions can be performed on the droplet-based chip. Syntheses involving volatile precursors, 
intermediates, or products, such as [18F]Fluorobenzaldehyde and [18F]AMBF3-TATE [67], have 
exhibited low crude radiochemical yield (RCY) in the droplet-based chip, due to significant amount 
of reagent or labelled compound loss. Though useful amounts of product can be obtained, 
engineering improvements may be helpful in reducing the losses. Furthermore, routine use in 
such cases would require a means to manage the released compounds to avoid radiation 
exposure and releases to the environment. 
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To overcome this challenge, several strategies can be employed. For example, by adding a 
cover chip during the reaction, the emission of volatile species can be significantly reduced. 
Alternatively, a small suction system incorporated with adsorbents could be positioned inside the 
shielding box to ensure safe operation by containing any releases.   
9.3. Outlook of the high-throughput droplet-based radiosynthesizer 
The high-throughput methods I developed can be used to optimize the synthesis of new or 
existing tracers or compounds. With each reaction performed in a microdroplet, reagent 
consumption during the optimization process is minimized, and many reactions can be carried 
out in parallel from the same batch of radionuclide. Though in this study we examined the effect 
of reaction volume and reagent concentrations, one could also study variables such as reaction 
temperature or time, by using multiple heaters, or by running multiple chips sequentially on the 
same heater. Further increase in throughput could be accomplished by operating multiple heaters 
(and multiple chips) in parallel. 
Even though the operation of synthesis (like reagent loading and collecting) is manually 
performed using a pipette, our lab is currently developing a compact robotic system to automate 
those operations. With the robotic system, it is expected that the synthesis time can be further 
reduced and operators can be relieved of tedious reagent and sample handling and can be better 
protected from radiation exposure. Such automated operation may also make it possible to do 
even larger numbers of experiments per day. 
9.4. Dissemination of technologies to the community 
With the high-throughput droplet-based radiosynthesizer and automated droplet-based 
radiosynthesizers, we envision much greater efficiencies in the field of radiochemistry. The high-
throughput platform will enable more rapid and thorough synthesis optimization studies, which will 
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be especially beneficial during early tracer development when very little starting materials are 
often available for synthesis. The compact droplet-based synthesizer will enable far more reagent, 
time, and space-efficient radiosyntheses. The droplet synthesizer also offers advantages such as 
improved molar activity and less reagent waste when producing small batches of tracers, and 
simplified purification due to reduced amounts of toxic reagents and impurities. 
One way these technologies could be deployed is through commercialization of the two 
instruments. While the droplet synthesizer will be practical for most radiochemists to install and 
operate, the high-throughput system is far more bulky, costly, and complex to operate. For 
application-focused users, e.g. pharmaceutical companies that need to produce a new tracer for 
studying pharmacokinetic properties and biodistribution, or academic researchers developing a 
novel tracer for a new biological target, an interesting model may be to house this technology in 
a core facility to avoid the need for investment in the platform, radiation shielding (hotcells or 
minicells) and personnel training. The core facility could perform basic development of a droplet-
based synthesis protocol, and the end user could implement this optimized protocol on their own 
compact droplet synthesizer. With this workflow, users can maximize the benefits of these new 
technologies with lower investment.  
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